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This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

The Broken Hip
“ Breaking a hip” usually refers to frac
ture of the upper part of the femur
through the neck or in the region of the
trochanters. In either location, hip frac
tures present clinical problems that may
lead to death or loss of independence for
an elderly person. Women are particularly
at risk since they are most affected by
osteopenia and many of them live alone.
The incidence of hip fractures in North
America is approximately 5 per 1000 peo
ple between the ages of 70 and 79 years
and 20 per 1000 between 80 and 89 years;
71% of victims are women (mean age 73
years).1
In a study from the Mayo Clinic,2
proximal femoral fractures amounted to
30% of all admissions to hospital for
fractures and 50% of all days spent in
hospital for their treatment.
Several publications from Europe have
suggested that there has been a substan
tial increase in the incidence of hip frac
tures.3'5 Melton and colleagues2 on the
other hand have shown that the increase
is the result of a larger elderly population.
When sex- and age-specific tests are
applied, there does not appear to be a rate
increase. Any increase in total numbers
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Intertrochanteric fractures on the other
hand do not affect the blood supply to
the femoral head. They do, however,
occur at an angular location in the femur
where there are major bending moments.
These fractures are unstable — often the
thin bone in that region o f the femur is
shattered. The fracture usually occurs in
bones that are moderately or severely
osteoporotic. Internal fixation is essential
for treatment.
Zukor and colleagues, in this issue
(pages 391 to 395), compare two tech
niques of internal fixation for inter
trochanteric fractures. There is little to
choose between them: in one technique,
the long, curved, steel rods of Ender are
introduced through a small port in the
lower inner aspect of the femur just above
the knee joint. Three to five rods are
pushed up the medullary cavity o f the
femur until their pre-curved leading upper
ends are located in the femoral head. The
advantage of their use is in the small sur
gical procedure required, using a wound
remote from the fracture site and the
patient’s groin. There were no operative
infections in the reported series o f 53
cases. The other technique involves open
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of fractured hips does, however, imply a
need for additional health resources. In
Scandinavia, the average hospital stay is
24 days during which the mortality is
8.6%. The mortality at 1 year is 27%.
Thereafter, it is similar to that of the nor
mal population.6
In Canada, the average length of hospi
tal stay is closer to 12 days but that applies
only to acute-care hospitals. The inhospital stay would increase if convales
cent, rehabilitation and chronic-care
hospital days were included.
Fractures of the femoral neck within
the capsule of the hip joint (subcapital)
damage, to a variable extent, the blood
supply of the femoral head. If the head
dies, it will collapse between 1 and 2 years
from the time of fracture. The fracture
may in the meantime heal, but the head
becomes deformed and the joint painful
and stiff. In treating femoral neck frac
tures, it is most important to reduce the
fracture as accurately and as soon as pos
sible if blood flow to the head is to be
maintained. The reduction must be held
by internal fixation using a device that can
adapt to minor shortening of the femoral
neck as the fracture settles.
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reduction and internal fixation using a
compression screw and a sliding, fixedangle nail plate. It is a bigger operation,
takes longer and, in Zukor’s series, was
accompanied by infection in seven
patients (13.7%), two of whom died.
Why not manage all intertrochanteric
fractures with Ender rods? In fact, in
Z ukor’s series there was a higher inci
dence o f reoperation with Ender’s rods
due to their migration inside the femur,
an increased incidence of cardiovascular
complications and an increased overall
mortality. Not enough experience has
been gained to favour one method over
the other. Close matching of many more
patient pairs is required to draw reliable
conclusions.
In the first half of this century and
before, breaking a hip was often the last
significant physical act in the lives of the
elderly. I vividly remember the day

George Bernard Shaw fell from a ladder
as he pruned an apple tree. His hip broke
and he died shortly after that. He was one
of many elderly but otherwise well, think
ing, productive people for whom, now,
a broken hip is an unfortunate and pain
ful incident in life but not necessarily the
finale. With present techniques, survival
is usual and return to normal living,
common.
Two main events have made possible
this remarkable change: the development
in 1912 of stainless steel and in 1925 the
invention of the three-flanged hip nail by
Smith-Petersen. The quality and proper
ties of steel have been refined since then.
The design of the fixation device and the
surgical procedure have greatly improved.
With safe anesthesia and bold rehabilita
tion, the majority of patients no matter
how old are returned to their preinjury
state. Patients are out of bed within 48

hours, before bed sores, pneumonia and
bladder infection develop.
While the treatment of broken hips has
improved substantially the prospects for
survival and return to normal living, hip
fracture is still a dangerous injury.
Attempts at reducing the frequency of its
occurrence, often from minor trauma,
should be directed at the treatment and
prevention o f its underlying cause,
osteopenia of the ageing population.
Charles Sorbie , mb, ch b, frcs, frcsc
Member,
Editorial Board.
Professor and Head,
Department of Surgery,
Queen’s University,
Kingston, Ont.
K7L 3N6
continued on page 395

SESAP IV Question

IT E M 247

A man sustains blunt chest trauma causing a pneumothorax and multiple rib fractures. After several sequential tube
thoracostomies, the chest roentgenogram shown above is obtained 15 days later. His temperature is now 39.2 C. He has
mild pleuritic pain, and the chest tube is no longer draining. The best management would be
(A)
(B)
(C)
(D)
(E)

a ten-day course of systemic antibiotics
multiple additional chest tubes
thoracotomy and evacuation (decortication) of the pleural cavity
instillation of enzymes via the chest tube
instillation of antibiotics via the chest tube

For the incomplete statement above select the one answer that is best of the five given. For the critique of Item 247 see
page 458.
(Reproduced by permission from SESAP IV Syllabus; Surgical Education and Self-Assessment Program No. 4. For enrol
ment in the Surgical Education and Self-Assessment Program No. 4, please apply to the American College of Surgeons,
55 East Erie St., Chicago, IL 60611.)
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CORRESPONDENCE
►

Contributions to the Correspondence section are welcomed.
They should be written and double spaced.

*

^

r

Penile Dressing After
Hypospadias Surgery

^

To the editors.—A successful result fol
lowing hypospadias repair, or any penile
surgery requiring penile skin flaps or skin
mobilization, depends on the following
factors among others:

.

Comments

► ~‘l

r

y
.

^

^
y

"

• Adequate tissue vascularity.
• Absence of excessive edem a1,2
postoperatively, since its presence may
enhance thrombosis of the small vessels
and prevent formation of new vessels to
the flap.
• Absence of hematoma1,2 within the
skin flap.
• Adequate immobilization of the
penis postoperatively.
• Avoidance of excessive pressure on
the tissue due to very tight dressings.
The wide variety of dressings used1'3
after penile surgery, especially hypospadias
repair, suggests the lack of a simple, ade
quate dressing that will meet most of the
criteria. We describe a simple, effective
penile dressing for hypospadias repair that
we believe may be similarly employed in
other reconstructive penile surgery, particularly to reduce edema, bleeding and
hematoma.

^

Technique

r

Early in the operation, a 2-0 Prolene
suture is inserted through the glans penis,
with the needle left on; it is used for
retraction of the penis. At the end of the
surgical procedure, three to four plain
gauze dressings are tightly rolled into a
cylinder. The cylinder is placed trans-

»
*

versely over the suprapubic area behind
the dorsal aspect of the penis (Fig. 1). The
Prolene suture is passed through the skin
of the suprapubic area above the cylinder
of dressing so that the penis is hyperextended over the cylinder of the dressing.
The tension in the Prolene suture can be
varied to maintain hemostasis.

The advantages of this simple dressing
are as follows:
• Postoperative edema is markedly
reduced, decreasing morbidity and
enhancing primary healing.
• The penis is adequately immobi
lized, giving the tissues optimal healing
conditions.
• Bleeding, especially from the cor
pora cavernosa, may be further controlled
by either increasing the bulk o f the
cylinder or the tension on the Prolene
suture without compromising the surgi
cal suture lines or the skin flaps.
• Since no part of the wound is occlusively covered, it is easy for both the med
ical and nursing staff to examine and
assess the surgical repair.
• Fecal soiling of the dressing, as may
occur in children, is completely eradi
cated.

G .G . L ip p e r t ,

Penile erections, when they occur with
this dressing, may be slightly painful but
are not a serious problem.

Ste. 305,
18 Pine St.,
Kitchener, Ont.
N2H 5Z8

Benjam in A. O kafo , md
H . G. K iru lu ta , m d , frcsc

Reference

Health Sciences Centre,
Memorial University of Newfoundland,
St. John’s, Nfld.
A1B 3V6

References
I. Matielaer JJ, Baert L, van Dorpe EJ; Silastic foam
dressing — the.ideal penile dressing. Urology 1983; 22: 68
2. C romie WJ, Bellinger MF: Hypospadias dressings and
diversions. Urol Clin North A m 1981; 8: 545-58
3. FALKOWSKI WS, F irlit CF: Hypospadias surgery: the Xshaped elastic dressing. J Urol 1980; 123 : 904-6

FIG. 1—Penis hyperextended over cylinder
of gauze dressings with suture through supra
pubic area.

March 1985, pages 183 to 186), I was
pleased to read the article by A. Camp
bell Derby, entitled “ The military
surgeon—not least in the crusade” .
Regarding the Canadian field surgical
team in Korea attached to 8055 MASH
for 90% or more of its tour, Dr. Richard
Hooker was an American surgeon who
wrote the book MASH and wrote under
a pseudonym. His proper name is Richard
H. Hornberger, and he practises thoracic
surgery in Maine. I met him in Toronto
at the Mount Sinai Hospital, several years
after working with him and other sur
geons at MASH 8055. The 25th Canadian
field surgical team serving in Korea was
commended by General James van Fleet
during its tour of duty there, thus:

The Military Surgeon
To the editors.—In a recent issue (vol. 28,

Van Fleet wrote that the Canadian unit,
which had augmented the surgical section of
an American army mobile from May to
August, “ showed resourcefulness and initia
tive in integrating themselves into the hospi
tal, working tirelessly for extremely long hours
in order that the wounded might receive
prompt care” .
Attention was given to medical officers
Major Charles Egan of Kingston, Major G.G.
Lippert of Kitchener and Captain William
Crawford of London, Ontario, and also to the
enlisted men of the unit.1
m d , c m , frcsc , facs

1. Van Fleet praises 25th surgical team, Kitcheher- Waterloo
Record, 1951

Transluminal Angioplasty in
Peripheral Vascular Disease
To the editors.—We have read Sheiner’s
editorial (Can J Surg 1985; 28: 193-4),
commenting on our article on translumi
nal angioplasty for advanced peripheral
vascular disease (Can J Surg 1985; 28:
150-2). First, we do not calculate our ini
tial success rate to be 41%; 70% of
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patients had a lessening of symptoms or
return of previously absent pulses, or
both, after dilatation. Repeat angioplasty
was performed in nine patients, but the
interval between first and second
angioplasty ranged from 2 to 51 months.
Whether the success rate is 41% or
70%, the important issue raised in our
article is that dilatation can be successful
in many of these high-risk patients with
advanced peripheral vascular disease
using percutaneous translu m in al
angioplasty. Morbidity and mortality are
low and surgery remains an option.
Robert M aggisano, md , frcsc
Beverly A. J ones , md , frcsc
E ric Saibil , md , frcpc
Sunnybrook Medical Centre,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5

Splenectomy for Idiopathic
Thrombocytopenic Purpura
To the editors.—The report by Roy, For
tin and Leblond on splenectomy for idi

opathic thrombocytopenic purpura (Can
JSurg 1985; 28; 160-2) appears to present
a skewed view of pulmonary complica
tions following this procedure. They
report an incidence of 66% for those who
had the splenic bed drained versus 20%
for those who did not; the overall pulmo
nary complication rate was 27.5%. A
review of complications in a similar group
of adult patients with steroid-resistant idi
opathic thrombocytopenic purpura in our
hospital revealed only one pulmonary
complication in 24 cases (4%), in a patient
not having drainage postoperatively. I
agree that morbidity is increased substan
tially with drainage of the splenic bed; 5 of
9 patients drained (56%) had a postoper
ative complication, while only the pulmo
nary complication was noted in the 15
patients not drained (7%). The compli
cations in our series were deep venous
thrombosis, subphrenic abscess, upper
gastrointestinal bleeding and wound
infection.
Roy and colleagues mention two
studies1,2 in which the pulmonary com
plication rate was 5.8% and 4.4%; these
figures appear more accurate for this
complication. The incidence of pulmo
nary complications is increased following

removal of greatly enlarged spleens, as
might be expected. Effusion and atelec
tasis have an incidence of 38% and
21 %3 respectively while there is no
increase in the risk of pneumonia.4
It would be interesting to know, in
Roy’s study, the breakdown of pulmo
nary complications and whether spleno
megaly might have affected their pulmo
nary complication rate. This may well be
a more important factor in creating this
complication than the presence or absence
of a drain.
T imothy W esley-J ames, md
Resident in Urology,
Ottawa Civic Hospital,
1053 Carling A ve.,
Ottawa, Ont.
K1Y 4E9
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Canada Health Act Court Action

y

*■

►

y

y

Whether or not the legal representatives
of the Canadian Medical Association
enter a courtroom this month to argue
with their counterparts who are acting on
behalf of the federal government and the
Province of Ontario about the constitu
tionality of the Canada Health Act and
of the province’s compliance, new CMA
president, general surgeon William J.
Vail, of Newmarket, Ontario, says he’s
not holding his breath about a final
decision.
In an interview with CJS, Vail declined
to speculate on the implications of win
ning or losing the historic argument with
government, but he alluded to the ration
ale behind the CMA’s action, citing as
one of the priorities during his term of
office “ to ensure or try to ensure that the
interests of the members of the profession
are protected,” particularly when “ gov
ernments at whatever level interfere with
the doctor-patient relationship” .
In mid-July, the CMA challenged the
federal government’s authority to dictate
how the provinces must run health insur
ance programs if they want to draw on
federal coffers for part of the costs of care
and alleged that the conditions governing
the cost-sharing arrangements were incon
sistent with the Canadian Charter of
Rights and Freedoms. The Association
filed a statement of claim in the Supreme
Court of Ontario that Ontario — in com
plying with the Canada Health Act — was
impinging on the personal rights of Dr.
James McPhee and Ruby Evelyn Kelley.
On the one hand, the province requires
Ms. Kelley to be a member of the health
insurance plan and, on the other, refuses
to reimburse her for the costs of health
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.

care from McPhee, even though the serv
ices are insured under the plan and
McPhee is a qualified medical practitioner
as defined by the Canada Health Act.
Vail took office just days after
Canada’s attorney general denied allega
tions, maintaining that any infringement
was within justifiable limits.
Said Vail, “ The subject matter is basi
cally out of our hands now as far as mak
ing any influence. We’ve made our deci
sions and the matter is now a judiciary
type of process.”
Out of the Association’s hands, per
haps, but not far from its thoughts, as
Vail’s list of priorities showed. During his
presidency Vail aims to deal with the
issues surrounding the numbers o f phy
sicians in Canada and to continue to let
the public know that health services are
not being adequately funded.
While none of Vail’s priorities promises
to be free of controversy, he is reasona
bly comfortable with medical politics. He
has been a long-time member of , the
Ontario Medical Association, has held a
variety of offices for the provincial body
since the mid-1960s and chaired the board
of directors of the national association
from 1981 to 1983.

CMA Secretariat to
Investigate Organ Shortage
Over the next year, the secretariat of
the Canadian Medical Association will be
collecting statistics on the numbers of
people who are awaiting organs for trans
plantation and will be investigating ethi
cal means of alleviating any shortage.
The CMA’s Committee on Ethics has
reported that “ there is a recurrent,
though implicit, criticism of physicians

CMA President William Vail

for failing to persuade relatives to autho
rize the removal of healthy organs from
recent victims of sudden an d /o r acciden
tal d e a th ,” and th a t “ when the
patient/victim has already manifested his
(or her) consent, such as by signing the
appropriate portion of his (or her)
driver’s licence or some other consent
form , no other consent is legally
required.”
Between the lines in the committee’s
report was the space separating firstco n tact physicians fro m surgical
specialists on the issue. CMA President
Bill Vail as chief of surgery and, since
1963, consulting surgeon for York
County Hospital, acknowledged the
dilemma of needing vital organs to save
lives and of asking a bereaved family for
organs from an individual who, though
clinically dead, is still alive to them. “ I
think it’s a matter of public relations —
in other words, getting you and me as
members of the public to know that such
situations take place so that when it does
happen to us we are better prepared to
deal with it. My experience is that most
people — most next of kin — are amena-
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ble but I have encountered next of kin
who are not and they have their own good
private reasons.”
Dr. Wilbert J. Keon, director general
of the University of Ottawa Heart Insti
tute, agrees but is keenly aware of the res
trictions engendered by a shortage of
healthy organs. Said Keon, in an inter
view with CJS, “ The major problem is
the reluctance of physicians, out of
respect to the grieving family, but there
is nobody who can do this as effectively
as the family physicians. There is an obli
gation on the part of all medical practi
tioners to see that healthy organs are not
wasted, given the tremendous success of
kidney transplant programs and, to a
lesser degree, heart and liver transplants.
Our own experience in heart transplan
tation is a good example. We have done
six transplants successfully, and 24
patients expired while on the transplant
list. The experience is universal. Vital
young people are expiring from single
organ disease. One week we had an
18-year-old and a 22-year-old girl expire
just because they needed a heart. This is
tragic.” Currently, the institute has eight
patients who will die without a new heart
— two are too sick to leave hospital.
A look at five healthy people who
received another heart to live through
Keon’s hands clarifies the frustration of
knowing that healthy organs are on their
way to the grave. At the end of next
m o n th , the th ird recipient, Clive
Devereaux, will have survived a year.
A new organization that may be able
to play the public relations role envisioned
by Vail is called Transplant International.

Launched on July 18 at University Hospi
tal in London, Ontario, the organization
was the brainchild of Nephrology and
Transplant Division chief Calvin Stiller
and Bill Brady of CFPL radio. The group
will attempt to familiarize people with the
concept of being a donor and perhaps
encourage them to decide for themselves
rather than put the onus on their family
at the time of an accident. Anne Lake,
the executive coordinator, said that a
brochure about the group and a donor
card that will satisfy the requirements in
all the provinces (currently, the consent
forms on driver’s licences are not univer
sally accepted) will be available. Before
joining Transplant International, Lake
worked at a transplantation centre in
Toronto. She commented that more than
80% of people say they would donate a
family member’s organs compared with
about 60% who would donate their own.
She said families often called the centre
after losing a loved one in an accident say
ing, “ I found the consent form on the
driver’s licence when I got home. Is it too
late to use the organs?” She maintained
that many people have signed the consent
forms but not many medical or surgical
staff are searching for the forms in emer
gency rooms. She said the organization
will be attempting to reach the public
through rotary clubs and other local
groups. It will also be publishing a news
letter, “ Transplant Lifeline” , that will
focus on the successes in transplantation
as well as encourage people not only to
donate but to let their relatives know their
wishes. Obviously, the more people who
make their consent known, the fewer the

physicians who will be caught between
their colleagues and their patients’ fami
lies, dodging the label of callousness.

Manitoba University Head
of Surgery Steps Down
After 12 years as head of the Depart
ment of Surgery at the University of
Manitoba, Allan R. Downs, FRCSC, is
embarking on a year of academic leave
to pursue research on vascular grafts.
For the next 6 months he will be work
ing with Drs. Jean G. Couture and
Robert Guidoin at Laval University,
focusing on late complications. He then
will spend 3 months at New England Med
ical Center, Tufts University, Boston, fol
lowed by a stint at St. Mary’s Hospital
in London, England, where he did some
of his postgraduate training. He plans to
observe and update his knowledge on the
investigation and treatment of vascular
diseases.
Leaving his position as surgeon in chief
at University Hospital, he began his sab
batical immediately, settling into Quebec
City by mid-July.
Early this month he was part of the
faculty providing a course on peripheral
vascular surgery at the annual scientific
meeting of the Royal College of Physi
cians and Surgeons of Canada held in
Vancouver, contributing an overview of
aortoiliac occlusive disease.
A westerner born in Saskatchewan,
Downs joined the University of Manitoba
first as an undergraduate, receiving his
medical degree there; after completing the
McLaughlin travelling fellowship and
study abroad, he returned in 1960 as a
faculty member. Besides distinguishing
continued on page 458

Party celebrated first anniversary of Ottawa’s second heart transplant recipient, Daniel Galon
(third from left). Others attending party were, from left, Mila Galon (Daniel’s mother), JeanGuy Villeneuve (heart recipient, first anniversary, May 29), Clive Devereaux and Neil Showell
(heart recipients) and Ross Davies (cardiologist assisting Keon). In front are Cecile Michaelson
(most recent heart recipient) and W .J. Keon.
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A.R. Downs, MD, FRCSC
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D .J. Zukor , md ;* B.J. Miller, m d , frcsc ;*
A.J. Hadjipavlou , md , frcsc;* P. Lander , md , frcpci

Hip Pinning, Past and Present: Richards’ CompressionScrew Fixation Versus Ender’s Nailing

V

►

A

A

►

»

The authors trace the operative treat
ment of intertrochanteric hip fractures
from the earliest to the most modern
methods and describe how current fixa
tion devices evolved. The operative and
perioperative morbidity, mortality and
outcome in 57 patients treated by
Ender's nailing were compared with
those of 51 patients treated by Richards'
compression-screw fixation. Results
were comparable to those found in an
extensive review of the literature except
for a higher mortality in the group
managed by Ender's nailing. The authors
conclude that both methods of treatment
are acceptable and that the ultimate
choice of fixation device should be based
on the surgeon's experience tailored to
the individual patient's needs.
Les auteurs font I'historique du traitement chirurgical des fractures intertrochanterienne de la hanche, depuis les
methodes les plus anciennes jusqu'aux
plus nouvelles, et ils decrivent revolution
des presents dispositifs de fixation. Les
resultats de meme que la morbidity et la
mortalite operatoires et peroperatoires
notes chez 57 patients traites par
enclouage de Ender ont ete compares
avec ceux de 51 patients traites par fixa
tion a I'aide de vis de compression de
Richards. Les resultats obtenus etaient
comparables a ceux releves dans une
vaste revue de la litterature, sauf pour
un taux de mortalite plus dleve dans le
groupe traite par enclouage de Ender.
Les auteurs concluent que les deux
modes therapeutiques sont acceptables
et que le choix definitif du dispositif de
fixation doit reposer sur I'experience du
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chirurgien par rapport aux besoins individuels des patients.

Hip fractures are a serious problem, tak
ing up ever-increasing amounts of health
care dollars.1'3 Up to 20% of orthopedic
beds are occupied by patients with hip
fractures and a recent study estimated the
annual cost of treatment in the United
States to be $1 billion.4 The morbidity
associated with this fracture is incalcula
ble and the mortality in the first 4 to 6
months after operation is reported to be
12% to 15%.5-7 Intertrochanteric frac
tures occur most commonly in post
menopausal, osteoporotic women, due to
low-energy injuries such as falling.
Early operation is universally accepted
as the treatment of choice of these frac
tures, in order to avoid the complications
of prolonged bed rest (up to 3 months)
that would otherwise be necessary.8
Ironically, it is considered that the need
for surgery is inversely proportional to the
general medical condition of these usually
frail, elderly patients, and that surgery
should not be delayed longer than 24 to
48 hours.9

fractures. Johanson,14 in the hope of
reducing avascular necrosis and nonun
ion, pioneered a technique of closed
reduction and blind insertion o f the fixa
tion device.
The tri-flanged nail remained in use for
almost 50 years but, although it was an
excellent device, it alone was not enough
to control rotation adequately or prevent
the tendency of the femoral head to drift
into varus. Also, it tended to “ back out”
of the bone with subsequent loss o f fixa
tion. Thus, Preston introduced a side

Historical Perspective10
The technique and internal fixation
devices used to manage intertrochanteric
fractures have evolved from a crude to a
sophisticated level, since Von Langenbeck11 first reported the use of a nail to
fix a fractured hip in 1878. Senn,12 in
1881, was the first to use a screw, but
treatment at that time usually consisted
of a body cast, because of the increased
dangers of infection and of corrosion or
breakage of the implant.
Smith-Petersen’s13 contributions sub
stantially changed the management of
intertrochanteric fractures. His incision
was refined, making exposure of the frac
ture site a matter of careful anatomic dis
section and his tri-flanged nail (Fig. 1),
used initially in 1925, was the first implant
expressly designed for the fixation o f hip

‘T'dsiSi
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FIG. 1—Tri-flanged nail.
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plate to overcome these difficulties.10
However, this required bending the device
to fit the shaft of the femur. Thornton’s
plate (Fig. 2) was the first attachable to
the Smith-Petersen nail and McLaughlin’s
nail-plate (Fig. 3) eliminated the need for
bending because of its variable-angle
design.
Another device in use was the one-piece
nail designed by Jewett in 1941 (Fig.
4 ).15 This became the most popular
method of fixing these fractures for
nearly 30 years. Then, in 1964,
Clawson16 reported his experience with a
new and innovative device, the compres
sion screw and side-plate combination,
produced by the Richards Manufacturing
Company of Memphis, Tenn. (Fig. 5).
This versatile, high-strength system
allowed compression of the fracture site
at operation, as well as gradual impaction
of the fragments with weight bearing.
Acting as an internal splint, it sufficiently
stabilized the femur to allow early ambu
lation of the patient, which is precisely the
goal of treatment. With these important
advantages, the Richards compression
system rapidly gained widespread accep
tance and remains the current standard
of treatment for intertrochanteric frac
tures in most North American hospitals.
Recently, a “ challenger” , the con-

dylocephalic nail, has gained popularity
in North America (and is already widely
used in Europe). Lezius17 in 1950 was the
first to promote the idea of fixing frac
tures of the trochanteric region by
introducing a curved nail from the distal
femur. The operative technique is simple,
involving minimal exposure of the femur
medially, just proximal to the knee. A
small cortical window is made and three
to five flexible metal rods are introduced
into the region of the femoral head,
thereby maintaining and sometimes even
improving on a previously performed
closed reduction. No incision is required
in the region of the fracture. Kiintscher18
in 1967 and Harris19 in 1973 introduced
a single semi-rigid nail for this purpose.
In 1970, Ender and Simon-Weidner
described multiple, flexible pins20 (Fig.
6). The intramedullary position of the
implant allows it to be more medial and
therefore closer to the compression side
of the femur. This provides a biomechan
ical advantage as the result is a decreased
bending m om ent of the fixation
device.21’22 Also, “ dynamic controlled
motion” occurs; this concept, put forth
by Pankovich and Tarabishy,23 describes
the favourable amount of motion of the
fracture fragments that promotes healing.
The net result is early weight bearing for
the patient after a simpler, smaller, oper
ative procedure.24

FIG. 2—Nail-plate combination with fixed
angle.

FIG. 3—Variable-angle nail-plate combi
nation.
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Both Richards’ compression-screw fix
ation and Ender’s nailing procedures
allow early mobilization of the patient.
Ender’s nailing is a smaller procedure,
remote from the fracture site and claims
lesser operative morbidity. This attractive
advantage stimulated us to carry out a
retrospective review and comparison of
two similar groups of patients who had
undergone either Richards’ compressionscrew fixation or Ender’s nailing for inter
trochanteric hip fractures.
Patients and Methods
Between January 1980 and August
1982, 58 Ender’s nailings were performed
in 57 patients with intertrochanteric frac
tures (group 1). This group was compared
to a group of 51 patients with similar frac
tures treated by compression-screw fixa
tion between February 1977 and Novem
ber 1979 (group 2).
Data were obtained from review of the
patients’ charts and roentgenograms with
a follow-up of at least 6 months for all
patients. All pathologic fractures were
excluded. Fractures were classified and
matched according to Tronzo’s classifi
cation of intertrochanteric fractures.25
Variables examined included age, sex,
volume of blood lost and transfused,

FIG. 4—One piece nail-plate combination.
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duration of operation and anesthesia,
time to weight bearing, morbidity, mor
tality and roentgenographic findings at
follow-up.
Findings
Fifty-three patients in the Ender’s nail
ing group (group 1) and 51 patients in the
R ichards’ compression-screw group
(group 2) were available for study. The
mean ages for the two groups were 80.2
and 80.0 years respectively. There were
slightly more men in group 2 (Table I).

The duration of both operation and
anesthesia was less in group 1 and the
amounts of blood lost and transfused
were approximately half in this group.
Group 1 patients were able to weight bear
in similar to slightly less time than group
2 patients (Table I).
Complications
There was only one intraoperative com
plication, a supracondylar fracture of the
femur in a patient who underwent
Ender’s nailing.

Postoperatively, there was a difference
in the infection rate, 13.7% in group 2
compared with 0% in group 1. There
were slightly more cardiovascular compli
cations in the Ender’s nailing group but
a similar incidence of other postoperative
problems (Table II).
The number of deaths was somewhat
higher in group 1, especially those due to
cardiovascular disorders (Table III).
Technical failures again were slightly
more frequent in the Ender’s nailing
group, particularly those due to varus
deformity and shortening, but there were
no instances of nonunion or implant
failure in this group (Table IV).
Discussion
A review of the literature21"24,26’32 rev
ealed that intertrochanteric fractures fixed
with Ender’s nails are generally associated
with minimal blood loss, a low postoper
ative complication rate and a low mor
tality. An increased incidence of external
rotation deformity has been reported with
Ender’s nails but this is not important
clinically in elderly patients.23 On the

FIG. 5—(Left) Richards’ compression screw, showing individual components: threaded
lag screw, side plate with barrel, compression screw. (Right) Device assembled.

T a b le 1 - F a c t o r s C o m p a re d

F a c to r
Age, yr
M ean
Range
M a le , n o . (% )
F e m a le , n o . (% )
D u ra t io n (m in ) o f
o p e ra tio n , m e a n (ra n g e )
a n e s th e s ia , m e a n (ra n g e )
A m o u n t (m L ) o f b lo o d
lo s t, m e a n (ra n g e )
tr a n s f u s e d , m e a n (ra n g e )
T im e (d) to w e ig h t
b e a rin g , m e a n (ra n g e )

G ro u p 1
(n = 5 3 )

G ro u p 2
(n - 5 1 )

8 0 .2
5 2 -9 6

8 0 .0
5 1 -9 5

8 (1 5 .1 )
4 5 (8 4 .9 )

11 (2 1 .6 )
4 0 (7 8 .4 )

5 5 (3 3 - 1 4 5 )
102 (6 3 -2 2 5 )

81 ( 4 0 - 1 8 5 )
123 (7 5 -2 4 5 )

2 3 3 (1 0 0 -5 0 0 )
241 ( 0 - 7 5 0 )

4 5 3 (1 0 0 - 1 5 0 0 )
4 8 0 ( 0 -1 7 5 0 )

5 (1 -1 1 )

7 (1 - 9 2 )
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Table II— Postoperative Com plications

Com plication

Group 1, no. (%)
(n - 53)

Group 2, no. (%)
(n = 51)

Infectious
Superficial
Deep
Cardiovascular
Pulm onary
Throm boem bolic
G astrointestinal
Genitourinary
M iscellaneous

0
0
8 (15.1)
2 (3.8)
4 (7.5)
1 (1.9)
5 (9.4)
5 (9.4)

5 ] ( 1 3 .7 )
5
2
5
3
7

(9.8)
(3.9)
(9.8)
(5.9)
(13.7)

2 (3.9)

Table I ll- C a u s e s of Death

Cause o f death

Group 1, no. (%)
(n - 53)

Group 2, no. (%)
(n = 51)

S ep sis
C ardiovascular disorders

0

2 (3.9)

4 (7.5)

Pneum onia
Cerebrovascular accident

1 (1.9)
1 11.9)

1 (2.0)
0
0

Chronic lym phocytic leukemia

1 (1.9)

0

T o ta ls

7 (13.2)

3 (5.9)

Table IV—T echnical Failures

Cause

Group 1, no. (%)
(n - 53)

Group 2, no. (%)
(n = 51)

Nonunion

0

1 (2.0)

Proxim al migration
Im plant failure

1 (2.0)

Varus and shortening

1 (1.9)
0
7 (13.9)

1 (2.0)
2 (3.9)

T o ta ls

8 (15.1)

5 (9.8)

other hand, an increased incidence of
reoperation after Ender’s nailing is
reported, due to migration of pins and
knee pain. Our study confirmed most of
these findings. In addition, we found a
slightly increased incidence of cardiovas
cular complications and a higher mortal
ity than in the group managed by
Richards’ compression-screw fixation,
but this might have resulted from patient
selection as some of the surgeons in the
study may have chosen the lesser opera
tion for the higher-risk patients.
In considering the technical complica
tions encountered with Ender’s nailing,
we note that no surgeon had had previ
ous experience with this technique. Com
plications were highest early in the series
and diminished as each surgeon’s
experience with the procedure increased.
In contrast, all surgeons had had con
siderable experience with the com
pression-screw method.

i

■4

Conclusions

Modern technology has provided
today’s orthopedic surgeon with a wide
choice of excellent internal fixation
devices. Both Ender’s condylocephalic
nail and Richard’s compression screw
achieve the goals of surgical stabilization
of the fracture and early mobilization of
the patient. On the basis of this study and
a review of the literature, no clear-cut
superiority of one method over the other
could be demonstrated (Fig. 7). Ulti
mately, the method of treatment chosen
should be based on the surgeon’s
experience, in conjunction with the needs
of the individual patient.

4

4
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and serum
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Keeps the wound area soft and moist, preventing
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Ectopic Pregnancy
Ectopic pregnancy is no longer depen
dent on laparotomy for definitive diagno
sis. When patients present with massive
hemoperitoneum, the diagnosis is usually
obvious; but most patients do not
present this way, so diagnostic aids are
required. Culdocentesis is associated
with unusually high false-negative and
false-positive results. Laparoscopy is
accurate but is an invasive procedure
unwarranted in most cases for diagnosis.
Although it is unusual to make the diag
nosis of unruptured ectopic pregnancy
by ultrasonography alone, when
ultrasonography is combined with quan
titative beta-subunit determinations of
human chorionic gonadotropin, many
ectopic pregnancies can be diagnosed
before rupture occurs. The treatment of
the woman with a ruptured ectopic preg
nancy and in shock is immediate
laparotomy and salpingectomy. Salpin
gostomy with removal of the ectopic
mass and preservation of the tube may
enhance a patient’s subsequent fertility
and may be useful in carefully selected
women.

De nos jours, le diagnostic d§finitif de
grossesse ectopique ne depend plus de
la laparotomie. Quand une patiente presente un hemoperitoine massif, le
diagnostic, habituellement, ne fait pas de
doute. Toutefois, la plupart des patientes
n'arrivent pas dans cet etat, d'ou la
n£cessite de disposer d'aides diagnostiques. La ponction du cul-de-sac de
Douglas donne un nombre anormalement
eleve de faux n6gatifs et de faux posltifs. La laparoscopie est exacte mais il
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s'agit d'une intervention invasive, non
justifiee a des fins diagnostiques la plu
part du temps. Bien qu'il soit inhabituel
d'etablir un diagnostic de grossesse
ectopique non ruptur6e par echographie
ultrasonique seulement, plusieurs grossesses ectopiques peuvent etre diagnostiquees avant rupture quand on associe
echographie ultrasonique et determina
tion quantitative des sous-unites beta de
la gonadotrophine chorionique humaine.
Le traitement d'une grossesse ectopique
rupturee avec choc necessite une laparo
tomie immediate et une salpingectomie.
Dans certains cas bien choisis, une salpingostomie avec interruption de la gros
sesse ectopique et conservation de la
trompe peut ameiiorer les chances de la
patiente de redevenir enceinte.

One hundred years ago, Tait1 first
described the operative treatment of five
women who had ruptured ectopic preg
nancies. A difficult, cantankerous gyne
cologist from the English Midlands, Tait
described both the diagnosis and treat
ment of this condition. He commented on
the diagnosis in these trenchant words;
“ Only a fool would await the diagnosis
with certainty” and he advised early
laparotomy and excision o f the uterine
appendage. In the succeeding 80 years,
diagnosis and therapy have remained
essentially unchanged. During the course
of this essay, I shall describe the use of
new diagnostic aids that permit diagno
sis early in the development of the con
dition before rupture occurs. I shall
describe the diagnosis, which does not
require recourse to laparotomy. With
early diagnosis, surgery that conserves
rather than removes the fallopian tube
becomes an option. As this article will
make clear, there has been notable
progress in the treatment of ectopic preg
nancies.
Diagnosis
The most dramatic clinical picture seen

on gynecologic wards is that of a patient
with a massive hemoperitoneum due to
a ruptured ectopic pregnancy. The
patient, who is in her reproductive years,
presents in shock with a history of
abdominal pain and menstrual upset. The
diagnosis is clearly that of a ruptured
ectopic pregnancy; laparotomy to control
the hemorrhage must be undertaken
immediately. The need for immediate sur
gery without delay or attempt at labora
tory confirmation cannot be overstated.
However, in developed countries the
majority of ectopic pregnancies do not
present in this fashion; in the absence of
rupture, diagnosis is much more difficult.
The symptoms of pelvic pain and men
strual irregularity are nonspecific and the
principal physical finding of a pelvic mass
is often absent. Unruptured ectopic preg
nancies will be diagnosed only when
sought, and suspicion alone is not suffi
cient for definitive diagnosis. Clinically,
such disparate conditions as threatened
abortion, pelvic inflammatory disease,
endometriosis and a variety of medical
and surgical conditions mimic ectopic
pregnancy.
Since clinical methods alone are
unreliable in diagnosing this condition
with accuracy, ancillary diagnostic aids
are required. The measure of the effi
ciency of these aids is their ability to diag
nose an ectopic pregnancy before rupture
occurs and without operative inter
vention.
Culdocentesis, a technique that in
volves the insertion of a reasonably widebore needle into the cul-de-sac, has been
used for many years to assist in diagno
sis. However, culdocentesis has fallen into
disrepute. Those who oppose the proce
dure believe that the high false-positive
rate (26%) and the frequent absence of
blood in the cul-de-sac when the ectopic
pregnancy has not ruptured (35%) make
the test so unreliable that management is
rarely augmented by the findings of the
culdocentesis.2,3 On the other hand,
those who do use the procedure point out
that the test can be done quickly and with
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little discomfort, and thus eliminates the
delay and expense of further investiga
tion. Although recent literature supports
its continued use, the procedure is seldom
performed in our clinic.4
Laparoscopy has been suggested as a
screening device when the presence of an
ectopic pregnancy is suspected.5 There is
no question that laparoscopy can provide
accurate diagnosis of various pelvic dis
orders. Furthermore, its increased use is
associated with the ability to diagnose an
increasingly large number of ectopic preg
nancies before rupture.6 In spite of its
undoubted accuracy, the use of the
laparoscope as a screening device is ques
tioned. Even when its use is limited to
patients whose positive pregnancy tests
make them suspect, nearly one out of
every three women will be found to have
no ectopic pregnancy.7 The risk and
expense of a frequently unnecessary oper
ative procedure are such th a t its
indiscriminate use for this purpose can
not be recommended. This view must be
balanced by the recognition that, when
the diagnosis is in doubt, laparoscopy will
ease the mind of both the physician and
the patient.
In the past few years a laboratory test
(beta-subunit pregnancy test) and an
echographic technique (pelvic ultrasono
graphy) have radically changed our diag
nostic approach to these patients. The
beta-subunit pregnancy test is a new and
remarkably sensitive pregnancy test.8 It
permits the physician to diagnose preg
nancy within 9 days of conception. A
negative test rules out the possibility of
pregnancy of any sort. This degree of cer
tainty is in contrast to former pregnancy
test results, including hemagglutination
tests, which all too often gave negative
findings when the patient did in fact have
an ectopic pregnancy. Human chorionic
gonadotropin (HCG) (secreted by placen
tal tissue) consists of an alpha and beta
portion. The alpha portion is common to
the glycoprotein hormones, follicle
stimulating hormone, luteinizing hor
mone and thyroid stimulating hormone,
secreted by the anterior pituitary, whereas
the beta portion is specific to placental
chorionic gonadotropin. Commercial
radioimmunoassay kits are now available
that permit such diagnosis within an
hour.9 Furthermore, it is now possible
not only to give a qualitative determina
tion of the presence of /3-HCG but also
to determine quantitatively the precise
concentration of /3-HCG in the blood. In
effect, we can now predict the length of
gestation from such blood concentra
tions. Furthermore, the increasing con
centration of /3-HCG in early pregnancy
can now be determined. The rate of
increasing concentration of /3-HCG in the
circulation is found to vary both with the
implantation site and the viability of the
pregnancy. When implantation is in the
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uterine cavity and the pregnancy is nor
mal, the /3-HCG level increases by 100%
within 2 days.10 The lower limit of a nor
mal rise is 65%, but in the presence of
ectopic pregnancy, the rise is less than
60% (this is true in 87% of the cases). The
subnormal production of (3-HCG in ec
topic pregnancy is thought to be the result
of reduced blood supply to the conceptus.
Reduced /3-HCG secretion may also result
from an abnormal pregnancy with a dead
or dying trophoblast in a normal intra
uterine location, as happens in threatened
or missed abortion; these conditions are
the most common cause of a falling /3HCG level.
Diagnostic ultrasonography is also
most useful in further delineating this vex
ing clinical problem. There is no question
this method can rule out ectopic preg
nancy by demonstrating that the preg
nancy is intrauterine. In this case, the
diagnosis of pregnancy is made by visuali
zation of the fetus itself or, at an earlier
stage, the fetal amniotic sac. Although the
visualization of the fetus is a definitive
sign, there may be some confusion about
the diagnosis of an amniotic sac. In some
ectopic pregnancies (20%) the ultrasonic
picture of the uterine cavity resembles the
picture seen in an early pregnancy.11,12
The usefulness of ultrasonography is fur
ther limited because most patients with
ectopic pregnancy present early in preg
nancy and are often seen before the sac
or the fetus would be expected to develop.
In such instances, ultrasonography is not
helpful. When negative findings are used
as the sole indication for diagnostic
laparoscopy, an unacceptably high false
positive rate (19%) results.7,13
These difficulties can be overcome and
the usefulness of ultrasonography greatly
increased if the findings on ultrasono
graphy are linked directly to the quantita
tive level of /3-HCG. It has been demon
strated th at a normal intrauterine
pregnancy can be detected by ultrasono
graphy when the /3-HCG concentration is
greater than 6000 IU /L .10,12 This in
formation can be extrapolated further.
If the /3-HCG is over 6000 IU /L and
no intrauterine sac can be seen, then an
ectopic pregnancy is likely. On the other
hand, if the /3-HCG level is less than 6000
IU /L and ultrasonography identifies
a sac, the combination would suggest that
the pregnancy is a threatened or missed
abortion. Although this information is
useful, the number of cases where it can
initially supply the diagnosis is limited by
the fact that ectopic pregnancies normally
present with /3-HCG levels that are less
than 6000 IU /L .4
With the above information in mind,
the following approach to the diagnosis
of ectopic pregnancy is suggested (Fig. 1).
• Is the patient hemodynamically sta
ble? If the patient is unstable and if the
clinical diagnosis is that of a ruptured

ectopic pregnancy, then laparotomy
should be undertaken. Physicians need no
reminder that young women tolerate
blood loss extremely well and the first and
possibly the only sign of vascular insta
bility is tachycardia.
• In all other cases, if the diagnosis is
so uncertain that laparoscopy is needed
for accurate differentiation, ultrasono
graphy and quantitative /3-HCG should
be requested instead of proceeding with
immediate surgery. A number of diagnos
tic options will then become available
(Table I).
When the location and nature of the
pregnancy are uncertain, the (3-HCG
measurement should be repeated in 48
hours; the results of the second test will
make it clear whether one is dealing with
a normal intrauterine pregnancy, an
ectopic pregnancy or an abortion. In nor
mal cases, the /3-HCG will double in 48
hours; in the other circumstances the rise
will be less pronounced. The diagnosis of
ectopic pregnancy or abortion will be con
firm ed by curettage follow ed by
laparoscopy if necessary. When intrauter
ine pregnancy is diagnosed, the diagno
sis should be confirmed within a week by
diagnostic ultrasonography to rule out

FIG. 1—Suggested approach to diagnosis of
ectopic pregnancy.

Table 1-Diagnostic Options Outlined by
Ultrasonography and Beta-Human Chorionic
Gonadotropin (/3-HCG) Measurement
Not pregnant
/3-HCG < 10 IU/L
Intrauterine pregnancy
Normal intrauterine pregnancy
Fetal heart seen
Intrauterine sac + /3-HCG > 6000 IU/L
Abnormal intrauterine pregnancy
Intrauterine sac + (3-HCG < 6000 IU/L
Ectopic pregnancy
No intrauterine sac + (3-HCG > 6000
IU/L
Complex pelvic mass + /3-HCG > 10
IU/L
Nature and location of pregnancy uncertain
No intrauterine sac + /3-HCG < 6000 IU/L
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those rare cases in which ectopic gesta
tion produces normal /3-HCG levels.
Use of this protocol will increase the
numbers of ectopic pregnancies diagnosed
before rupture and limit the numbers of
unnecessary diagnostic laparoscopies.7 It
has made the diagnosis of ectopic preg
nancy a more exact science.
Management

In the hemodynamically unstable
patient with rupture of the uterine tube,
surgery must be undertaken without
delay. It may not be possible to resusci
tate the patient fully until the bleeding is
controlled. It is therefore a grave error to
delay surgery while vain attempts are
made to raise the patient’s blood pressure
to normal. The patient is best brought to
the operating room immediately. While
the patient is prepared for surgery, a
bolus of intravenous fluid (Ringer’s solu
tion) is given. A lower midline incision is
made. The hemoperitoneum is ignored
and the surgeon immediately identifies the
uterus, which leads the hand to each
appendage in turn. If a mass is felt on one
side or the other, then that appendage is
delivered into the wound. Over 90% of
ectopic pregnancies occur in the outer two
thirds of the tube and are obvious on pal
pation. Sometimes no mass is palpated
and in this case the uterus itself should
be brought into the incision. An ectopic
pregnancy may be found in the isthmical
portion of the tube. Although these are
often small, they are especially dangerous
because particularly severe hemorrhage
may occur. When the site of the preg
nancy has been found, bleeding is con
trolled by placing Kelly clamps across the
mesosalpinx and the cornual portion of
the tube. No single tube should be
clamped until the other has been visual
ized and found to be normal. Once the
hemorrhage is controlled the patient’s
condition will improve dramatically. At
this point the blood and clot can be aspi
rated from the peritoneal cavity,
peritoneal toilet performed with saline
and blood given. The tube may now be
removed without haste. The actual tech
nique is relatively unimportant, but may
be neatly done if fenestrations are made
in the mesosalpinx, and the isolated blood
vessels are then clamped and ligated with
fine catgut. Cornual resection of the tube
is no longer recommended. It is unneces
sary; not only does it fail to prevent cor
nual ectopic pregnancies but may also
result in localized myometrial defects that
may well compromise a future pregnancy.
In most patients with ectopic preg
nancy, salpingectomy is done in a way
that is unchanged since Tait’s time.
Although clearly life-saving, it may fail
to prevent other problems that the patient
with an ectopic gestation must face in the
future. One of these is that following an

ectopic pregnancy, one half of the women
will not conceive again and 15% are sub
ject to repeat ectopic pregnancy. These
disheartening figures have remained con
stant for some years with the occasional
exception in selective reports.14
The possibility of improving this poor
prognosis was first addressed by Jeffcoate15 who suggested that the removal
of the adjacent ovary would improve the
tubal pick-up of the ovum by preventing
transperitoneal migration of the fertilized
ovum. Although the thinking was ingeni
ous, the results of the procedure have
remained both equivocal and controver
sial and the procedure is no longer recom
mended. Salpingo-oophorectomy as a
treatment for ectopic pregnancy has never
been subjected to proper trial.
At present, the thrust o f gynecologic
thinking is that the outcome of subse
quent pregnancies will best be improved
by preserving the tube. This will be pos
sible only when the ectopic pregnancy is
diagnosed before rupture. What remains
controversial, however, is the question of
whether such conservative surgery is
worthwhile. DeCherney and Kase16 in a
definitive study were unable to show an
increased pregnancy rate or a decreased
ectopic pregnancy rate. A good case for
this surgery may be made for the young
woman whose opposite tube is absent or
damaged and who wishes to retain her
fertility. DeCherney and colleagues17
described the effect of salpingostomy for
unruptured ectopic pregnancy in the
presence of one tube only. The absence
of the contralateral tube ensures that sub
sequent pregnancy results from ovum
transport through the tube that had had
tubal surgery. His results were most
worthwhile for women wishing more
babies although there was an increased
risk of another ectopic pregnancy. The
pregnancy rate was 53% and the rate of
repeat ectopic pregnancy was 20%. In
these special instances, therefore, conser
vative surgery does seem to be beneficial.
Microsurgery includes linear salpin
gostomy with a needle cautery, teasing
out of placental tissue with fine forceps,
immaculate hemostasis with bipolar cau
tery and the irrigation of the operative
area with a heparin solution. The tubal
incision may be closed with 6-0 Dexon or
left alone with no effort at closure.
Postoperatively, RhoGAM is given as
required and the level of the /3-HCG is
monitored at weekly intervals.
Summary

Ectopic pregnancy has become a com
mon surgical emergency. The increased
rate of ectopic pregnancy relates to the
increased incidence of pelvic inflamma
tory disease.18 Both history and physical
examination, except in women with tubal
rupture, are inconclusive. To diagnose an

ectopic pregnancy before rupture of the
tube occurs and without invasion of the
peritoneal cavity, quantitative /3-HCG
measurements and diagnostic pelvic
ultrasonography are recommended. A
diagnostic plan has been outlined. For the
most part, surgical therapy is limited to
salpingectomy. The very necessary,
although limited, place for conservative
surgery is also outlined.
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Fate of Claudicants After Femoropopliteal Vein Bypass:
Prospective, Long-Term Follow-up of 100 Patients
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Fem oropopliteal bypass g ra ftin g fo r clau
dication is a co n tro ve rsia l procedure.
One hundred co n s e c u tive p a tie nts so
treated w ere analysed fo r v e in -g ra ft
patency, subsequent ope ra tio n and sur
vival. Initial success, tre a tm e n t o f
in cip ie n t g ra ft fa ilu re and a ttritio n from
death w ere th e three c ritic a l fa c to rs
in flu e n cin g lo n g -te rm b e n e fit. Cum ulative
g ra ft patency, a fte r revision w h e n neces
sary, w as 8 9 % , 8 6 % and 7 8 % a t 2, 5
and 10 years re sp e ctive ly. In assessing
the real be n efit o f su rg e ry in th is group,
it is im p o rta n t to co n sid e r the e ffe c t of
late deaths, as th e life e xp e cta n cy o f
these patients is so o fte n shortened by
related disease; th e "c u m u la tiv e pallia
tio n " (patient alive and g ra ft pa ten t) was
8 2 % , 6 7 % and 2 8 % a t th e same tim e
intervals. The c o n c e p t o f cu m u la tive pal
liation sets a high standard in assessing
results o f vascular su rg e ry, adding
im p o rta n t in fo rm a tio n to th e usual graft
patency rates th a t ignore the e ffe c t of
death. These resu lts su g g est a place fo r
fem o ro p op lite a l vein bypass g ra ftin g in
selected claudicants.

in itia l, le tra ite m e n t d 'u n e thro m b o se
im m in e n te du g re ffo n e t I'a ttritio n par le
deces fu re n t les tro is p rincipa u x fa cte urs
qui o n t in flu e n ce le benefice a longue
echeance. La p erm abilite cu m u la tive du
g re ffo n , apres revision si n£cessaire, fu t
de 8 9 % , 8 6 % e t 7 8 % , a 2 , 5 et 10 ans
re sp e ctive m e nt. En e valuant le benefice
reel de la ch iru rg ie dans ce groupe. il est
im p o rta n t de considerer I'e ffe t de la m or
ta lity ta rd ive car I'e x p e c ta tiv e de vie de
ces p a tie nts e st so u ve nt reduite a cause
de m aladies associ£es; " la palliation
c u m u la tiv e " (p a tie n t v iva n t avec une
g re ffe perm eable) fu t de 8 2 % , 6 7 % et
2 8 % , aux m em es in te rva lle s. Le co n ce pt
de pallia tio n cu m u la tive a ta b lit un sta n 
dard yieve dans E v a lu a tio n des resultats
de la ch iru rg ie vasculaire en a jo u ta n t une
in fo rm a tio n im p o rta n te aux taux
habituels de p e rm abilite du g re ffo n qui
ne tie n n e n t pas co m p te des deeds. Ces
resu lta ts su g g ere n t q u 'il y a place pour
un pon ta g e ve ineux fe m o ro -p o p lite chez
des p a tie n ts bien selectionnes, presenta n t de la clau d ica tio n.

Le pontage fe m o ro -p o p lite p o u r la claudi
cation in te rm itte n te e st co n tro ve rsy. Les
dossiers de 1 0 0 p a tie n ts, tra itg s consecutivem ent par pontage veineux
fe m o ro -p o p lite pour une claudication
im portante, fu re n t revises q u a n t a la per
m abilite de la g re ffe , une ch irurg ie subsequente et la su rvie du p a tie nt. Le succes

Femoropopliteal grafting for claudication
is controversial. Linton and Darling1
p ublished their classic paper on
femoropopliteal vein grafts in 1962. Two
thirds o f their patients had claudication.
However, in the succeeding 20 years,
results and opinions have varied consider
ably as to whether this operation is indi
cated for claudication.2-4 This study was
initiated to assess the long-term result,
fate and, more importantly, what was
actually achieved in a series o f 100 con
secutive patients each o f whom received
a primary reversed femoropopliteal vein
graft for claudication.
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Each patient suffered symptoms o f clau
dication after walking less than 200 m, 22
were limited to less than 50 m. They were
not accepted for operation unless their
symptoms had been stable for at least 3
months or were deteriorating. Seven
patients had received a femoropopliteal
graft previously in the contralateral leg,
three had been treated elsewhere for clau
dication and four by us for ischemia. Ten
had undergone aortoiliac “ inflow” proce
dures previously. The mean age o f these
patients was 60 years (range from 41 to
77 years). There were 30 women.
Associated risk factors were standard for
arteriosclerotic disease (Table I). Only
five patients had never smoked. O f the
121 limbs, 16 had only one patent tibial
vessel to the foot, the remainder had two
or three. The minimum follow-up was
over 5 years for a total o f 862 limb-years.
M e th o d s

Starting in July 1964, details o f all vas
cular operations done at St. Paul’s Hospi
tal in Vancouver were entered prospec
tively onto a comprehensive computer
form .5 The first vein graft for claudica
tion was performed in November 1964
and the most recent, in this series, in

T a b le 1— P r e o p e r a t i v e R is k F a c t o r s in
100

C la u d ic a n t s S e le c t e d f o r S u r g e r y
No. of

R is k f a c t o r

p a tie n ts *

C a r d ia c d is e a s e ( in c lu d e s e le c tr o C e r e b r o v a s c u la r d is e a s e

10

H y p e r t e n s io n

21

D ia b e t e s

10

P la s m a t r ig ly c e r id e
le v e ls > 2 . 2 6

P a tie n ts

m m o l/L

6

P la s m a c h o le s t e r o l
le v e l > 7 . 7 6

Initially, only patients who were una
ble to work were selected for surgery.
Later, we accepted patients whose life
style was frustrated by their limitation
and who requested surgery on that basis.

41

c a r d io g r a p h ic a b n o r m a lit ie s )

m m o l/L

15

P la s m a u ric a c id
le v e l > 4 7 6
T o ta l
*3 5

y zm o l/L

5
108

p a t ie n t s h a d n o id e n t if ie d ris k f a c t o r s .
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November 1978. A two-team approach years were 75%, 68% and 54% respec
was used; the first author (J.G.S.) was the tively (Table II, Fig. 1). Thirty of our 121
primary surgeon in all cases, usually in grafts had to be revised because of
association with the second author incipient failure — usually stenosis within
the first 2 years. Graft patency including
(J.L.G.).
Grafts associated with common or the positive effect of these operations
superficial femoral endarterectomy, or (i.e., secondary patency) was 89%, 86%
arising from the superficial femoral artery and 78% at 2, 5 and 10 years (Table III).
above the adductor hiatus, were included. If we assume that the grafts that were
The lower end of the vein graft termi revised, all of which were severely
nated in the popliteal artery above the stenosed, would have failed at an aver
knee in 44 of the 121 grafts. We were age of 3 months, then there was a signifi
more aggressive in our use of “ border cant statistical gain from the revision (p
= 0.003, Lee-Desu statistic).
line” vein than we would be today
Twenty-one of the 100 patients had a
because of our lack of enthusiasm for the
alternatives at that time. This probably subsequent contralateral femoropopliteal
resulted in more operations for revision. vein graft for claudication and 1 for ische
Patients were followed up at 3, 6, 12 and mia. Ten patients had a subsequent
18 months after surgery, then annually to inflow procedure and in 7 serious
the time of death or occlusion. None were abdom inal aneurysm s developed.
lost before occlusion, but one patient has Twenty-five of the 121 grafts throm
been lost to follow-up since the graft bosed. Three of these were treated by
occluded. The closing date for this study thrombectomy, but only one was perma
was Dec. 31, 1984. Absence of symptoms nently salvaged. In all, five limbs were
associated with easily palpable pulses was amputated, all late, two of them within
accepted as evidence of graft patency. All 2 months of the patient’s death.
Cumulative survival for the 100
patients with grafts of questionable
patency underwent femoral arteriography patients was 79% at 5 years and 39% at
or the graft was considered occluded. The 10 years. This is compared with the life
tables of cumulative patency and pallia expectancy curve for 60-year-old persons
tion, risk factors and cause of death were in Fig. 2. Smoking-related diseases of the
set up initially on an IBM personal com vascular and pulm onary systems
accounted for 36 of the 42 deaths of
puter then confirmed on SPSS.6 '
known causes (Table IV).
To assess what was actually achieved
Results, Fate and Palliation
in this series, we considered a live patient
Primary patency rates at 2, 5 and 10 with patent grafts as the criterion for suc-
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FIG. 1—Cumulative graft patency. Primary
patency (solid line) ends with reoperation (revi
sion or thrombectomy), regardless of outcome,
and graft failure. Secondary patency (broken
line) reflects effect of maintenance operations
and ends with graft failure only. Average num
bers of limbs at risk during interval are noted
below curves which were calculated from limb
data base (N = 121).
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FIG. 2—Cumulative survival of 100 patients
after femoropopliteal bypass for claudication
(average age 60 years) (solid line) compared to
sex-adjusted life expectancy at age 60 (broken
line).
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In te rv a l
s ta rt, y r

N o . e n te rin g
in te rv a l

No.
w ith d r a w n

N o . at
risk
121

1

0

121

30 d
1

120

0
4

100

7

118
9 6 .5

1

8 0 .5

12
4

5
11

7 3 .5

2

2
3
4
5

81
76
69
57

16

6 3 .5

1

8

53

6

45
36

1
1

6
7
8

48
41
28

10
4

9

23

10

In te rv a l, %

C u m u la tiv e

S ta n d a rd

S u c cess

success, %

erro r, %

1
14

99
86

9 9 .2
8 5 .7

0 .8

12

88

5
3
2

95
97

7 5 .1
7 1 .3
6 9 .4

No.
fa ilu re s

Failure

26

3
1

18

1

6

4 .2

98
98

6 8 .3

4 .3
4 .4

6 7 .0

4 .5

98
92

6 5 .5
6 0 .1

4 .6
5 .2

96
94

5 7 .8
5 4 .5

6 .1
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success, %

S ta n d a rd

S u c cess
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96
93
99
100
99
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8 8 .8
8 7 .9
8 7 .9

0 .8
2 .0
2 .9
3 .0
3 .0
3 .2

95
98
100
100

8 0 .3
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7 8 .6
7 8 .6

2
2
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1
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1
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cess. Thus, patients who had bilateral
femoropopliteal bypass grafting for clau
dication were considered palliated until
the first graft occluded or the patient
died. On this basis, the palliation rates at
5 and 10 years were 67% and 28% respec
tively (Table V, Fig. 3). Five patients with
patent grafts were to some extent disabled
before death (one by stroke, one by renal
failure and three by “ old age” ). Disabil
ity is a “ soft” end point and accounted
for only 7 of a total of 760 patient-years
of follow-up. For this reason we used
only occlusion and death as criteria for
failure of palliation. Each of the follow
ing groups was analysed and compared
with its counterpart for graft patency and
palliation: age older than 64 years and
older than 69 years, female, claudication
at less than 50 m, single-vessel outflow

FIG. 3—Secondary graft patency (ability to
maintain patent grafts) and cumulative palli
ation (patient alive and grafts patent) were cal
culated from patient data base (N = 100). Lat
ter gives critical additional information in
assessing patient benefit from operation. Num
bers of patients at risk are noted below curve.

Table IV—Causes of Death *
No. of
patients

Cause
Cardiac
Cerebrovascular (stroke)
Vascular
Lung cancer
Other
Unknown

30
6
1
2
7
17

*37 alive.

and the lower end of the graft below the
knee. The group with single-vessel out
flow fared worst but the difference was
not statistically significant in this small
sample.
Discussion
Early results in vascular surgery depend
upon case selection and technical exper
tise. There was only one early failure
(within 30 days of operation) and no
operative deaths in this series. A twosurgeon approach is advocated to shorten
the procedure and to allow more flexibil
ity in time if a difficult technical situation
is encountered. The graft patency results
presented here are surprisingly similar to
those of Donaldson and Mannick4 and
appear to be reproducible. The late ampu
tation rate, 0.6% per year at risk, com
pares favourably with the natural history
for claudicants of 1.4% amputations per
year7 but certainly does not, in itself,
justify operation.
Selecting claudicant patients for sur
gery is a challenge, but there are bench
marks. Within 10 years of the onset of
symptoms 25% of claudicants will die,
the annual mortality from cardiovascu
lar causes being about four times higher
than normal.8 If we select claudicants
with angina or those who smoke, the risk
of death rises to six or seven times nor
m al.8 Stated another way, the annual
mortality in patients with angina is about
4% and is about 5% after a nonfatal
myocardial infarction.9 However, claudi
cation by itself has little effect on 5-year
mortality if we eliminate the cardiovas
cular risk factors and smoking.10 We
stressed the risk of smoking to our
patients and nearly all stopped before sur
gery. Unfortunately, many resumed the
habit but usually at a lower level. Finally,
if we are to expand our indications in
femoropopliteal surgery to include some
claudicant patients, life-style becomes
critical. Patients must be selected on their
need, wish and ability to lead a more
active life.
We did not operate on claudicants with
poor outflow. For this reason, graft

failure was almost always due to graftrelated stenosis. The consequences of
femoropopliteal graft occlusion are seri
ous, even when the original grafting was
done for claudication.11 Five of our 25
thrombosed grafts resulted in amputation
of the limb. Incipient graft failure must
be diagnosed and treated promptly if the
graft is to be saved.12 The hallmarks of
graft stenosis are return of claudication,
weakening pulses and a bruit over the
graft. Patients must be prewarned to
report any recurrence of claudication. A
drop of 0.2 in the ankle index is seri
ous.13 The bruit occlusion test12 is very
useful in localizing graft stenosis clini
cally, and the diagnosis is confirmed by
careful angiography.14
Reporting results in vascular surgery by
the life-table method is mandatory. The
standard life table of graft patency is very
helpful in comparing grafts, groups of
patients or surgeons. Comparing primary
and secondary patency rates gives a good
indication of the operation’s durability.
However, as death is dropped out of
cumulative patency results, these curves
bear little relation to what the surgeon or
patient can expect from the operation.
Previous reports have stressed the late
mortality after peripheral vascular sur
gery, reporting patient survival and
cumulative survival.15'16 The fact that
most of these patients die o f related vas
cular and pulmonary disease is well
docum ented.10'17 The key to a true
reflection of treatment is to combine the
cumulative effect of graft failure and
death. We have named this curve
“ cumulative palliation” . With the use of
in-situ vein grafts, long-term graft
patency in the femoropopliteal area may
improve, but it is noteworthy that the pal
liation curve in this series followed the
survival curve; 80% of the surviving
patients were palliated at 5 years and 70%
at 10 years, leaving a relatively small
increment to be gained by improved graft
ing procedures. The concept of “ cumula
tive palliation” is very useful in assess
ing the success of vascular surgery, adding
important information to the usual graftpatency curves which neglect the effect of

Table V-Patient Data Base. Cumulative Palliation
Interval
start, yr

No. entering
interval

No.
withdrawn

No. at
risk

No.
failures

0
30 d
1
2
3
4
5
6
7
8
9

100
99
92
82
78
74
66
57
48
34
28

0
0
0
0
1
0
0
4
3
1
3

100
99
92
82
77.5
74
66
55
46.5
33.5
26.5

1
7
10
4
3
8
9
5
11
5
5

------- Interval,
Failure

%
Success

Cumulative
success, %

Standard
error, %

1
7
11
5
4
11
14
9
24
15
19

99
93
89
95
96
89
86
91
76
85
81

99.0
92.0
82.0
78.0
75.0
66.9
57.8
52.5
40.1
34.1
27.7

1.0
2.7
3.8
4.1
4.3
4.7
5.0
5.0
5.0
5.0
4.8

4
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death. The fact that about two thirds o f
these patients were alive with patent
femoropopliteal vein grafts 5 years after
operation indicates that there is a group
o f claudicant patients who can be well
palliated by this operation. The surgeon’s
challenge is to identify these patients and
keep their grafts functioning.
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Statistical Prediction of Cardiac Risk in Patients
Who Undergo Vascular Surgery
S ince A u g u s t 1 9 8 2 , an exte nsive co m 
p u te rize d data base has been developed
on all p a tie nts a d m itte d to th e D ivision
o f V a sc u la r Surgery at th e O tta w a Civic
H o s p ita l. For each p a tie nt, 1 80 variables
are recorded, including in fo rm a tio n about
p re o p e ra tiv e risk fa c to rs and p ostopera
tiv e c o m p lica tio n s. Since cardiac co m p li
c a tio n s are a m ajor cause o f m o rta lity
and m o rb id ity , th e data file has been
used to s tu d y po stop e ra tive cardiac co m 
p lic a tio n s in patients w h o undergo
a rte ria l re c o n s tru c tiv e operations.
B e tw e e n A u g u st 1 9 8 2 and Decem ber
1 9 8 3 , 3 5 3 artery repairs w ere per
fo rm e d , excluding ruptured aneurysm s.
C a rdiac co m p licatio n s developed fo llo w 
in g s u rg e ry in 56 p atients. Risk fa c to rs
w e re in itia lly studied using co n tin g e n cy
ta b le analysis. Four o f these fa cto rs
w e re fo u n d to be s ig n ifica n t: elec
tro c a rd io g ra p h ic evidence o f previous
m y o c a rd ia l in fa rctio n (p = 0 .0 0 0 3 ), non-
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specific ST-segm ent changes (p =
0 .0 0 0 7 ), N e w York H eart A ssociation
cla ssifica tio n o f sym pto m s (p = 0 .0 0 0 3 )
and age (p = 0 .0 1 ).
A fu rth e r sta tistica l stu d y w as based
upon m u ltip le lo g istic regression. The
authors believe th a t the id e n tifica tio n o f
a high-risk group, using these criteria, is
helpful in selecting pa tie nts fo r in tensive
preoperative in ve stig a tion , including
coronary arteriography.

Depuis ao u t 1 9 8 2 , une vaste banque de
donnees sur ordinateur a ete generee a
p a rtir de to u s les pa tie nts repus au Ser
vice de ch irurgie vasculaire de I'h o p ita l
Civique d 'O tta w a . O nt §te enregistr^es
p o u r chaque patient, 1 8 0 variables do n t
I'in fo rm a tio n concernant les fa cte urs de
risque preoperatoires et les co m plications
p o stoperatoires. Com me les com plica
tio n s cardiaques representent une cause
m ajeure de m orta lite et de m orb id ity, le
fic h ie r de donnee a 6t§ utilisee pour etudier les co m p lica tio n s postoperatoires
chez les p a tie nts qui subissent une ope
ratio n de reco n stru ction arterielle.
Entre ao u t 1 9 8 2 et decem bre 1 9 8 3 ,
3 5 3 reparations art^rielles o n t ete e ffe ctu e es si I'o n excepte les ruptures d'anevrism e. Des co m p licatio n s cardiaques
postop e ra toire s sont survenues chez 56
patients. Les fa cte urs de risque o n t to u t
d 'a b o rd 6te etudies par analyse des
tables de contingence. Q uatre de ces
fa cte u rs se so n t a v e rts im p orta n ts: les
signes electrocardiographiques d 'u n
in fa rctu s du m yocarde ancien (p =
0 .0 0 0 3 ), des m od ifica tio n s non specifi-

ques du segm ent ST (p = 0 .0 0 0 7 ), la
cla ssifica tio n des sym ptom es de la N ew
Y ork Heart A sso cia tio n (p = 0 .0 0 0 3 ) et
I'age (p = 0 .0 1 ).
Une seconde analyse s ta tistiq u e par
regression lo g istiq u e m ultiple a ete e ffe ctuee. Les auteurs croien t que I'id e n tific a tio n , a I'aide de ces criteres, d 'u n groupe
a risque eleve, perm et de ch o isir les
p a tie nts qui devraient etre soum is a un
exam en preopSratoire pousse com prena n t une arteriographie coronarienne.

Cardiac complications are the commonest
cause of death following peripheral
arterial reconstruction. If we could relia
bly identify preoperatively, using simple
criteria, the patients most likely to suffer
such complications, we might be able to
reduce the incidence of cardiac death
postoperatively. The present study was
carried out in an attempt to predict
cardiac risk in patients requiring
peripheral arterial repair, using statistical
methods.

Method
In 1982 we began an ongoing statisti
cal study o f all patients admitted to the
Vascular Surgical Service o f the Ottawa
Civic Hospital. This involved the develop
ment o f a coded questionnaire contain
ing 180 variables that was filled out on
each patient. Following validation, the
information was entered into the Univer
sity o f Ottawa mainframe computer,
creating a large data base that provided
a detailed profile of each patient, includ-
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ing the clinical findings, preoperative
investigations, operative procedure and
postoperative course. We decided to use
this data base to investigate postoperative
cardiac complications in patients who
underwent peripheral arterial repair.
Potential cardiac risk factors identified
for the study were: arteriosclerotic heart
disease, diabetes, hypertension, obesity,
smoking, hyperlipidemia, previous vascu
lar surgery and age. Assessment of arteri
osclerotic heart disease included informa
tion about previous documented myo
cardial infarction, previous coronary ar
tery repair, angina, arrhythmias and elec
trocardiographic abnormalities. Symptom
severity was assessed according to the
New York Heart Association (NYHA)
classification. Resting admission elec
trocardiograms were read independently
and coded according to the presence of
rhythm other than sinus, bundle branch
block, evidence of previous myocardial
infarction, ST-segment and T-wave
changes, and left ventricular hypertrophy.
Previous infarction was determined by the
presence of Q waves greater than 0.04
seconds in duration and 2 mm in depth.
ST-segment depression of 1 mm or more
was considered abnormal.
Postoperative cardiac complications
studied were: acute myocardial infarc
tion, acute congestive heart failure and
arrhythmias requiring treatment. Acute
myocardial infarction was diagnosed by
electrocardiographic evidence of new STsegment elevation, corroborated by the
finding of elevated cardiac enzyme levels.
Congestive failure was diagnosed by clin
ical evidence of acute pulmonary edema
with jugular venous distension or a third
heart sound, and by hemodynamic
criteria with pulmonary capillary wedge
pressure greater than 18 mm Hg and a
cardiac index of less than 2.2.
All patients who underwent arterial

reconstruction were included except those
with ruptured aneurysms. They were
excluded since the need for immediate
surgery prevented adequate preoperative
evaluation of their cardiac status. The
study was retrospective, and involved an
18-month period from August 1982
through November 1983.
The results were subjected to statisti
cal evaluation. In the first part of the
analysis, we considered each factor
individually, and constructed a contin
gency table to study the relation between
each risk factor and postoperative cardiac
complications.
Further study focused on all risk fac
tors and attempted to assess the individual
and joint effects of the variables. In order
to investigate these effects, we fitted a
logistic model to the data. The logistic
model specified that the probability of
cardiac complications depends upon a set
of risk factors. The selection of each
predictor variable was done by stepwise
logistic regression,1-2 adding those varia
bles to the model that maximized the
likelihood of cardiac complications.

Further analysis was carried out by mul
tiple logistic regression.
ST-Segment Changes
Sixty-one patients had abnormal ST
segments on their resting electrocardio
gram. Nineteen (31.1%) suffered cardiac
complications postoperatively. Thirtyseven of 291 patients with normal ST seg
ments (12.7%) suffered cardiac compli
cations. This difference was significant (p
= 0.0007). The tracing for one patient
was not available.
Myocardial Infarction
The degree of risk involved when there
was electrocardiographic evidence of
previous myocardial infarction depended
upon the location of the infarct (Table II).
The risk was greatest when there was evi
dence of an anterior myocardial infarct
(33.3% had complications) or both
anterior and inferior infarcts (57.1% had
complications).
N Y H A Class

Results
During the study period, arterial recon
struction was done in 353 patients; 56
(15.9%) of them suffered cardiac compli
cations and 19 (5.4%) died. Twenty-three
suffered myocardial infarction, with 16
(70%) deaths (Table I).
Contingency table analysis indicated
that four factors were significant in
predicting cardiac risk. These were non
specific ST-segment changes on the rest
ing electrocardiogram (p = 0.0007), elec
trocardiographic evidence of previous
myocardial infarction (p = 0.0003), sym
ptom severity as classified by the NYHA
(p = 0.0003) and age (p = 0.01). There
were no other significant risk factors.

Table 1-Postoperative Cardiac Complications
Complication

No.

Acute myocardial infarction
Acute congestive failure
Arrhythmias
Severe angina and hypotension without myocardial infarction

23
5
21
7

Died,
Survived no. (%)
7
4
19
7

1 6 (7 0 )
1 (20)
2 (1 0 )
0 ( 0)

The New York Heart Association clas
sification of symptom severity was the
third significant predictor of postopera
tive cardiac complications, the risk being
highest for patients with class III sym
ptoms — 33.3% suffered cardiac compli
cations (Table III).
Age
Age was the least important of the sig
nificant risk factors (p = 0.01) (Table
IV). The patients ranged in age from 34
to 94 years. There were no cardiac com
plications in patients under 40 years of
age, and the risk was highest over age 70.
The introduction of age as a predictor did
not alter the significance of electrocardi
ographic changes or symptom severity.
In the second part of the analysis, a
logistic regression model was fitted to the
data. The results of step-wise logistic
regression showed that the likelihood of
cardiac complications was increased 9%
by the presence of ST-segment changes on
the electrocardiogram, 10% by evidence
Table Ill-N e w York Heart Association
Classification and Cardiac Complications

Table II—Electrocardiographic Evidence of Myocardial Infarction
and Cardiac Complications for 352 Patients*
Electrocardiographic findings

No.

Complications,
no. (%)

No infarction
Inferior myocardial infarction
Anterior myocardial infarction
Inferior and anterior myocardial infarctions

257
52
36
7

3 3 (1 2 .8 )
7 (1 3 .5 )
1 2 (33 .3)
4 (5 7 .1 )

* Tracing for 1 patient was not available,
p - 0.0003.

NYHA class

No.

Complications,
no.(%)

1
II
III
IV
0*

170
55
21
7
99

25 (14.7)
15 (27 .3)
7 (33.3)
2 (28.6)
6 ( 6.1)

‘ No symptoms, normal electrocardiogram, 1 pa
tient was not classifiable,

p = 0.0003.
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of previous infarction, 7% by the NYHA
symptom classification and 4% by age.
The total number of complications that
could be predicted by these four signifi
cant variables was thus 30%.
Discussion
The importance of acute myocardial
infarction as a cause of death following
peripheral artery repair has been well
documented by Hertzer.3 O f 273 con
secutive patients who underwent lower
extrem ity revascularization at the
Cleveland Clinic between 1969 and 1973,
myocardial infarction caused 52% of the
early postoperative deaths and 55% of
late deaths up to 11 years. Since 19784
routine preoperative coronary angiogra
phy has been recommended for all
patients in his institution who required
lower limb arterial repair. Significant cor
rectable coronary artery lesions were
found in 54% of patients with aortoiliac
disease who had preoperative evidence of
coronary artery disease and in 13% of
patients with no such evidence.4 Early
results indicated a low risk following
preliminary coronary artery repair. In a
subsequent report of 1000 patients,
presenting with peripheral vascular dis
ease who had coronary arteriography,
Hertzer and associates5 carried out
preliminary cardiac procedures in 226,
with 12 postoperative deaths (5.3%); 130
o f these patients had subsequent
peripheral vascular operations and 1 of
them died. It has also been suggested by
Crawford and associates6 that the risk of
noncoronary operations is decreased fol
lowing successful coronary bypass
surgery.
While careful assessment of cardiac
risk is most important before carrying out
peripheral vascular reconstruction, the
appropriate extent of this evaluation may
be difficult to determine in an individual
case. All of our patients were assessed
clinically by a consultant cardiologist.
Recording of one or more resting elec
trocardiograms was routine. Exercise
stress testing was not possible in many
p a tie n ts, since their claudication
prevented them from walking far enough
on a treadmill to produce cardiac symp
toms. Coronary artery catheterization

T a b le I V - -A g e an d C a rd ia c C o m p lic a tio n s

A ge, yr

No.

C o m p lic a tio n s ,
n o .(% )

< 40
4 0 -4 9

3
20
68
122
98
42

0101
2 (1 0 !
3 (4 .4 !
2 1 ( 1 7 .2 )
2 1 ( 2 1 .4 )
9 (2 1 .4 )

5 0 -5 9
6 0 -6 9
7 0 -7 9
>

80

p - 0 .0 1 .
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was used selectively, and we are reluctant
to advise it as a routine procedure without
additional evidence that its use would
markedly lower the incidence of postoper
ative cardiac complications, as well as
reduce overall mortality.
Goldman’s group7'9 have produced a
good deal of statistical information about
cardiac complications following 1001 con
secutive operations, subjecting the data
to multivariate analysis. Factors that cor
related independently with cardiac deaths
were: clinical evidence of congestive
failure, myocardial infarction within 6
months, rhythm other than sinus or
premature atrial contractions on the
preoperative electrocardiogram, more
than five premature ventricular contrac
tions a minute, significant aortic steno
sis, age over 70 years, emergency surgery
and type of operation. While Goldman’s
patients underwent a wide variety of
thoracic, abdominal, gynecologic, urologic and breast operations, there were 80
procedures for abdominal aortic aneu
rysms and he noted an increased cardiac
risk following abdominal aortic surgery.
The usefulness of Goldman’s cardiac risk
index has been confirmed by others.10
Congestive heart failure preoperatively
is known to increase surgical risk, and the
increment is proportional to the degree of
hemodynamic compromise. Skinner and
Pearce,11 in a study of cardiac patients
who underwent general surgical proce
dures, found that mortality increased
directly with the NYHA functional class:
class I, 4.3%; class II, 10.6%; class III,
25%; and class IV, 67%. In our patients,
the preoperative NYHA classification
predicted an increasing number of cardiac
complications postoperatively from class
I (14.7%) to class III (33.3%). However,
only two of the seven patients in class IV
(28.6%) suffered cardiac complications.
This is at variance with reported data11
and may be related to the small number
of patients in class IV who were operated
upon.
The most significant electrocardio
graphic finding was the presence of signs
of previous myocardial infarction of
indeterminate age (p = 0.0003). The risk
of complications depended upon the loca
tion of the infarct, being greatest when
both anterior and inferior infarction had
occurred (58%) and less with anterior
(30%) or inferior (14%) infarction alone.
History of a remote, clinically docu
mented infarction previously was not sig
nificant. The increased risk within 6
months of acute infarction is well known
and patients were not operated upon
under these circumstances.
The second most important predictor
was the presence of nonspecific STsegment changes (p = 0.0007). Goldman
noted that nonspecific or nonclassifiable
ST changes and flat or negative T waves
were associated with an increased

postoperative cardiac mortality (4% to
8%) by univariate but not multivariate
analysis.7 T-wave changes were not sig
nificant in our series. Age was the least
significant predictor of cardiac risk in our
patients. The incidence of cardiac com
plications postoperatively increased from
0% under age 40 to 21.4% among those
over age 80. Cardiac risk began to
increase at age 60, and was greatest over
age 70. A striking increase in patients over
70 years has been reported in a number
of other series.9 It is also of interest in
this series to note that age itself did not
alter the significance of other predictors
(electrocardiographic, NYHA class).

*4

Conclusions
Patients who undergo vascular surgery
run a substantial risk of cardiac compli
cations following operation. Among
patients requiring peripheral artery repair,
it is possible to identify a high-risk group
based on routine preoperative elec
trocardiographic findings, NYHA clas
sification of symptom severity and age.
We believe that patients in this high-risk
group should undergo intensive cardio
logic investigation before operation,
including cardiac catheterization and
coronary artery repair where appropriate.
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Intraoperative Bacterial Contamination of
Vascular Grafts: a Prospective Study
The establishment of graft infection
depends on host response, an appropri
ate field and bacterial contamination.
Intraoperative bacterial contamination of
prosthetic graft material was studied
prospectively in 77 patients. Vascular
reconstruction was indicated for abdomi
nal aortic aneurysm (15% ), claudication
(42% ), rest pain (25%) and ulceration or
gangrene (18% ). In 78% of cases the
procedure was elective. Staphylococcus
epidermidis was isolated in 80% of cul
tures; mixed flora were more frequent in
patients with rest pain (60%) and ulcera
tion or gangrene (45%) than in those
with aneurysms (22%) or claudication
(16% ). Grafts became contaminated in
56% of cases using standard techniques;
this was lowered to 35% when the sur
geon changed gloves before preclotting
the graft. There was no significant differ
ence with respect to the surgeon who
performed the operation, the indication
for operation, primary versus secondary
repair or the use of skin barriers. One
patient (1.3% ) had an established graft
infection. It is concluded that the inci
dence of contamination is high but may
be decreased by glove changing.
L'infection d’une greffe depend de la
rgponse de I'hote, de la presence d'un
champ favorable et d'une contamination
bactgrienne. On a etudie de fagon pros
pective, chez 77 patients, la contamina
tion bact6rienne peroperatoire d'un
greffon prothetique. II s'agissait de
reconstruction vasculaire pour angvrisme
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de I'aorte abdominale (15% ), claudica
tion (42% ), douleur au repos (25%) et
ulceration ou gangrene (18% ). Dans
78% , il s'agissait d'interventions differees. Du Staphylococcus epidermidis a
ete isole dans 80% des cultures; une
flore mixte etait plus fr£quente chez les
patients souffrant de douleur au repos
(60% ) et d’ulceration ou de gangrene
(45% ) que chez ceux qui presentaient un
anevrisme (22%) ou de la claudication
(16% ). Avec les techniques conventionnelles, il y a eu contamination du greffon
dans 56% des cas. Ce chiffre a ete
abaisse a 35% lorsque le chirurgien a
change de gants avant la precoagulation
du greffon. On n'a constate aucune dif
ference significative attribuable au chirur
gien, a I'indication operatoire, au fait
qu'il s'agisse d'une reparation primaire
ou secondaire, ou a I'utilisation de barrieres cutanees. Un patient (1.3% ) a vu
I'etablissement d'une infection de gref
fon. On conclut que la frequence des
contaminations est grande mais qu'elle
peut §tre reduite par un changement de
gants.

host response can be improved preoperatively. Bacterial contamination may
occur in the operating room or in the
early or late postoperative period.
Intraoperative contam ination of
prosthetic graft material was assessed
prospectively in this study to address the
following questions: What is the incidence
of graft contamination intraoperatively?
What organisms are involved? Are there
identifiable factors associated with con
tamination? and Can such contamination
be minimized intraoperatively?
Patients and Methods

A prospective study was conducted of
all patients who underwent vascular
reconstruction with a prosthetic graft
over an 18-month period at St. Joseph’s
Health Centre in Toronto. There were 77
patients; 4 were excluded because of
incomplete culture collection. Two groups
of patients were studied: group 1, 30
patients in whom operative care was rou
tine (i.e., no glove changing) and group
2, 43 patients for whom the operating
team changed gloves before preclotting
Infection of a vascular prosthetic graft is the graft. The indications for surgery
associated with substantial morbidity and included abdominal aortic aneurysm
mortality that ranges from 25% to 75%, (15%), claudication only (42%), rest pain
depending on the location of the graft.1 (25%), gangrene or ulceration, or both
Those who survive must spend a (18%) (Table I); secondary procedures or
prolonged period in hospital at consider revision surgery were included unless
able cost, many must undergo multiple established graft infection was present.
Of the 73 patients forming the study
procedures and 36% to 40% will lose a
limb.2’3 Improved supportive measures, population, 50 (68%) were men. The
potent broad-spectrum antibiotic therapy patients’ mean age was 65 years (ranging
and aggressive surgical management have from 48 to 94 years). Six patients had
not improved the results in established undergone previous vascular reconstruc
infections.2 Despite our awareness of the tion. The operations performed included
problem, careful surgical technique and axillofemoral bypass, femorofemoral
antibiotic prophylaxis, the incidence of bypass, aortic tube grafting, aorgraft infection still ranges from 2% to tobifemoral bypass and femoropopliteal
bypass. The procedures were elective in
5 % . 1-4
An appropriate field, a bacterial 78% and emergency in the remainder. All
challenge and the patient’s host response patients were managed in a standard
are factors in the establishment of a graft fashion by two vascular surgeons. All
infection. The open operative field is received cefazolin (1 g intravenously) 60
clearly unavoidable. Increasingly, patients to 90 minutes before operation; no sup
with an inadequate host response due to plemental antibiotics were given systemage, diabetes mellitus or malnutrition can ically or locally during surgery. In elec
be recognized and, where possible, their tive cases, the skin was shaved using a
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blade 12 to 18 hours before operation; in
emergency cases, the patient was shaved
immediately preoperatively. Skin scrubs
were done using povidone iodine. Sterile
reusable cloth drapes and gowns were
used in all cases. A plastic skin barrier
(Op-Site; Smith & Nephew Inc., Lachine,
PQ) was used by one surgeon (D.L.W.) for
part of the study period. External velour
grafts (Meadox Medicals, Inc., Toronto,
O nt.) were used; preclotting was per
formed in a standardized fashion with the
patient’s own blood using repeated flush
ing and stripping of the graft.
Cultures were taken from the patient’s
skin before scrubbing, the surgeon’s
gloves at the time of glove changing and
before preclotting the graft, the dry graft
before preclotting, the graft immediately
after preclotting and at the last anasto
mosis. A brain-heart-infusion (BHI)
medium was used for all cultures. Speci
men handling was supervised by one
microbiologist (SK).
Routine in-hospital, clinic and office
follow-up for 18 months was used to
detect established graft infection.
Statistical evaluation was performed
using the paired Student’s /‘-test.
Findings
There was no significant difference in
age, sex, indication for surgery or opera
tions performed between the two groups.
All skin cultures taken before skin
preparation yielded positive cultures.
O f these, 80% grew Staphylococcus
epidermidis. The other 20% grew
Staphylococcus aureus, Staphylococcus
saprophyticus, diphtheroids, anaerobic
Streptococcus, micrococci, Klebsiella sp
and Proteus sp. The incidence of organ
isms other than S. epidermidis was sig
nificantly (p<0.01) higher in patients
with rest pain (60%) and ulceration or
gangrene (45%) than in those with
aneurysms (22%) or claudication (16%).
The incidence of graft contamination
with the same species of organisms as
found on the patient’s skin in each study
group is shown in Table II. Most con
tamination occurred at preclotting in both
groups, but glove changing decreased the
incidence of contamination in group 2 by
10%. The surgeon’s gloves were contami
nated with the same species of organisms
as found on the patient’s skin in 53% of
cases. Although glove changing lowered
the contamination rate at preclotting,
ongoing contamination was evident in
both groups (Table II).
The incidence of contamination did not
differ with either surgical team (37%
versus 36.5%) or with the use of the plas
tic skin barrier (36% versus 37%). A posi
tive culture was obtained in 5 of 14
patients in whom no skin barrier was used
and in 6 of 16 with a skin barrier. There
was no correlation with the patient’s age
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or sex or with the type or duration of
operation. There were no gross breaks in
technique in any procedure and no addi
tional concom itant intra-abdominal
procedures were performed with the vas
cular repair.
One established graft infection was
identified in follow-up to 18 months. The
patient had had three revisions for graft
failure before signs of graft infection
developed; the offending organism (S.
aureus) belonged to the same species by
biotyping and antibiogram as that cul
tured at the initial procedure.
Discussion
The incidence of graft contamination
with glove changes (25% to 35%) and
without (37% to 56%) was remarkably
high but the incidence of established graft
infection was 1.4%. While long-term
follow-up over many years is needed to
rule out graft infection, infection from
intraoperative contamination should
become evident within 18 months of
grafting. Cruse and Foord5 showed base
line infection rates for “ clean” operations
of 1.81% and for “ clean vascular” pro
cedures of 3.7%; few studies report on
graft contamination alone. Ernst and
colleagues6 found that in 20% of
patients who underwent abdominal
aneurysm repair, the bowel bag or
aneurysm wall was contaminated, but
they did not culture the graft material
itself intraoperatively. Blomgren and
associates7 reported that 43% of wounds
and prostheses became contaminated dur
ing total hip procedures in conventional
operating rooms; Lidwell’s group8 found
a correlation between airborne contami
nation and joint sepsis in orthopedic
cases. Furthermore, they showed a
decrease in joint sepsis with prostheses if
contamination was decreased by using
“ ultraclean air systems” .9 Kluge and
colleagues10 noted similarly high rates of
contamination of tissues during cardiac
surgery.
Our study reports only the incidence of
contamination and, as quantitative
studies were not available, we cannot indi
cate the number of organisms present or
if a critical level of contamination was
reached. Foreign material has been shown

to initiate complex bacteria-graft-host
response interactions thereby potentiat
ing infection.11 Clinical composition,
shape and surface characteristics of the
graft and mechanical factors may all play
a ro le .11 Whereas some laboratory
models fail to show this potentiation of
infection,2 these results may be mislead
ing due to contrived bacterial chal
lenges12,13 or excessive numbers of
organisms.14 Bennion and colleagues14
have shown with small, graduated
challenges that different types of grafts
have varying patterns of resistance to
infection. Clearly, graft material renders
normally innocuous bacterial contamina
tion significant and infection by organ
isms of low pathogenicity may have seri
ous consequences.6
Many intraoperative sources of bac
teria are present. They include the patient,
nurses, surgeons and anesthetists, equip
ment in the operating room, the operat
ing room air and gross breaks in tech
nique. Contamination from staff is
generally episodic and associated with one
organism; in this study there was no con
sistent pattern of contamination despite
many personnel and the use of different
operating rooms. No gross breaks in tech
nique were identified, no patients were
systemically septic and graft cultures cor
related well with the flora found on the
patients’ skin. Therefore, the patient’s
skin was the most likely source of con
tamination. This is consistent with the
findings of sternotomy infections in
cardiac surgery.15 Further studies, using
endonuclease restriction analysis in order
to trace the organism from skin to graft,
are in progress.
In 80% of samples, S. epidermidis was
identified; this is consistent with the find
ings of this organism in 60% of patients
in the series of Ernst and colleagues.6 In
our series, the remaining 20% of samples

Table II—Contamination of Graft
With Same Organism as Found on Patient's Skin
Cultures obtained
After preclotting
At last anastomosis

Table I—Indications and Operations
Group 1,
no. <%)
Indication/operation
(n - 301
7123)
Aneurysm
14(47)
Claudication
6(20)
Rest pain
3(10)
Ulcer
18(60)
Aortobifemoral bypass grafting
9(30)
Extra-anatomic bypass grafting
3110)
Femoropopliteal bypass grafting

Contamination, %
Group 1
Group 2
35
25
56
35

Group 2,
no. (%)
(n - 43)
5(12)
16(37)
12(28)
10(23)
21 (49)
13(30)
9(21)
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grew other organisms, which correlated of wound infections and pneumo
with those cultured from ulcers or skin nia.2’11'15,17 Szilagyi and associates3 and
flora in patients with rest pain. Although Fry and Lindenauer18 have shown low
it is evident that patients with the gross incidences of graft infection with no
skin breakdown of ulceration and gan antibiotics and Fry and Lindenauer18
grene will have a more varied flora, the found no difference with antibiotics.
correlation with rest pain in 60% of Kaiser and associates16 in a randomized
instances is striking and unexpected; no double-blind study showed a decrease in
similar reports are available in the litera all infections with antibiotics; all graft
ture. It is proposed that patients in whom infections occurred in the group not given
perfusion is so borderline as to produce antibiotics. Antibiotic soaks and topical
rest pain are susceptible to minor and agents are ineffective.2 Recent animal
unnoticed areas of skin breakdown or studies with antibiotic bonded grafts show
cracking as well as a decreased immune good protection against infection in
response, allowing overgrowth of such experimental settings with Dacron,19
organisms. This finding may be impor human umbilical vein14 and polytant when selecting antibiotics for tetrafluoroethylene.20 The selection of
prophylactic use in patients with rest pain. the best antibiotic for such grafts is still
Rather than one drug given routinely to under study.
all patients with aneurysm, claudication
In view of the high incidence of con
and rest pain, patients with ulceration tamination of vascular grafts with the
should receive prophylactically antibiotics standard operative technique, antibiotics
specific to the organisms grown in pre should be given prophylactically.
operative cultures. Further studies are in Methods to decrease contamination by
progress to address this issue.
variations in operative technique are
As the incidence of contamination, being investigated.
sometimes with unexpected organisms, is
high, are there any factors that can be Conclusions
identified and controlled to limit such
contamination? All patients were shaved This study demonstrated a high inci
the night before surgery for elective cases dence of contamination of prosthetic
and immediately preoperatively for emer material during vascular reconstructive
gency procedures; there was no difference surgery. This contamination is indepen
in the rate of contamination in these two dent of the indication for surgery,
subgroups. We recognize that shaving in whether a primary or secondary repair is
the operating room or use of depilatory performed, the surgeon involved, the skin
agents decreases the incidence of infection preparation used and the use of plastic
in clean cases;5 however, the present ser barriers. The organisms identified are
ies does not address that issue. Routine consistent with the patient’s skin flora
skin preparation with an effective and may include a wide range of organ
agent16 was used in all patients. The use isms in patients with rest pain or ulcera
of plastic skin barriers has been impli tion. Contamination occurs prominently
cated in high rates of contamination in at preclotting and can be decreased but
orthopedic procedures7 but in this study not controlled by changing gloves. Ongo
there was no difference with or without ing contamination occurs throughout the
its use. No special ventilation or handling and placement of the graft.
“ ultraclean air” devices were used.
Antibiotics should be used in an attempt
The incidence of contamination imme to control established infection due to this
diately after preclotting using a standard contamination.
technique of flushing and stripping the
graft with their patient’s blood was 37%. References
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Introduction
Carcinoma of the large bowel is one of
the most common visceral malignant
lesions seen in the West. Worldwide inci
dence is also high with geographic varia
tions. In North America, the age-adjusted
mortality per 100 000 population shows
the highest rates in Canada (19.5), fol
lowed by the United States (17), then
Mexico (2.9). The diagnosis and manage
ment of patients affected with carcinoma
of the large bowel is therefore of great
concern to physicians and surgeons in
these countries.
This symposium has brought together
a distinguished panel of speakers to share
with us their practice and recommenda
tions in dealing with this common car
cinoma.
There is a saying that we should learn
from the mistakes of others, for we can
not live long enough to make them all
ourselves. This adage should be
paraphrased for our panel of specialists
so that “ we should learn from the
experiences of others for most of us as
general surgeons cannot have the volume
or live long enough to have them all our
selves” .

Our first speaker, Professor John
Goligher, is well known for his many arti
cles and his up-to-date complete text
book, “ Surgery of the Anus, Rectum and
Colon” . Professor Goligher will present
a paper on sphincter-saving operations
for rectal carcinoma.
Surgery must still be the principal treat
ment for malignant tumours of the large
bowel. The 5-year survival rates have not
really improved over the past 30 years.
Technically, surgery may have advanced
as far as it can, so we require other
modalities to assist us in extending treat
ment. The word “ adjuvant” is defined as
assisting, aiding or assisting another. Dr.
Norman W olmark’s paper on the role of
adjuvant chemotherapy in colorectal car
cinoma will help to do that.
The first two contributors deal with
what is hoped, initially, to be a curative
approach to colonic and rectal carcinoma.
To deal with the real spectre of recurrence
of the disease, which will occur in approx
imately 50% of patients, regardless of
stage, Dr. Bernard Langer will present his
views and recommendations on the
management of metastatic disease secon
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dary to colorectal carcinoma and Dr.
Alfred Ketcham will discuss the manage
ment of recurrent rectal carcinoma.
We know that in 50% of patients who
have recurrent disease after an operation
for cure, the recurrence will appear in the
first 18 months and the remainder within
4 to 6 years of the operation. Since there
is approximately 50% 5-year survival,
regardless of stage, how can we tell which
patients will have recurrent tumour? This
places a considerable commitment for
after-care and follow-up on the physician
and patient alike. Dr. James Langevin of
Calgary will tell us what he considers to
be the appropriate follow-up for patients
with colorectal carcinoma.
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1. Current Use of Sphincter-Saving Excision
in the Radical Treatment of Rectal Cancer
The author examines the recent
increased use of sphincter-saving forms
of excision to treat carcinomas of the
middle third and upper part of the lower
third of the rectum. This trend has been
due chiefly to technical innovations —
especially the introduction of the circular
stapler, which has extended the down
ward reach of low anterior resection —
and the willingness to accept a distal
margin of clearance in resections of 2.0
to 2.5 cm instead of 4 to 5 cm.
Published data show that these inno
vations are associated with a low opera
tive mortality and that satisfactory
anorectal function can be retained.
Insufficient length of follow-up, however,
has made it impossible so far to calcu
late valid long-term survival rates and the
high incidence of local recurrence in
some reports has been disturbing.
L'auteur examine I'augmentation r6cente
du recours b des formes d'excision
visant a sauvegarder le sphincter dans le
traitement des cancers du tiers moyen et
de la partie superieure du tiers inferieur
du rectum. Cette tendance est due principalement a des innovations techniques
— tout sp6cialement a I'av&nement de la
brocheuse circulaire et etend la portee
vers le bas de la resection anterieure
basse — et (’acceptation pour la resec
tion d'une marge distale de 2.0 £ 2.5 cm
plutot que 4 a 5 cm.
Les publications r£v£lent que ces inno
vations sont reliees a une faible mortalite
peroperatoire et qu'elles permettent de
conserver une fonction anorectale ade-
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quate. Le peu de recul du suivi fait toutefois qu'il est impossible de calculer un
taux de survie a long terme valable, et la
frequence eievee des recidives locales
signaiee dans certaines publications est
inquietante.

In a patient with carcinoma of the rec
tum, it is a very pleasant bonus to be able
to excise or destroy the tumour in such
a way that a permanent colostomy is not
necessary — provided that this does not
increase the operative mortality, lessen the
prospects of ultimate cure or leave
anorectal function so impaired as to
represent little better than a perineal
colostomy.
For virtually all carcinomas of the
upper third of the rectum, this ideal can
be readily attained by conventional
anterior resection.1,2 It is when we apply
sphincter-saving resection to cancers of
the middle and lower parts of the rectum
that controversy arises. At one time most
surgeons were reluctant to use this oper
ation for such lesions for various reasons
(Table I). Over the past 6 or 8 years, there
has been a revival of interest in more con
servative surgery for malignant disease of
the middle and lower thirds of the rectum.
This has been due mainly to technical
advances.
Before discussing these innovations, I
want to emphasize that what makes it
possible even to contemplate sphincter
saving resection, certainly for cancers of
the middle and lower segments of the rec
tum, is the fact that when the lateral liga

ments are divided at operation and the
rectum is mobilized down to the anorec
tal ring, the anteroposterior and lateral
curvatures of the rectum are abolished
and the bowel straightens out and
lengthens (Fig. 1). Consequently, a
tum our seen preoperatively at sig
moidoscopy to be 5 to 6 cm from the anal
verge moves proximally to 7 to 8 cm so
that it can be resected together with a dis
tal margin of clearance of 2.0 to 2.5 cm
— now considered adequate by most,2-5
but not all,6 surgeons — and yet leave
the anal canal and sphincters intact, often
with a small fringe of rectal ampulla. The

t

-4

«-t

A
A

FIG. 1—When lateral ligaments are divided
and bowel is mobilized down to anorectal ring,
rectum straightens out and lengthens, so that
tumour 5 to 6 cm from anal verge on preoper
ative sigmoidoscopy rises to 7 or 8 cm, allow
ing resection to be performed with distal mar
gin of clearance of 2 to 3 cm, yet leaving intact
not only anal canal and sphincters but also
sm all fringe o f rectal ampulla (after
Goligher2).

1

Table 1-Choice of Radical Operation in 100 Consecutive Unselected Patients
With Rectal Carcinoma
Site of tumour
Upper and middle thirds
Difficult growths of middle
third and some of lower third

Operation
Anterior resection with hand suture
Extended low anterior resection with stapler
Abdominoanal or abdominosacral resection
Hartmann's procedure or abdominoperineal excision
with colostomy
Abdominoperineal excision with colostomy

No. of
patients
55
20

25
Remaining growths of lower
third or anal canal
In addition 2 or 3 very early tumours in the lower third might be deemed suitable for local excision
or destruction instead of abdominoperineal excision, according to the philosophy of the surgeon.
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problem then is whether and how colorec
tal continuity can be restored.
Much depends on the site of the
growth, on the sex and physique of the
patient (low resections are much easier in
women than men and in thin than obese
subjects) and on the technical methods
that the surgeon can deploy. If standard
anterior resection is the only sphincter
saving method he can offer, some of his
patients (mainly men with tumours of the
lower middle third of rectum), though
eligible on pathological grounds for a
sphincter-saving resection, will be denied
that opportunity and instead be treated
by abdominoperineal excision and crea
tion of a permanent colostomy.
Alternative Methods of SphincterSaving Excision (or Treatment)

Abdominoanal (Pull-Through) Resection
Originally, this technique achieved

union between the resulting colonic stump
and the anorectal remnant simply by
drawing the colon through the latter, to
protrude for 7 to 10 cm beyond the anus.
After 2 or 3 weeks the excess colon was
amputated. Later versions have been
more elaborate, as in Parks’s method,7
which provides for a sutured endocavitary
coloanal anastomosis. Abdominoanal
resection was once popular in certain
clinics in the United States but its
popularity has declined.2

using the new circular staplers.2'10 The
great attraction of the circular stapler is
not that it constructs anastomoses more
quickly or securely than hand suturing but
that it makes possible from above some
anastomoses that would be impossible
without it, especially in heavily built men
with tum ours o f the low m iddle
third2'10'11 (Fig. 2). With the aid of the
stapler, about 15% of patients requiring
operation for cancer of the rectum can
now have an anterior resection.

Abdominosacral (or Abdominoposterior
Transsphincteric) Resection

Local Disc Excision o f the Primary
Tumour Through a Perianal or Posterior
Transsphincteric Approach,2 or Its Des
truction by Diathermy Fulguration'2-'3
or Endocavitary Contact Irradiation'4

In abdominosacral resection,2 after a
thorough mobilization of the left colon
and rectum down to the anorectal junc
tion during an initial abdominal phase,
resection and anastomosis are performed
through a sacral incision. Currently, the
leading exponent of this technique is
Arthur Localio of New York,8 who has
had most impressive results with it. In
Britain, Mason9 has been an equally
staunch advocate of a modification of the
operation in which the sacrococcygeal
approach is replaced by a posterior trans
sphincteric one. Despite the enthusiastic
reports of these two advocates, neither
version of the procedure has attracted
much support.
Extended Low Anterior Resection
Using the New Circular Staplers
From personal experience2 with
abdominoanal and abdominosacral resec
tion, I know that both are eminently prac
ticable methods, but unquestionably far
simpler to perform and much more popu
lar is the extended low anterior resection

Table II—Characteristics of a Sessile Rectal
Cancer, Suggesting That it May Be an Early or
Entirely Submucosal Lesion
Not more than 3 cm in diameter
Protuberant or not deeply ulcerating
Mobile on underlying muscle coat
No palpable pararectal lymph nodes
At least moderately well differentiated on biopsy

The rational use of these measures
depends on two conditions. The first is
that on pathological examination of
excised specimens, some rectal cancers are
found to be confined strictly to the rec
tal wall (Dukes’ class A); 15% of tumours
are in this category with 3% actually lying
entirely within the submucosa.2 The
second is that it is possible to recognize
with a high degree of accuracy (although
not 100%) on clinical examination which
carcinomas are in this category. To les
sen the risk of error, most surgeons try
to select for purely local treatment not
just Dukes’ class A cases but also those
with submucosal lesions, using the clini
cal criteria listed in Table II. But I stress
that, even if the surgeon is correct in
determining that direct spread of a
tumour is confined to the submucosa,
there is still an 11 % risk of nodal
metastases being present,15 for which
purely local therapy is quite ineffective.
To compensate for this weakness, local
treatment carries virtually no operative
mortality, even in poor-risk patients, as
against an immediate mortality for rec
tal excision in such unfit subjects of 8%
to 10%. In other words, local excision or
destruction is best reserved for patients
with early favourable lesions, who are
also unfavourable candidates for formal
rectal excision.
Relative Use of Sphincter-Saving
Techniques for Cancers o f the Middle
or Lower Thirds of Rectum

Table Ill-Satisfactory Findings on
Histopathological Examination of Disc-Removal
Specimen of Rectal Carcinoma

Fig. 2b
FIG. 2—Roentgenograms after small cau
tiously administered Gastrografin enemas, 12
days following low anterior resection in very
obese men with carcinomas of lower middle
third of rectum. Sites of anastomoses are indi
cated by metal staples. There is no leakage
(after Goligher2).

Confirms that in no part of the tumour on
multiple sections is the lesion of less than
average differentiation
Shows that the tumour is confined to the
submucosa or at most invades only the most
superficial part of the muscle coat
Reveals a margin of 0 .5 -1 .0 cm of normal
bowel wall at all parts of the periphery of
the lesion

In Table III, I have attempted to put
the indications for the recently favoured
sphincter-saving procedures for carci
nomas of the middle and lower part of
the rectum in proper perspective in the
overall management of rectal cancer. As
many as 75% of patients with rectal
cancer may npw be treated by a sphincter
saving type of resection—in about 55%,
a conventional anterior resection with
hand suture may be used, while in 20%
other forms of sphincter-saving resection
are required for lesions in the middle or
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Table IV-Comparison of 5-Year Survival Rates After Abdominoperineal Excision and Abdominoanal
Resection for Carcinomas of the Middle Third of the Rectum
Level above
No. patients
No. (%) alive
Type of operation
anal verge, cm
treated
> 5 yr
Abdominoperineal excision
6-10
182
93 (51)
Abdominoanal resection
5 -1 0 (in 81% of cases)
131
69 (53)
Hospital deaths and palliative cases were excluded. Adapted from Waugh and Turner.21

Site of lesion
Upper third
Middle third
Lower third
All sites

Table V-Incidence (%) of Local Recurrence After Abdominoperineal
Excision for Rectal Carcinoma According to Various Authors
Series
Stearns and
Gilbert sen24
Binkley23
(N = 369)
(N = 117)
?
14
?
20
?
30
22

24

Morson and
associates25
(N - 1596)
5
8
14
10

Table VI—Incidence of Local Recurrence After Anterior Resection With Hand Suture for Rectal Cancers
in the Upper and Middle Thirds of the Rectum
Series
Deddish and Stearns, 196126
Cullen and Mayo, 196327
Site of lesion
No.
No. (%)
No.
No. (%)
in rectum
treated
recurrences
treated
recurrences
Upper third
99
5 (5)
158
20(13)
Middle third
51
6112)
81
19(23)
All sites
150
11(7.3)
239
39(16)
Of 50 local recurrences, 32 were anastomotic, 18 pelvic.

lower thirds. Purely local treatment is
reserved for as few as 2% to 3% of
patients with growths in the lower third.
Results of the Newest Sphincter-Saving
Forms of Resection for Cancers of the
Middle and Lower Thirds of the Rectum

Operative Mortality and Morbidity
There are many published re
ports2'8,11'16'20 showing that the operative
mortality after the three forms of resec
tion has been roughly similar, about 3%
to 4%. The average incidence of anasto
motic leakage after low stapled anasto
moses has been about lWo2'10’11'16'17 and
a similar figure is quoted in the literature
for abdominoanal and abdominosacral
resections,8'18'19 although my modest
experience2 of the latter two procedures
has been less favourable, with more com
plications from dehiscence, pelvic sepsis
and hematoma formation than after low
anterior resection with the stapler.
Functional Results
Recent experience with very low resec
tions has shown conclusively that after
colorectal anastomoses as low as 4 and
5 cm from the anal verge or even after
coloanal anastomoses, anal control can
eventually often be normal.2,17 The rele
vant word is “ eventually” , because func
tion is at first usually greatly disturbed,
with frequency and urgency of defeca
tion; often the patient has 8 to 12 bowel

Table VII--Incidence of Local Recurrence After Sphincter-Saving Resection for Carcinomas
Mainly of the Middle Third of the Rectum in Recent Years
Series

Operative method

Goligher, 19821
Localio and associates, 19838
Parks and Percy, 198219
Keighley and Matheson, 198020
Hurst and associates, 198228
Luke and associates, 198329
Anderberg and associates, 198330
Lasson and associates, 198431
Reid and associates, 198432
Heald, 1984 (personal communication)
Oates, 1984 (personal communication)
Goligher, 1984 (unpublished data)

Abdominosacral
Abdominosacral
Abdominoanal
Abdominoanal
Anterior resection
Anterior resection
Anterior resection
Anterior resection
Anterior resection
Anterior resection
Anterior resection
Anterior resection

with
with
with
with
with
with
with
with

Period of
follow up, yr

No. patients
treated

No. (%) of
recurrences

2 -5
5+
1-5
1-3
0.5-2
2.5-5
?
0.5-3
2 -6
0.5-4
0.5-4
2 -7

18
89
73
7
34
44
39
40
29
110
60
120

2(11)
13(15)
6(8)
3(43)
11 (32)
10(23)
9(23)
8(20)
8(28)
3(3)
4(7)
11(9)

stapler
stapler
stapler
stapler
stapler
stapler
stapler
stapler

Table VIII—Outcome of Local Excision for Small Early Frank Sessile Rectal Cancers According to Various Authors
Early reoperation
Length of
for suspected
No. of
follow
incomplete
No. (%) of
Method
patients
Series
up, yr
removal, %
recurrences
42
14
Hawley and Ritchie, 198033
Mostly peranal
1-30
7 (20)*
Hermanek and associates, 198034
48
Peranal
20
Mean 3
5(13)*
?
Mason, 1983 (personal communication)
Posterior trans sphincteric
36
5-15
5(14)

No. (%)
of cancer
deaths
216)*
1 (3)*
2(6)

“ Patients having early rectal excision were excluded from the calculation of local recurrence.
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movements in 24 hours that cannot
always be com pletely co ntrolled.
However, over the next 3 to 6 months,
there is usually gradual improvement, the
frequency of bowel movements is reduced
to four or fewer daily and full continence
is regained.
Ultimate Cure
Five-year survival.—Unfortunately,
not enough patients with growths of the
middle and lower thirds of the rectum
have yet been treated by the newer
sphincter-saving resections or followed up
for long enough to enable worthwhile
5-year survival rates to be calculated; in
another 2 or 3 years sufficient data should
emerge. Meanwhile, some older statistics
from the Mayo Clinic warrant attention.
There, in the 1940s and 1950s, John
Waugh did many abdominoanal resec
tions for tumours of the middle third of
the rectum. He used the Bacon-Babcock
technique2 which gave poor functional
results and has since been abandoned;
nevertheless, insofar as excision was con
cerned, this technique did not differ sig
nificantly from the more recent tech
niques of sphincter-saving resection now
in favour. Admittedly, Waugh and
Turner’s21 comparison of abdominoanal
resection with abdominoperineal excision
(Table IV) was not properly controlled,
but it did suggest that the two operations
were almost equally effective in the cure
of middle-third tumours. A similar study
recently from St. M ark’s Hospital, Lon
don,22 reached the same conclusion.
Incidence or absence o f local recur
rence.—As is well known, local recur
rence is a not-infrequent sequel to
abdominoperineal excision for rectal
cancer, being commoner the more
advanced the growth and the lower it is
located in the rectum (Table V23'25). It
might have been expected that recurrence
would be at least as frequent after
sphincter-saving resections. That this is
not so is presumably owing to a degree
of selection of patients for these opera
tions with rejection of those who have
really low growths or particularly exten
sive spread. But the incidence of local
recurrence after sphincter-saving resection
also increases the more advanced the
lesions are and the deeper they lie in the
rectum (Table VI26,27). Some of the
recurrences are closely related to the
anastom otic site, others are more
diffusely situated in the pelvis. The data
in Table VI relate to patients treated in
the late 1950s. As the tendency in the
recent revival of sphincter-saving resec
tions has been to take on even lower
growths, a still greater incidence of local
recurrence would be a reasonable conse
quence. Some recent reports (Table
y j j i t8,i9,20,28-32) have jn fact recorded
recurrence rates of the order of 30% after
extended low anterior resection using the

circular stapler, but fortunately several
other workers, who have used the stapler
a great deal for this purpose, have not so
far encountered any large number of local
recurrences. Obviously, these recurrence
rates need to be monitored closely. It is,
however, hard to understand how the
method of joining two segments of bowel
together should affect the incidence of
recurrence.
Results of Local Excision of the Primary
Tumour
Some of the more important published
reports on the results of local removal are
shown in Table VIII. It should be empha
sized that the lesions dealt with in all these
cases were small, frank, sessile carci
nomas and not just apparently benign
polyps removed by snaring and found on
histologic examination to be malignant.
The series of Hawley and Ritchie33 and
Hermanek and colleagues34 represented
the collective efforts of St. Mark’s Hospi
tal, London and the University Surgical
Clinic, Erlangen, respectively, while the
report from Mason (personal communi
cation, 1983) refers to an entirely personal
series. In the first two series note the
resort to early reoperation in 14% and
20% of the cases, when the pathologist
found that the growth in the excised disc
specimen was more deeply invasive or
more active than had been thought on the
preoperative clinical examination and
biopsy. A 10% to 20% recurrence rate
may not seem excessive, but it must be
remembered that nearly all the cases in
these series had Dukes’ A or super A
(entirely within the submucosa) lesions,
which makes it somewhat less creditable.
Conclusions
Evidence has accumulated to show
that, in the recent wave of sphincter
saving excisions for cancers of the mid
dle and lower parts of the rectum during
the past decade, most of the objections
hitherto levelled at this type of operation
for such tumours seem to have been over
come. However, there is still uncertainty
as to the precise incidence and mechan
ism of local recurrence after their use for
very low lesions and continued close scru
tiny of this issue is of paramount impor
tance.
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2. Adjuvant Chemotherapy in Colorectal Cancer
The current status of adjuvant therapy
for colorectal cancer is reviewed using
examples from selected, recently com
pleted, randomized, prospective, clinical
trials. Although adjuvant systemic ther
apy is of limited therapeutic efficacy in
cancer of the colon, there have been
examples of beneficial effects in specific
patient subsets. The rationale and cur
rent status of adjuvant portal vein
hepatic perfusion suggest that it
represents a potentially promising
approach that must be evaluated in a
large prospective randomized study.
Finally, the value of adjuvant radiother
apy and chemotherapy for carcinoma of
the rectum is assessed. Although one
study has demonstrated increased
disease-free survival for patients receiv
ing a combination of chemotherapy and
radiotherapy, the small numbers in the
study preclude any definitive conclu
sions. The current National Surgical
Adjuvant Breast Project, rectal protocol
R-01, the largest rectal cancer study
with a concomitant "untreated" control,
is reviewed and discussed.
La situation actuelle des traitements
d'appoint du cancer colorectal est etudiee a la lumiere d'exemples tires
d'essais cliniques prospectifs randomises
qui ont ete termines recemment. Bien
que le traitement systemique d'appoint
soit d'une efficacite therapeutique limitee
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dans le cancer du colon, on a constate
des exemples d'effets benefiques parmi
des sous-groupes specifiques de malades. Les raisons et la situation presente
de la perfusion veineuse porte utilisee en
traitement d'appoint indiquent que cette
approche represente possiblement une
m£thode prometteuse valant la peine
d'etre evaluee dans un vaste essai ran
domise. On examine finalement I'interet
de la radiotherapie et de la chimiotherapie d'appoint pour le cancer du rectum.
Bien qu'une etude ait montre une prolon
gation du temps de survie exempt de
maladie chez des patients qui ont regu
une association de chimiotherapie et de
radiotherapie, le petit nombre de sujets
compris dans I'etude ne permet aucune
conclusion definitive. Le protocole R-01
du National Surgical Adjuvant Breast Pro
ject pour le cancer du rectum, la plus
vaste etude du cancer du rectum ayant
un groupe temoin "non traite," est
decrit et commente.

baseline, but the anticipated synergism
between the two agents was found to be
specious in the setting employed. Even
though the premise for those adjuvant
trials was erroneous, it was essential to
review the data objectively.

The emphasis placed on studies in adju
vant therapy depends on the natural his
tory of the disease under consideration.
Survival data for colorectal cancer indi
cate that a complacent attitude towards
surgery alone is unjustified. The belief
that microdissemination is present at the
time of surgery has led to current efforts
in assessing systemic therapy as an
adjunct to operative resection. The
greatest drawback to the use of adjuvant
chemotherapy for colorectal cancer is the
failure to identify agents that are partic
ularly effective in patients with advanced
disease. Colorectal cancer is particularly
resistant to chemotherapeutic manipula
tions. The early promise of such combi
nations as methyl-cyclohexyl-chloroethylnitrosourea (MeCCNU), 5-fluorouracil
(5-FU) and vincristine (VCR) for
advanced colorectal cancer has been
dampened by the subsequent demonstra
tion that these combinations have no
advantage over 5-FU alone.1'2 The previ
ous generation of randomized prospective
trials in adjuvant chemotherapy for
colonic cancer has been based mostly on
the nitrosourea-fluorinated pyrimidine

This trial (Table I), which studied 653
patients between 1973 and 1979, deserves
special mention because it provides the
longest follow-up of any study of com
bination chem otherapy, nearly all
patients having been studied for 5 years.
Patients randomized to receive chemo
therapy were given 5-FU intravenously,
9 mg/kg daily for 5 successive days, along
with a single oral dose of MeCCNU, 120
mg/m2, on day 1. Cycles were repeated
every 7 weeks for 12 months. Of the 653
patients, 645 were available for evalua
tion. When the data were analysed in all
patients without regard for nodal status,
no significant differences in survival were
found.3 However, when the presence or
absence of regional nodal metastases were
considered, patients with positive nodes
demonstrated prolonged survival that was
attributable to the chemotherapy. This
statistically significant difference (p =
0.004) in survival was derived exclusively
from patients with one to four nodes posi
tive for malignant disease. This study
represents one of the few instances in
which com bination chem otherapy
appears to have altered the natural his-

Adjuvant Clinical Trials of
Multiple Agents

Selected representative examples of
adjuvant clinical trials will provide a
reasonable overview of the whole. It is
regrettable that some studies did not
include a concurrent “ untreated” control,
thus eliminating the ability adequately to
analyse the data and to assess the natural
history of the disease in a controlled set
ting. The following three studies illustrate
the current efforts being made to treat
colonic cancer.
Veterans’ Administration Surgical Oncol
ogy Group ( VASOG), Protocol 27 A 3
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tory of colonic cancer, although the alter
ation was limited to a specific subset of
patients.

National Surgical Adjuvant Breast
Project (NSABP), Protocol C-OI

Adjuvant Clinical Trials of Local
and Regional Therapy

Gastrointestinal Study Group (GITSGJ,
Protocol 6175 4
This study was started in 1975 and
completed in 1979 after 621 patients had
been randomized (Table I). It was a fourarm study evaluating com bination
chemotherapy (MeCCNU and 5-FU) and
immunotherapy (methanol-extractable
residue of bacille Calmette Guerin [MERBCG]). It included only patients with car
cinoma of the colon (more than 12 cm
from the anal verge) with full-thickness
penetration and positive nodes (Dukes’
classes B and C). Patients were stratified
according to the number of positive
nodes; a C, lesion was defined as a
tumour associated with fewer than five
histologically positive nodes and a C2
lesion as being associated with five or
more positive nodes. It is interesting that,
unencumbered by the results from the
VASOG study, the G1TSG trial 6175 has
been cited as indicative of the failure of
adjuvant chemotherapy to prolong
disease-free survival.4 The data indicated
that after more than 5 years of follow-up,
no significant differences were apparent
for either recurrence or survival. The
prolonged time to recurrence previously
reported for com bined chem oim munotherapy was no longer significant in
the most recent analysis. A critically
important aspect of this study was the
demonstration that 29% of the patients
receiving chemotherapy suffered grade 2
or worse hematologic toxicity and seven
patients were noted to have acute nonlymphocytic leukemia, presumably drugrelated. This information stresses the need
to assess any putative benefits in the light
of potential risk.

This protocol (Fig. 1, Table I) was
initiated in 1977 and was terminated in
1983 after 1166 patients with Dukes’ class
B or C tumours had been entered; this
was the largest number accumulated in
the current series of clinical trials.
Patients were randomized into three
arms: (a) control, no further treatment
after curative resection, (b) chemotherapy
and (c) BCG. Eligibility was limited to
patients with standard Dukes’ class B
lesions (Kirklin B2) and those patients
with Dukes’ class C tumours. A colonic
tumour was defined by the protocol as
any lesion that did not require opening
of the pelvic peritoneum to identify the
distal margin. The chemotherapy differed
from the other cooperative groups in that
three drugs were used: 5-FU, MeCCNU
and vincristine. The results of this study
have taken on a greater importance in the
light of the apparently conflicting conclu
sions obtained from the VASOG and
GITSG studies. Preliminary results (an
average study period of 41 months) indi
cate that the chemotherapy cohort
demonstrates a small but significant
(p = 0.05) prolongation in disease-free
survival independent of the Dukes class.
The differences noted with adjuvant
combination chemotherapy are clearly of
limited therapeutic application. With the
documented risk of acute non-lymphocytic leukemia attributable to MeCCNU,
it is inappropriate to use nitrosourea com
binations in the adjuvant setting. From
a biologic standpoint, however, it may
very well be that colonic cancer, like
breast cancer, is manifesting a heter
ogeneous response to adjuvant therapy in
that certain subsets may demonstrate a
response to adjuvant chemotherapy.

Before discounting studies in which the
therapy is regionally oriented, I must
point out that the most intriguing prelimi
nary results have been provided by just
such a study. In 1975, Taylor and associ
ates, in Liverpool, initiated an adjuvant
trial in which the portal vein was infused
with 5-FU following resection of the
primary tumour.5'7 The logic for this was
based on the contention that in a substan
tial proportion of patients with colorec
tal cancer, metastases will develop in the
liver as the first and only site of recur
rence. Although the exact incidence of
hepatic metastasis is difficult to establish,
it has been argued that a therapeutic regi
men which could effectively decrease
hepatic metastasis would alter the natural
history of the disease and result in
improved survival. Although most evi
dence suggests that established hepatic
metastases are supplied predominantly by
the hepatic artery, the portal vein has
been found to play an important role,
particularly in supplying smaller tumours.
Thus, in the trial undertaken by Taylor’s
group, patients were randomized after
resection to receive portal vein hepatic
perfusion through the umbilical vein or
no further treatment. 5-fluorouracil was
given on 7 successive days (1000 mg/d)
starting postoperatively; heparin (5000
units/d) was also given. Between 1975
and 1981,212 patients entered the study;
97 were evaluated in the control group
and 90 in the perfusion group. Hepatic
metastases developed in 17 control
patients compared with 5 treated patients;
however, the incidence of local and
regional recurrences appeared unchanged.
The patients who seemed to sustain the
greatest benefit from therapy were those
with Dukes’ class B tumours; those with
class C lesions derived minimal benefit.
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FIG. 1—National Surgical Adjuvant Breast
Project, protocol C-01. 5-FU = 5-fluorouracil,
MeCCNU = methyl-cyclohexyl-chloroethylnitrosourea (semustine), VCR = vincristine,
a = 325 mg/m2 intravenously, days 1 to 5,
375 mg/m2, days 36 to 40. b = 130 mg/morally, day 1. c = 1 mg/m2 (max 2 mg)
intravenously, days 1 and 36. a, b and c every
10 weeks for eight courses, d = scarification
every week for 12 weeks, then every 2 weeks,
28 times.
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These results were achieved with very lit
tle toxicity.
The design and patient randomization
in this study have been criticized. The
5-FU dose was constant and was not
determined by the patient’s surface area.
Moreover, the effect of adding heparin
to the infusate was not controlled and it
is possible that the heparin may have had
a tumour-inhibiting effect. The criteria
for eligibility were such that some patients
with Dukes’ class D tumours were
entered, making data interpretation more
difficult. In spite of these criticisms, the
study provided preliminary results that
warrant optimism. If nothing else this
treatment regimen is certainly worth test
ing on large numbers of patients in a
cooperative group setting.
In an effort to assess the propriety of
portal vein hepatic perfusion, the NSABP
initiated protocol C-02 in March 1984.
Patients with colorectal carcinomas in
Dukes’ classes A, B and C are ran
domized to receive portal vein hepatic
perfusion with 5-FU, 600 mg/m2, and
5000 units of heparin on 7 successive days
or no further treatment following colonic
resection carried out for cure. To date,
over 300 patients have entered the study.
This trial represents a definitive test of
regional hepatic perfusion in the adjuvant
setting and will be instrumental in assess
ing a potentially innovative adjuvant
therapy.

study defined a rectal cancer as being
within 12 cm of the anal verge. Patients
were randomized into four arms after
resection of the primary tumour (Table
II): (a) control — no further treatment,
(b) chemotherapy consisting of MeCCNU
and 5-FU, (c) radiotherapy consisting of
4000 to 4800 rad delivered in 4 Vi to 5 Vi
weeks and (d) a combination of b and c.
The initial projected sample-size estimates
were for 520 patients to be evaluated in
order to detect a 50% increase in median
survival time for 2 to 3 years. In Febru
ary 1980, it was noted that one of the ran
domized arms was inferior to the other
three; as a result, that arm was unblinded.
The inferior group proved to be the con
trol group and as a result randomization
into this arm was discontinued and the
protocol was terminated shortly there
after. Consequently, the number of
patients in each group is small: of the 202
patients, 58 were untreated, 48 received
chemotherapy, 50 radiotherapy and 46
combination therapy. Results of this
study after a median follow-up of 80
months have recently been disclosed.8
They indicated that 55% of the control
group had recurrent tumour compared
with 46% for chemotherapy alone, 48%
for radiotherapy and 33% for the com
bined regimen.8 A significant (p = 0.009)
pair-wise difference in disease-free sur
vival was noted when the control group
was compared with the combined therapy
group. The strongest therapeutic benefits
were evident in patients with Q lesions
Adjuvant Trials in Rectal Cancer
(fewer than five affected nodes) in whom
Two studies have satisfactorily significant differences were evident
addressed the propriety of adjuvant ther among the treatment arms. Analysis of
apy in rectal cancer (Table II).
site of recurrence information again sug
gested an advantage in favour of the com
bined treatment arm. There was no sig
Gastrointestinal Study Group,
Protocol 7175
nificant difference in survival for any of
the treatment arms over operation alone.
In this study a beneficial effect has been Two treatment-associated deaths in the
claimed for adjuvant therapy. Because of combined treatment arm were attributed
the important influence that these find to radiation enteritis. The long-term inci
ings may have and have already imparted, dence of radiation enterocolitis has yet to
it is essential to review the data carefully be determined. The toxicity of this regi
and in detail. This study was started in men has been addressed by a subsequent
1975 and terminated in September 1980 rectal protocol initiated by the GITSG in
after 227 patients had been randomized; 1980 (GITSG 7180). This study represents
202 were available for evaluation. The a retreat from GITSG 7175 in that the

identical combined radiotherapy-chemo
therapy arm is compared to one in which
the MeCCNU has been eliminated in fa
vour of the 5-FU only.
The data from the GITSG protocol
7175 must be regarded as a major con
ceptual advance. They must be viewed as
an important initial indicator of the value
of adjuvant therapy in patients with
Dukes’ class B and C rectal cancers.
However, with only 46 patients available
for analysis in the group demonstrating
the greatest benefit and with the magni
tude of major toxicity encountered, it is
premature and inappropriate to extrapo
late these results to the treatment of
patients outside the context of clinical
trials. The GITSG results must await con
firmation from trials now in progress in
which adequate sample sizes are available.
National Surgical Adjuvant Breast
Project, Protocol R-01
The final study that merits review is
that of the NSABP. This study was
initiated in 1977 and to date over 500
patients with Dukes’ class B or C rectal
lesions have been randomized after resec
tion into three treatment arms: control
with no further treatment, chemotherapy
consisting of 5-FU, MeCCNU and VCR
and postoperative radiotherapy with a
central midline dose of 3200 to 4000 rad
delivered in 18 to 22 fractions (Fig. 2). A
rectal tumour is defined by this study as
one that requires the intraoperative open
ing of the pelvic peritoneum in order to
define the distal margin of the lesion. This
protocol, which has presently accrued the
largest number of patients, is the only
study currently in a position to compare
the results of adjuvant chemotherapy and
radiotherapy to a concomitant untreated
control. Consequently, the results of this
study are of pivotal importance. As of the
middle of 1984 with 41 months’ mean
time in the study, there appear to be
differences in men younger than 65 years.
Since the groups remain blinded with
respect to identity, conclusions on the
efficacy of the treatment modalities can
not be formulated. Until the results of this
study become available, adjuvant therapy
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FIG. 2—National Surgical Adjuvant Breast
Project, protocol R-01. a, b and c as in Fig. 1.
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either in the form of chemotherapy, radi
otherapy or the combination o f the two
must be regarded as experimental in car
cinoma of the rectum.
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3. Colorectal Cancer: Managing Distant Metastases
The best o p p o rtu n ity fo r cure in colorec
tal cancer is early diagnosis and c o m 
plete excision o f th e prim ary disease.
C urrently, m eta sta tic disease develops in
about 5 0 % o f patients, m ost o fte n in the
liver. Resection o f s o lita ry liver
m etastases is w a rra n te d , and a 5-year
survival o f a t least 2 5 % can be
expected. Patients w ith lim ite d unilobar
m ultiple m etastases m ay also b e n e fit
fro m resection. Extensive m e ta sta tic
disease to th e liver m ay respond to sin
gle or co m b in a tio n c h e m o th e ra p y.
Response rates are highest w ith hepatic
artery in fusion ch e m o th e ra p y, b u t
im provem ent in survival has n o t clearly
been show n. S olitary or lim ite d lung
m etastases, w h e n unassociated w ith
o ther m eta sta tic disease, should also be
resected. M ultiorg a n in v o lv e m e n t may
respond to syste m ic c h e m o th e ra p y but
results are generally poor. P alliation is an
im p o rta n t ob je ctive o f th e ra p y, in volving
n o t only a n tica nce r tre a tm e n t (surgery,
chem otherapy, radiotherapy) b u t also
general su p p o rtive care.
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La m eilleure chance de guerison du can
cer co lo re cta l repose sur un dia g n ostic
precoce e t I'excisio n co m p le te de la
tu m e u r p rim itive . Dans I'e ta t a ctu el des
choses des m etastases apparaissent
chez e n viron 5 0 % des p a tie n ts, la plup a rt du te m p s au foie. La rese ctio n des
m etastases hepatiques so lita ires e st indiquee et on peut s 'a tte n d re a une survie a
5 ans de 2 5 % . Les p a tie nts qui presente n t des m etastases m u ltip le s lim itees a
un seul lobe peuvent aussi p ro fite r d'un e
resection. Les m etastases hepatiques
etendues pe u ven t repondre h une c h im io 
th e ra p ie sim ple ou d is s o c ia tio n . Les
m eilleurs ta u x de reponse s o n t ob ten u s
par ch im io th e ra p ie a d m inistree en p e rfu 
sion dans I'arte re hepatique mais on n'a
pu d e m o n trer d 'a m e lio ra tio n n e tte de la
survie. Les m etastases p u lm onaires so li
ta ire s ou lim itees, quand elles ne sont
pas reliees a d 'a u tre s a tte in te s m eta sta tiques, d e vra ie n t aussi etre resequees. Les
a tte in te s de plusieurs organes peuvent
repondre a une ch im io th e ra p ie system ique m ais les resu lta ts so n t gendralem ent
m auvais. Un e ffe t p a llia tif c o n s titu e un
o b je c tif im p o rta n t du tra ite m e n t e t sup
pose non seulem ent le tra ite m e n t anticancereux (chirurgie, ch im io th e ra p ie,
radiotherapie), m ais dgalem ent des soins
de so u tie n generaux.

The 5-year survival rate for resected
primary colorectal cancer is approxi
mately 50%, with prognosis being related
to the stage of the disease. The liver is the
commonest site of hematogenous spread
and is involved in over 80% of patients
who have metastatic disease.1’2 One third
of these patients have liver involvement
only, the rest have widespread disease.
Pulmonary involvement occurs in only
about 10% to 15% of patients with

metastases and is commoner in those with
rectal cancer than in those with more
proximal colonic lesions. Isolated single
liver metastases are seen in 4% to 5% of
these patients, and lung metastases in 1%
to 2%. Considerable controversy remains
regarding both the selection of treatment
for metastatic colonic cancer and the
expected results from such treatment.
Metastases to the Liver
In patients whose liver metastases are
a part of widespread secondary disease,
regional treatment of the liver other than
for control of symptoms is inappropriate.
When metastases are confined to the liver,
regional therapy, consisting of either
resection or hepatic infusion chemother
apy, can be considered. To assess the
results of such therapy, detailed informa
tion on the natural history of the
untreated disease is needed.
The expected survival of patients with
liver metastases from colorectal cancer

Time a fte r m e ta s ta s e s (years)

FIG . 1— Survival of 39 patients with solitary
(solid line) hepatic metastases, 31 patients with
multiple unilateral (broken line) hepatic
metastases and widespread (dotted line) liver
m etastases, re p o rte d by W agner and
associates.5
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varies, depending on the extent of liver
involvement and presence or absence of
other metastatic disease. The older
reported data3 4 suggest survival times of
6 to 9 months for such patients and have
been used to support claims for effective
ness of new therapies that produce bet
ter mean survival in uncontrolled series.
Clearly, the use of such unselected,
unstaged historical data is inappropriate,
since patients who are selected for either
resection or infusion are usually those
with regional disease and most often less
advanced disease as well. If historical data
are to be used for comparison, the dis
ease must at least be staged; when this is
done,5 a difference in survival between
patients with solitary, unilobar multiple,
and widespread liver metastases is noted
(Fig. 1). These data also show that
without resection even patients with soli
tary metastases rarely survive for 5 years.
Resection of Liver Metastases
P rim ary and secondary hepatic
tumours were resected as early as 1888.6
Reports in the 1950s and 1960s indicated
survival rates following resection for
metastatic disease of approximately
20%.7
The technique of liver resection has
been improved to the point at which
major resections can be carried out with
a mortality of 5% or lower.8’9 It is also
now widely accepted that the results of
resection of liver metastases are as good
with adequate regional resection as with
formal anatomical lobectomy. The latter
is performed only to obtain adequate
tumour clearance and leave viable tissue.
Critical to achieving this low morbidity
and mortality are a good understanding
of hepatic vascular and ductal anatomy,
and sufficient experience in surgery of the
liver.
Although many authors now report
5-year survival rates after resection of
liver metastases ranging from 25% to
30%,8,9 there remain differences of opin
ion regarding the results of synchronous
versus m etach ro n o u s excision of
metastases, the importance of positive
lymph nodes related to the primary dis
ease, and the advisability of resecting
multiple liver metastases. Virtually no one
recommends liver resection in the
presence of uncontrolled primary disease

or other metastatic disease outside the
liver.
In the past, the tradition was that
metastases to either lung or liver should
not be resected until the primary tumour
was demonstrated to have been controlled
and other metastases had not ap
peared.10 Although many still hold this
view with regard to lung metastases, liver
metastases are usually treated more
aggressively. In the extensive review of
Foster and Berman,8 no significant
difference in survival was found between
patients having resection of metastases
discovered at the time of primary colonic
resection or of those that appeared later.
Wilson and Adson9 did note better sur
vival in metachronously resected secon
dary lesions but the results from both syn
chronous and metachronous excision
were encouraging enough to warrant an
aggressive approach in both situations.
The survival of untreated patients with
solitary liver metastases is clearly better
than in those with multiple metastases.5
One would expect the same difference in
the results of resection in these two groups
of patients. However, the reported data
do not clearly support this. Five-year sur
vival reported by Wilson and Adson9
clearly favours patients with solitary
metastases. However, the data accumu
lated by Foster and Berman8 showed no
clear difference in 5-year survival between
patients who underwent resection of sin
gle versus multiple metastases. Their
study did not clearly separate the unilo
bar from bilobar multiple metastases and
this may account for the favourable
results.
Our experience with resection of
hepatic metastases from various primary
cancers, reported in 1983,11 is outlined in
Table I. The large number of formal ana
tomical resections reflects in part our
earlier belief that lobectomy was the
preferred operation for malignant disease
of the liver. We are currently doing more
segmental and wedge excisions wherever
we can include adequate margins (at least
3 cm) of normal tissue.
Our actuarial survival curves (Fig. 2)
are in keeping with data reported in the
literature. We found a clear difference in
outcome between solitary and multiple
metastases, and we currently only resect
multiple metastases if they are unilobar
or, if multilobar, if they require only sim
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Hepatic Infusion Chemotherapy
Because of the generally discouraging
results of systemic chemotherapy in
metastatic colonic cancer, the technique
of infusion chemotherapy was developed
to allow higher drug concentrations to be
administered to the tumour area without
a comparable increase in systemic toxic
ity. Hepatic artery infusion has been used
since the 1950s, and in spite of technical
improvements in drug delivery systems
and the development of numerous regi-
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ple wedge excision. We found no differ
ence in survival between patients with syn
chronous or metachronous metastatic
disease.
Theoretically, about 2 of every 100
patients who undergo colonic resection
for cancer have, or will have, solitary liver
metastases and probably an equal num
ber with unilobar multiple metastases will
be suitable candidates for resection. It is
therefore important to look carefully for
such patients at the preoperative assess
ment, at operation for the primary
tumour and during follow-up. Serial
determinations of carcinoembryonic anti
gen and alkaline phosphatase levels, along
with physical examination, are used in the
follow-up of all patients who have cancer
of the colon. If liver tumours are sus
pected, either ultrasonography or com
puterized tomography are carried out.
When a tumour is deemed suitable for
resection, nuclear scanning is also done,
since it sometimes identifies multiple
lesions missed by the other modalities.
Angiography is always done preoperatively in patients thought to have resec
table metastases, to show the vascular
anatomy of the liver, and because it occa
sionally identifies patients with unresectable m ultiple lesions. When the
metastatic tumour is large and centrally
placed, hepatic venography is also used
to show the position of the hepatic veins
and to ensure that they can be cleared sur
gically.

FIG. 2—Actuarial survival of 16 patients
with colorectal cancer who had single (solid
line) or multiple (broken line) hepatic
metastases and underwent resection.
(Reproduced from Taylor B, Langer B, Falk
RE, Ambus U: Can J Surg 1983; 26: 215-7.)
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mens of combination chemotherapy there
is still no good evidence that infusion
chemotherapy prolongs life in patients
with liver metastases. Many authors
report response rates of 50% or more, but
most comparisons are with “ historical”
controls, and controlled trials have
yielded equivocal results.12 Infusion
chemotherapy should be reserved for
patients in whom systemic chemotherapy
has failed, or for patients entering con
trolled trials.
Metastases to the Lung

The first collected series of cases in
which metastatic disease of the lung was
resected was reported in 1947.13 Since
then, many have confirmed that
prolonged survival can be obtained fol
lowing removal of lung metastases.14,15
Secondary tumours from colon and rec
tum make up only about 20% of pulmo
nary metastases suitable for resection,
unlike the liver where they are by far the
commonest source of metastatic disease.
With modern surgical techniques and
conservative segmental or wedge exci
sions, the morbidity and mortality of pul
monary resection for metastatic disease
are low. Control of the primary disease
and absence of other metastatic disease
are necessary. Some still believe that
patients with a long disease-free interval
do better than those with synchronous
metastases, but others have found no
difference. Most workers are resecting
multiple metastases in selected patients
providing the lesions are few in number
and resectable with little loss of lung
parenchyma. In such patients there is no
significant difference in survival com
pared with patients who undergo resec
tion of solitary metastases. Five-year sur
vival rates of about 25% can be expected
after resection of colorectal metastases
using the above criteria.
Unresectable Metastases

Aside from a small number of patients
with isolated metastases to liver or lung,
or with early local recurrences, surgical
excision for cure is not possible in the
majority of patients with colorectal
metastases. The status of these remain
ing patients varies from the healthy
asymptomatic individual with small multilobar metastases to the liver only to the
moribund patient with widespread peri
toneal, hepatic and other disseminated
disease. In selecting from among treat
ment options in this heterogeneous group
of patients, a number of principles should
be kept in mind.
• Treatment is palliative only. There
are many reports of excellent responses
in symptomatic patients to a variety of

therapies that in the individual case seem
to prolong life as well as relieve symp
toms; however, there is no good evi
dence that any given treatment regimen
can predictably prolong survival.
• Treatm ent of asym ptom atic
patients with known disease, or patients
with unproven metastatic disease but at
a high risk for recurrence, can only be
justified as part of a controlled clinical
trial, because there is no good evidence
that treatment of such asymptomatic
patients either delays the onset of symp
toms or prolongs life.
• Palliative treatment of the sympto
matic patient should be based on detailed
information of the natural history of the
untreated disease, the side effects and
risks of the proposed therapy, and relia
ble information regarding the expected
response from the chosen therapy.
• The patient should participate fully
and in an informed way in decisions
regarding such therapy, with as full an
explanation of the expected benefits and
risks of medical therapy as one would
carry out in patients who undergo surgi
cal therapy.
The treatment options available for
patients with unresectable metastatic dis
ease include the following:
• Observation and supportive care.
This is required in all, but particularly in
those for whom specific antineoplastic
treatment is not thought to be worth
while. Therapy other than antineoplastic
agents for relief of symptoms is as impor
tant in such patients as the antitumour
therapy itself.
• Surgery should remain an option,
even in incurable disease, when required
for complications that can be corrected
with a reasonable expectation of pallia
tion, such as intestinal obstruction, bleed
ing and certain types of intractable pain.
• Radiotherapy is occasionally useful
to control pain, especially in bony or pel
vic recurrence.
• Systemic chemotherapy is indicated
in patients with symptomatic, systemic,
nonresectable disease, in patients who are
in satisfactory nutritional state, and in
those who are infection-free. Patients
over the age of 70 years tolerate such
chemotherapy poorly and selection of
such treatment in this group of patients
should be made with care. Acceptable
drug regimens in order of increasing
effectiveness, and also increasing toxic
ity, are 5-fluorouracil, 5-fluorouracil and
mitomycin C, and 5-fluorouracil,
mitomycin C and Adriamycin.
• Experimental therapy should be
used only under carefully controlled con
ditions and as part of organized clinical
trials. These include new combinations of
chemotherapy, immunotherapy and
hyperthermia.

Conclusions

The best opportunity for cure in
colorectal cancer is through early diagno
sis and adequate surgical excision. Care
ful follow-up of all patients is imperative
since in a small number of those in whom
recurrent disease develops, especially in
the liver, the cancer may still be curable
by surgical resection. The role of adju
vant therapy is still being defined.
Chemotherapy for symptomatic unresec
table metastatic disease should be selec
tive, remembering that the objective is
palliation, so that benefits may be max
imized and morbidity minimized.
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4. The Management of Recurrent Rectal Carcinoma
Rectal carcinoma remains an enigma to
surgical and medical oncologists. The
chemo- and radiotherapeutic approaches
have been fraught with failure, and when
this happens the patient is left to the
challenge of the surgical oncologist who
sometimes must perform extensive re
resection to include adjacent structures.
Experienced surgical judgement is
assisted by preoperative and intraopera
tive criteria, which are contraindications
to resection: preoperatively, they include
metastases, fixation of tumour to pelvic
wall, sciatica, obstruction of both ureters
and leg edema. Intraoperatively,
metastases within aortic nodes or
beyond the pelvis and extension of dis
ease laterally or deep to pelvic wall or to
multiple loops of bowel are all contraindi
cations. These tumours are often slow to
metastasize so that aggressive local sur
gical resection is warranted to minimize
the morbidity prone complications
associated with low-lying perineal or pel
vic recurrence of rectal cancer.

est laisse aux tentatives du chirurgien
oncologiste qui doit parfois proceder a
une deuxieme resection large, touchant
les structures adjacentes. Le jugement
chirurgical experiments considere les criteres preoperatoires et opSratoires qui
determinent les contre-indications de
resection: en preoperatoire on recherchera, les metastases, Tadherence de la
tumeur a la paroi pelvienne, une sciatique, I'obstruction des deux ureteres et
un oedeme des membres inferieurs.
Durant I'operation, les metastases des
ganglions aortiques ou au-dela de la
cavite pelvienne, et Textension laterale
ou profonde du cancer a la paroi pel
vienne ou a plusieurs circonvolutions de
Tintestin sont autant de contreindications. Ces tumeurs sont souvent
lentes a se metastasier de sorte qu'il est
justifie de faire une resection locale
aggressive pour reduire la morbidity et
les complications des recidives pelviennes ou perineales basses du cancer du
rectum.

Le cancer du rectum demeure une
enigme pour les oncologistes chirurgicaux et medicaux. La chimio et la radiotherapie debouchent trop souvent sur
Techec, et quand cela survient, le patient

Carcinoma of the colon and rectum is the
only malignant lesion of the gastrointes
tinal tract to be associated with a substan
tial cure rate. However, it is distressing
that the overall 5-year survival rate for
colorectal cancer patients approximates
only 42%. If the disease is diagnosed
before symptoms develop, then the sur
vival rate may reach 90%. It is difficult
to understand how there can be only a
42% survival rate from a disease that is
characterized early in its course by change
in the diameter, colour or consistency of
the stool, with or without associated
dietary gastrointestinal disturbances. This
failure of early recognition rests both with
the patient and the physician. Certainly
the American Cancer Society and other
health-oriented groups have publicized
the signs and symptoms of colonic cancer
to the extent that the reading and view
ing public should be aware that rectal
bleeding may arise from something other
than hemorrhoids. From the oncologist’s
standpoint, it is uncomfortable to realize
the number of patients who, upon leav
ing the physician’s office, have not had
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a digital rectal examination, or a guaiac
test for occult blood in the stool.
Late recognition with an overall sur
vival of less than 50% following primary
treatment leads next to the problem of
local failure. The recurrence of rectal
cancer is, in part, due to lack of early
recognition, but equally important, to
inadequate or less than optimal initial
treatment. Failure to recognize the extent
of the disease, locally within the bowel,
and the potential for spreading to other
areas at the time of the original surgery,
presents the surgeon with the challenge of
treating recurrent disease as if it can be
cured, not as if he will fail in 50% of
patients. It is equally important that the
extent of local disease or the identifica
tion of distant disease be recognized
before the surgeon decides on the
management techniques for proven recur
rent cancer of the rectum. If the goal is
symptomatic palliation because of pain,
bleeding or tenesmus, then the expense,
inconvenience and morbidity associated
with a metastatic work-up may not be
indicated. Before expensive and debilitat
ing local surgery is undertaken, it is
appropriate to establish the potential for
cure by ruling out, if possible, the
presence of liver, lung or distant lymphnode metastases. Computerized axial
tomography, liver scanning, hepatocellu
lar and hematochemical profiles and pos
sibly lymph-node biopsy of groin or
supraclavicular areas might all allow a
better understanding of the state of the
disease process.
Role of Therapy

The first question, then, must be
related to the role of therapy for the
recurrent colorectal cancer. Is it for
potential cure? Is it for palliation (in the
sense of relieving local symptoms)? Is it
to delay the expected local recurrence,
knowing that eventually metastases will
develop if the disease process is allowed
to continue unchecked? The final ques
tion that must be asked, particularly in
the academic environment, is: Is therapy
for study accrual based upon a ran
domized investigative protocol? It is with
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these questions in mind that the surgeon
must approach the local recurrence either
with local resection, cauterization, fulguration, chemotherapy, radiotherapy,
immunotherapy or the multidisciplinary
use of two or more of these modalities.
Today there is a trend towards conser
vatism in treating many cancers, partic
ularly in the lower colon and rectum. This
trend has been associated with an alarm
ing increase in recurrent disease being
identified at intervals that in no way allow
an opportunity for ultimate cure no mat
ter how aggressive the therapy might be.
It must be remembered that primary
abdominoperineal resection can be per
formed with a mortality of 0% to 2%.
Admittedly, the morbidity rates may
reach 50%, but morbidity can be toler
ated when one is dealing with a curative
procedure. Unfortunately, colorectal
cancer often extends laterally, requiring
removal of the endopelvic fascia and the
lymphatic and vascular structures
associated with the lateral pelvic walls,
and requires meticulous cleansing of the
iliac vessel system. Posterior extension of
the rectal tumour encroaching upon the
sacrum may require primary or secondary
partial sacrectomy. Unrecognized
penetration anteriorly into the vagina or
the prostate, bladder or urethra contrib
utes to failure in patients being treated
both primarily and secondarily. While
there is great reservation about the value
or need to remove the vaginal wall or the
prostate at the time of primary colorec
tal surgery, there should be no hesitation
in doing so when treating recurrent dis

Table I— Criteria Contraindicating
Exploration for Recurrent Rectal Cancer
Metastases beyond the pelvis
Tumour fixation to pelvic wall or frozen pelvis
unless there has been previous radiotherapy
Sciatic distribution of leg pain
Bilateral ureteral obstruction
Unilateral leg edema

Table II— Intraoperative Criteria
Contraindicating Resection
Aortic node metastases
Lateral or deep pelvic wall extension
Direct extension to multiple loops of bowel
Metastases beyond the pelvis

Table Ill-Clinical Prognostic Findings
Finding
Survival
One ureter involved
Decreased
Unilateral leg edema
Markedly decreased
Sciatic pain
Markedly decreased
Pelvic wall fixation
Markedly decreased
Both ureters involved
None

ease. I would minimize the role of local
intervention with cauterization, fig u ra 
tion or local resection in the absence of
identified metastatic disease. It is only the
experienced “ conservatist” surgeon,
using these techniques frequently, who
can successfully obtain disease control
through fulguration and other topical
local therapy regimens.
Adjuvant Therapy

Trends in treatment suggest that adju
vant radiotherapy with aggressive local
surgery results in a lower local recurrence
rate, but when the disease does recur, the
morbidity from repeat local resection is
overwhelming. It is therefore mandatory
that when adjuvant chemotherapy or
radiotherapy is used primarily or secon
darily, the surgeon must expect morbidity
associated with progression of the disease,
fistulization and urinary and bowel infec
tion. When one uses adjuvant radiother
apy, chemotherapy or even immunother
apy to convert the nonresectable lesion
into one that is potentially resectable, one
is dealing in the realm of the unknown.
Ordinarily, the extent of the procedure
needed to bring disease under control
after tumour shrinkage by adjuvant
chemotherapy or radiotherapy should be
identical to that required to bring about
total tumour removal without adjuvant
therapy. The diagnosis and management
of recurrent cancer of the pelvic structures
presents problems that do not have satis
factory solutions. The diagnosis is usually
tentative as histologic confirmation may
be difficult. The treatment is ineffective
in producing cure in many cases. Pelvic
recurrence occurs along the bony walls of
the pelvis but seldom invades the bone
until late in its development and causes
pain by pressure, particularly on the
nerves radiating usually down one leg.
Pain associated with recurrent pelvic
perineal cancer suggests non-resectable
recurrence. Seldom is perineal or radiat
ing pain associated with radiation fibro
sis alone. Few studies have authoritatively
documented any increase in survival
associated with the treatment of recurrent
rectal cancer using radiotherapy. Pallia
tion may be obtained but survival related
to distal disease is seldom altered. Distant
metastases remain the major cause of

death in patients with recurrent colorec
tal cancer.
Surgery for Cure

In the patient who is free of identified
metastatic disease, the surgeon may
decide to perform extensive local pelvic
surgery that almost never preserves
anorectal continence and seldom allows
preservation of the bladder and prostate.
The patient must be prepared for urinary
diversion with an abdominally placed
conduit as well as the usual colostomy for
fecal diversion if necessary. This exten
sive surgery necessitates removal of all
lymph-node-bearing tissue of the pelvic
structures and often resection of the
sacrum. When sacral resection must be
undertaken, the surgeon should not tran
sect above S3, for the dural sac extends
to the middle or lower portion of S2. For
tunately, if the bladder can be left intact,
bladder function is seldom impaired fol
lowing partial sacrectomy. Urinary com
petence may be delayed, but eventually
all patients will void normally.
Tables I and II briefly outline the
preoperative and intraoperative criteria
contraindicating surgical intervention and
operative resection for cure. Table III
outlines the prognostic significance of
specific clinical findings when dealing
with patients who have recurrent disease
of the pelvic structures. While these
criteria and prognostic findings are of
great help, they must be interpreted selec
tively, depending upon other clinical
manifestations in the individual patient.
Factors Contributing to Success
Several factors will contribute to suc
cess of surgery (Table IV). Cancer cells
can be disseminated within the wound by
instruments, gloves and rough operative
technique. It is therefore essential that the
wounds and adjacent structures be pro
tected from tumour-cell contamination by
one of the many new innovations in plas
tic wound drapes. Instruments must be
adequately cleaned or changed fre
quently. The washing of one’s gloves in
a wash basin beside the operating table
only leads to cells being washed off the
gloves and potentially picked up by cross
contamination to the assistant’s gloves

Table IV—Factors Contributing to Successful Resection
Elastic stockings
Gastrostomy?
Appendectomy?
Experience
Hemostasis (no packing)
Obliteration of dead space
Adeguate drainage
Peritonealization
Careful tissue handling

Wound protection
Instrument cleansing
Absence of glove and
instrument wash basins
Antibiotics
Bowel sterilization
Pulmonary toilet precautions
Fresh blood?
Early ambulation
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when he or she washes blood off.
Minimizing infectious complications by
thorough bowel preparation and ade
quate pulmonary precautions, with
efforts to prevent thromboembolism, will
all give a better opportunity for success.
Technically, the obliteration of all dead
space is mandatory, particularly in the
surgical field that has been irradiated.
Adequate drainage is essential and
peritonealization is ideal but is seldom
obtained. It has often been said that there
is no right way to do the wrong thing. So

often in the pelvic surgical intervention
for recurrent cancer, poor judgement has
been used in determining the feasibility
of cure. Surgical aggressiveness in the
irradiated lateral walls of the pelvis can
lead to unrelenting immediate or delayed
hemorrhage, particularly in the hands of
the uninitiated surgeon.

diagnosis of local recurrence of cancer in
the pelvis, this can be extended sometimes
indefinitely to the point of cure, by selec
tive surgical intervention. Surgeons
should approach perineal recurrence
aggressively for it is often curable. Pel
vic recurrence, however, is seldom cura
ble and it is never curable without a selec
tively aggressive attempt at resection. It
Conclusions
is unfortunate that surgeons sometimes
forget that the best way to avoid radical
While the median survival of 15 surgery is to perform major surgery at the
months is the accepted life span after first opportunity.

J ames M. Langevin, md, frcsc;* W. Douglas Wong, md, frcsc, FACst

5. What Is Appropriate Follow-up for the Patient
With Colorectal Cancer?
Overall recurrence rates after curative
resection for colorectal cancer average
3 0 % . The value of intensive follow-up
protocols is assessed from a review of
the literature, which reveals that recur
rent colorectal cancer can be detected at
an earlier stage (average 3 months) and
that repeat resection rates for cure can
be increased (twofold or more) by inten
sive follow-up. Despite this, no improve
ment in survival has been documented.
As nonsurgical modalities of therapy for
recurrence become further refined, earlier
detection of recurrent tumour will
become increasingly important. An inten
sive follow-up regimen is therefore pro
posed, based on a knowledge of the pat
terns and timing of recurrence, the
relative merits of the investigational
modalities available and the assumption
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that at some point earliest detection and
subsequent therapy will improve survival.
Dans I'ensemble, le taux de recidive
apres resection a visees curatives d'un
cancer du colon ou du rectum est en
moyenne de 30% . On evalue a travers la
litterature medicale, I'interet des protoco
les comportant des examens de surveil
lance intensifs; on y constate que les
recidives du cancer colorectal peuvent
6tre deceives a un stade plus precoce
(en moyenne de 3 mois) et que le nombre de deuxi&mes resections a visees
curatives peut etre augmente (pouvant
etre double ou davantage) grace a des
examens de controle frequents. Neanmoins, on n'a pu demontrer aucune ame
lioration de la survie. Avec le
perfectionnement du traitement non chirurgical des recidives, ('importance d'une
detection precoce ira en augmentant. En
consequence, on propose un programme
intensif d'examens de controle
s'appuyant sur revolution et le delai
caracteristiques des recidives, la valeur
relative des difterents examens disponibles et I'hypothese, qu'eventuellement,
une detection tres precoce et le traite
ment subsequent amelioreront la survie.

cure rate for colorectal cancer therefore
is approximately 50%.
At present, adjuvant treatment has had
no major impact on survival following
curative resection. Early detection and
surgical excision of recurrence currently
offer the best hope for improved survival.
What constitutes appropriate follow-up
to detect recurrence at the earliest possi
ble stage and of what value early detec
tion is, are controversial.
This paper will focus on four basic
aspects of follow-up. Where to look,
when to look, how to look and why to
look. A follow-up protocol is also recom
mended.
Risk, Pattern and Timing
of Recurrence

The first two aspects of follow-up
(where and when to look) must be based
on our current knowledge of the risk fac
tors, patterns and timing of recurrence.
Overall recurrence rates after curative
resection for colorectal cancer average
about 30% (Table I3'6). Stage at resec
tion, site of the lesion, size of the tumour
and patient age have consistently been
found to correlate with an increased risk
of recurrence. Those patients whose
Colorectal cancer is the second leading tumour has spread through the bowel wall
cause of cancer deaths in North are at greatest risk of recurrence. Of 285
America.1 In Canada, the mortality patients who underwent curative resection
from this disease has not changed over the at the Peter Bent Brigham Hospital in
last decade.2 Approximately 6000 Cana Boston, Malcolm and associates4
dians die annually of colonic and rectal reported an overall recurrence rate of
cancer and in a further 6000 the disease 27%. Lesions penetrating the bowel wall,
is diagnosed.2 Although two thirds of with or without positive lymph nodes,
the latter group will undergo a curative had the highest recurrence, 56% and 37%
resection, recurrent tumour will develop respectively. In this study patients less
in about one third of them. The overall than 60 years old and those with tumours
28, NO. 5, SEPTEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

larger than 4 cm in diameter were also at resulted from earlier detection by secondlook operation, which was carried out in
greater risk of recurrence.
A striking relation between the site of a high-risk group.
Late recurrence after curative resection
the primary tumour and recurrence rate
for colorectal cancer is low and is primar
has been demonstrated, with lesions in the
sigmoid colon and rectum at greatest risk ily distant. Welch and Donaldson9 found
for recurrence.4,7 In addition to having a that only 7% of recurrences occurred
after 5 years. Cass and associates"
higher overall rate of recurrence, patients
with rectal and rectosigmoid lesions have found only 6% of local recurrences after
that time. Late recurrence also occurs in
a higher rate of local recurrence compared
with those who have lesions of the prox patients whose primary tumour is more
confined. In the series of Welch and
imal colon.47-8 In a study of tumour
recurrences demonstrated at “ second- Donaldson, 33% of late recurrences
look” operations, Gunderson and Sosin8 occurred in patients whose primary
found that nearly 50% of recurrences tumour was classified as Dukes’ A; this
from rectal cancer were local or regional compared with an overall late recurrence
failures alone. Local failure was a com • rate of 14%.
In addition to late recurrence, follow
ponent in 92% of failures with only 8%
having distant recurrences alone. O f the up programs must be designed to incor
129 patients with cancer of the large porate surveillance for metachronous
lesions, which develop in approximately
bowel located proximal to the sigmoid
3.5% of patients surviving resection for
colon, Malcolm and associates4 found
no isolated local recurrence, but 88% dis colonic and rectal cancer. The mean inter
tant recurrences. A similar difference in val to detection of this tumour is about
11 years.12
the pattern of recurrence between prox
imal and distal large-bowel cancers was
Follow -up
demonstrated by Welch and Donald
A plethora of tests and examinations
son.9 They found no isolated local recur
are available for screening patients who
rences in lesions proximal to the sigmoid
have undergone a curative resection for
colon but local failure was a component
colonic and rectal cancer. To maximize
in 75% of patients with recurrence from
their usefulness, the decision to carry out
sigmoid and rectal cancer. This increased
these tests must be based on what is
recurrence rate is unrelated to stage,
known about location and timing of
although local failure rates also correlate
recurrence.
with the stage of the disease, increasing
with advanced stage and occurring
History and Physical Examination
primarily in the tumour bed and adjacent
History-taking and physical examina
structures.10
The timing of recurrence after curative tion are essential in follow-up, since
resection is relatively constant; 40% to
approximately 60% of patients will be
50% of recurrences will be manifest dur symptomatic when the recurrence is diag
ing the first year after resection, 70% by nosed, even when the follow-up has been
the second year and 90% or more by the intensive.13 A detailed history is more
fourth year (Table II6’8’9). The high early sensitive than physical examination in
recurrence rate in rectal cancer as demon diagnosing recurrence. Of the 48 patients
strated by G underson and Sosin8 with recurrent cancer found at follow-up
Table 1—Overall Recurrence Rates After Curative Resection
for Colorectal Carcinoma
Series

No.

Recurrence
no. (%)

Beart and O'Connell, 19833
Malcolm and colleagues, 19814
Cochrane and colleagues, 1980s
Berge and colleagues, 19736

168
285
180
639

48 (29)
76 (27)
71 (39)
217(34)

Table 11-Rates (%) of Recurrence at Various Intervals
After Curative Resection for Colorectal Carcinoma
Interval, mo
6

12

24

48

18

41
48
-

69
70
80

89
92
99

Series
Welch and Donaldson, 19789
Berge and colleagues, 19736
Gunderson and Sosin,* 1974s
‘ Rectal cancer only.

-
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by Beart and O’Connell,3 41 (85%) had
symptoms before or at the time the recur
rent tumour was detected by physical
examination, or biochemical or radiologic
abnormalities. Only 16 (33%) had posi
tive physical findings.5 The value of the
history and physical examination is
limited by the fact that the recurrence is
diagnosed late and only rarely can sym
ptomatic patients have their lesion
resected for cure. In a prospective study,
assessing the value of intensive follow-up
after curative resection for colonic and
rectal cancer, Tornqvist and associates13
found that in only 8% of symptomatic
patients was the recurrence resectable for
cure, compared with 39% of asym pto
matic patients.
Hemoccult Test
Stool testing for occult blood is simple
and inexpensive and is useful for detect
ing an asto m o tic recurrence and
metachronous lesions. In terms of detect
ing recurrence, however, the yield from
this test is low, because overall 90% of
recurrences are non-mucosal.3’13
Endoscopy
The endoscopic procedures available
for surveillance of recurrence are more
sensitive for mucosal recurrence than
either hemoccult test or barium enema
examination.14 They are both diagnostic
and p o ten tially th erap eu tic for
metachronous lesions, but they carry the
same limitation as the Hemoccult test in
that the majority of recurrences are nonmucosal. Of the 240 patients followed up
through colonoscopy by Nava and
Pagana,14 only 17 (7.1%) had mucosal
recurrence. Fifty-one patients (21%) had
a benign tumour resected and in 4.6% of
them a metachronous cancer developed
in the 4-year follow-up period.14 Beart
and O’Connell3 found that in only 3
(23%) of 13 patients with pelvic recur
rences after anterior resection could the
recurrent lesion be detected by proc
toscopy.
Biochemical Tests
These are used primarily to detect
hepatic m etastases. Kemeny and
colleagues15 evaluated prospectively the
usefulness of several biochemical tests of
hepatic function and carcinoembryonic
antigen (CEA) levels in identifying
patients with hepatic metastases. They
found no single laboratory test that gave
more than 65% accuracy in detecting
hepatic metastases and no combination of
tests increased this accuracy. Carcinoem
bryonic antigen, lactic dehydrogenase,
alkaline p h o sp h atase and alan in e
aminotransferase levels were, in that
order, the most accurate of 13 laboratory
tests studied. No patient with obvious
liver metastases on physical examination
was included in this study.15
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Radiologic Investigations
Of the conventional radiologic proce
dures, chest roentgenography continues
to play an important role in detecting
metastases. Approximately 50% of lung
metastases detected on the chest film are
asymptomatic and, of these, 50% or more
will be resectable for cure with a 5-year
survival of about 30% .13,16 Intravenous
pyelography in the past was used to deter
mine pelvic recurrence but is of no value
because by the time abnormalities are
detected, recurrence is advanced and nonresectable. D ouble-contrast barium
enema examination is of value in detect
ing anastomotic recurrence or meta
chronous lesions. It is most sensitive when
a baseline study is available for compari
son; however, it is less sensitive than
colonoscopy.14 It is a recommended
procedure when colonoscopy is not avail
able or is incomplete.
Imaging Techniques
Body imaging techniques are inap
propriate for screening as they are expen
sive and time-consuming. Liver scanning
and ultrasonography are both about 80%
accurate in demonstrating liver meta
stases.17 Computerized tomography is
slightly more accurate18 but its major
impact has been in identifying pelvic
recurrence.
Tumour Markers
Tumour markers will play an increas
ingly important role in the early detection
of recurrence. Carcinoembryonic antigen
is the most specific and sensitive of the
tumour markers, levels being elevated in
75% of recurrences.19 It is the first evi
dence of recurrence in 33% of patients
when done on a monthly basis after cura
tive resection and levels are elevated in
45% of patients before there is clinical
evidence of recurrence.19,20 In fact, this
elevation can be detected as early as 6
months before there is any clinical evi
dence of recurrence.21 Carcinoembryonic
antigen, however, is a poor indicator of
local recurrence.22,23 It is most sensitive
for disseminated disease and gives a high
rate of both false-negative and false
positive results. At present, its greatest
potential is in identifying patients who
would benefit from a second-look oper
ation.
Various other tumour markers are
being investigated as alternatives or
adjuncts to CEA. They include acutephase reactive proteins,24 Tennessee anti
gen,25 carbohydrate 19-9 antigen26 and
tissue polypeptide antigen.27 So far,
none of these have superseded CEA.
Although its clinical usefulness is not yet
established,28,29 radioimmunodetection
using labelled antibody to CEA and other
tumour markers may prove to be more
426

useful in detecting recurrence than assay
for tumour markers. An additional
benefit is the localization of recurrence.

tive resection. At Ohio State University,
M artin and associates32 have been
involved in a program of CEA-directed
second-look operations since 1972. In
Second-Look Operation
their retrospective series of 22 patients,
The most aggressive approach aimed at
the CEA level was determined every 3 to
identifying localized recurrence has been
6 months. Twenty-seven percent of
the second-look operation. Wangensteen
patients in this group underwent resection
and associates30 initiated this concept to
for cure. This represents a twofold
improve survival of patients at high risk
increase in the reoperation rate for cure
for recurrence. Despite 12% and 20% sal over routine follow-up not using CEA.13
In their prospective series which started
vage rates in the asymptomatic and
in 1976, 38 patients underwent secondsymptomatic groups respectively, this
approach did not gain wide acceptance look operations based on a rise of the
because o f the high false-negative CEA level determined at 45 to 60-day
laparotomy rate (50%) and the high mor intervals. Sixty-one percent of patients in
tality (10%).31 By adopting a second-, this group had recurrent tumour resected
look approach on the basis of an elevated for cure.
Early detection of recurrence is in itself
CEA, the high false-negative laparotomy
rate seen with the second-look procedure important and is achievable with an inten
alone can be greatly reduced.32 Such sive regimen. It will become increasingly
operations have been shown to increase important as nonsurgical therapeutic
repeat resection rates for cure but, modalities are refined. Other benefits of
although selectivity is enhanced by deter a follow-up program include detection
mining the CEA level, the false-negative and treatment of metachronous lesions,
laparotomy rate is still about 12%.33 an increased sense of patient well-being
Follow-up as yet is too short to demon and the opportunity for ongoing ther
strate any increase in survival by this apeutic assessment.
approach.
Based on current knowledge of recur
rence patterns, timing of recurrence and
Rationale and Protocol for
relative usefulness of available assessment
Intensive Follow-up
modalities, a follow-up protocol is recom
The prime rationale for intensive mended (Table III). It includes history
follow-up of the patient with colorectal taking, physical examination and Hemoc
cancer is to identify recurrences at a stage cult test, colonoscopy, sigmoidoscopy
when they may be resected for cure and and barium enema examination and chest
thus to improve overall survival. Repeat roentgenography. Liver function tests
resection rates for cure vary in the litera should be repeated at each patient visit.
ture from 2% to 20% but average about The CEA level should be determined
10%.13 This can be increased substan every 2 months for 2 years, every 4
tially by identifying recurrences early at months for 2 years, then every 6 months
an asymptomatic stage.13,32 Increased to 10 years. A second-look operation
survival by early detection of recurrence, should be performed as necessary, based
however, has yet to be demonstrated. The on the finding of an elevated CEA level.
5-year survival following resection of A metastatic work-up should be com
recurrence for cure, detected by routine pleted before operation to rule out incura
follow-up, averages about 30%.9 Car ble disease.
cinoembryonic antigen-directed secondlook operations appear to offer the References
greatest hope for increasing survival in
1. Third International Symposium on Colorectal Cancer.
patients with recurrence following cura
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Chairman’s Comments
Although cancer of the colon and rectum
has the highest cure rate of all cancers of
the gastrointestinal tract, with an average
5-year survival for all grades of 50%,
there are many aspects that still confound
surgeons in their attempt to improve the
cure rate. Surgery, except for a few
modifications and refinements, has prob
ably gone about as far as it can. Consider
able effort is going into earlier diagnosis
with patient education and further alert
ing the physician to the possibility of
colorectal cancer. With the observation
that the geographic distribution of
colorectal cancer has changed, and the
known deficiencies of roentgenographic
investigation, the development and
general use of colonoscopy has occurred
fortuitously. Earlier diagnosis and espe
cially the removal or identification of
premalignant lesions should improve
results. Time and study will show whether
this optimism is justified.
With respect to the usual presentation
of colorectal carcinoma, the standard
procedures are the backbone of surgical
treatment. In rectal carcinoma there has
been some change with the advent of cir
cular stapling devices, enabling more
anterior resections to be carried out

without the associated use of a colostomy
so that multiple procedures and a perma
nent stoma have been eliminated in a sub
stantial number of patients with rectal
carcinoma.
Recurrence, of course, is still the
spectre that looms in the wings following
surgery for “ cure” . In about 50% of the
patients with recurrence, the tumour will
appear in the first 18 months after resec
tion of the primary tumour and the
remainder in 4 to 6 years. Much has been
written on follow-up regimens that will
improve earlier detection of recurrence.
The initial optimism of tumour markers
has not been borne out. The most univer
sally used, carcinoembryonic antigen
(CEA), has been found wanting because
of false-negative and false-positive results
of over 30% at some centres. It has been
stated that by the time the CEA value
reaches significantly positive levels —
some 6 months before a clinical diagno
sis can be made — the recurrence is
unresectable. Even if attempted resection
is accomplished, it seldom produces a
cure. A search for more accurate and sen
sitive markers is necessary. In “ secondlook” procedures, the risk, cost and
disease-free period has not been realized.

Although much has been made regarding
follow-up regimens, with early and
repeated visits, and extensive investiga
tion, the detection o f early recurrence is
generally disappointing and recurrent
lesions so found are usually inoperable.
Computerized tomography provides
more accurate information on extramural
extension of postoperative malignant
tumours in the pelvic region and may also
give useful preoperative information on
the extent of the tum our, nodal involve
ment and degree of invasion.
To approach the problem with meas
ures other than surgery, adjuvant modal
ities such as chemotherapy, radiotherapy
and immunotherapy have not really made
significant changes in survival except in
a palliative sense. Much work still is to
be done before the possible benefits of
such agents are realized. Thus, in spite of
refinements in surgery and adjuvant ther
apy, the cure rate for cancer of the large
bowel has not increased appreciably.
Early diagnosis, meticulous technique
and standardization of surgical proce
dures may produce the best initial results.
A great deal must still be done in the field
of adjuvant therapy to increase the sal
vage rate.
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With the advent of the stapling gun,
more patients can undergo restorative
resection without needing a colostomy,
temporary or permanent, as Professor
Goligher has noted. The upper one third
of the colorectum presents no problem.
But when the tumour lies in the middle
and lower thirds, there is controversy over
the procedure of choice. With the stapling
technique, continuity can increasingly be
restored.
Goligher has reviewed the various
sphincter-saving operations and opts for
the circular stapling device. Up to 75%
of patients with rectal cancer can be
treated by sphincter-saving resection; of
these, 55% of procedures can be accom
plished by hand-sewn techniques and
20% can be done only by stapling tech
niques.
Combined adjuvant chemotherapy in
the form of local and regional chemother
apy, portal vein infusion chemotherapy
and combined chemotherapy and radi
otherapy has limited application in
prolonging survival of patients with
colorectal cancer, as Wolmark has
pointed out. He reviews and analyses
selected papers and protocols in adjuvant
therapy for cancer of the large bowel.
Although he draws no specific conclu
sions, it is apparent that the results have
not improved statistically. Much work has

yet to be done but at present colorectal
cancer is resistant to this type of therapy.
The liver is the most common site of
hematogenous spread o f colorectal
cancer. As Langer notes in his paper, it
is involved in over 80% of patients with
metastatic disease. One third have liver
involvement exclusively, others have
widespread dissemination, 4% to 5%
have an isolated single metastasis of the
liver and pulmonary metastasis occurs in
10% to 15%. Liver resection, when there
is no other disease, can now be performed
with approximately 4% to 5% mortality.
The outcome in patients with solitary
lesions is better than in those with multi
ple tumours. At one time the preference
was a formal lobectomy but more seg
mental and wedge excisions are being per
formed, provided adequate margins of
normal tissue can be obtained, and there
are reports of 5-year survival after resec
tion for liver metastasis ranging from
25% to 30%. Hepatic perfusion chemo
therapy has given discouraging results.
There is no good evidence that it prolongs
life. In secondary pulmonary lesions in
selected patients, the survival rate can be
up to 25%. The author gives an excellent
review of surgical options and require
ments for the treatment of distant
metastasis to liver and lung, as well as
guidelines for the management of
unresectable disease.

Dr. Ketcham recommends an aggres
sive approach to perineal recurrence and
radical surgery initially but, like most sur
geons, has found that recurrences are
often distant and therefore incurable and
that most local pelvic recurrences also
have probably progressed to this state at
the time of diagnosis.
Langevin in his paper describes the pat
terns of recurrence, which are most
marked in sigmoid and rectal tumours,
especially tumours more than 4 cm in
diameter and those in patients younger
than 60 years; these recurrences are more
commonly local ones. Proximally placed
tumours are associated with more distant
metastasis. He provides a good review of
some of the current thoughts on the
natural history, incidence and follow-up
for carcinoma of the large bowel. From
his observations he recommends a
postoperative protocol for follow-up of
patients with colorectal carcinoma.
R obert H. T horlak so n , m d ,
FRCS, FRCSC, FACS

Symposium chairman
Professor of Surgery,
University of Manitoba,
Winnipeg Clinic,
Winnipeg, Man.
R3C 0N2

Agarol*
A PRESCRIBING INFORMATION ^

INDICATIONS: Acute functional constipation:
debilitating disorders complicated by inadequate
bowel action; in post-operative cases, hyper
tensive or chronic cardiac disorders where
forcing a stool must be avoided; in constipation
of pregnancy; in bed-ridden or elderly patients.
CONTRAINDICATIONS: Symptoms of
appendicitis. Idiosyncrasy to phenolphthalein.
PRECAUTIONS: Frequent or prolonged use
of this preparation may result in dependence
on laxatives. If a skin rash develops, discontinue
the use of this or any other phenolphthaleincontaining preparation.

Agarol* goes to work overnight to gently
encourage bowel motility. Consider
its timely action for the relief of
occasional constipation.

Popular marshmallow flavour.

DOSAGE: Adults—2 to 4 teaspoonfuls at
bedtime; if necessary repeat this dosage the
next morning, two hours after breakfast
Children (three to six years)—J4 to 1 teaspoon
ful; (over 6 years)— 1 to 2 teaspoonfuls; (under
three years)— proportionately smaller doses
according to age. May be taken alone or in
milk, water, fruit juice or any miscible food.
SUPPLIED: Each 5 mL of creamy white,
marshmallow-flavoured, calorie-free emulsion
contains: mineral o il-1.60 mL, glycerin200.0 mg, phenolphthalein-65.0 mg. Also
contains agar. Sodium content: 8.3 mg/5 mL.
Available in 250 mL, 500 mL and 750 mL
plastic bottles.
Full information is available on request.

PARKE-DAVIS

Parke-Davis Canada Inc., Scarborough, Ontario

PARKE-DAVIS

IH Iil *Reg.T.M- Warner Lambert Company, .-------.
l££££J Parke-Davis Canada Inc., Auth. User l ' " “ -I

Parke-Davis Canada Inc., Scarborough. Ontario
I p a a b I ‘ Reg T M W a rn e r-L am be rt Com pany
P arke-D avis C anada Inc auth. user

lCCPPl

428

l P“ ACJ

VOLUME 28, NO. 5, SEPTEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

ORIGINAL ARTICLES
D.H. Hosking,

mb , frcs (edin), frcsc ;*

E.W . Ramsey ,

I.M. Morrow ,

md , fr c p ;!

mb , frcs , frcsc *

Percutaneous Removal of Upper Urinary Tract Calculi:
Experience With Ultrasonic Lithotripsy
From October 1983 to March 1985, the
authors removed upper urinary tract cal
culi percutaneously in 102 patients. In
89 patients, stones required disruption
with an ultrasonic lithotriptor before
removal. Fifty-two patients had a stone
in the renal pelvis and 20 had calyceal
stones only; 21 had stones at both sites
and 9 had a stone in the upper ureter.
Complete removal of all stone material
was achieved in 67 of 68 patients with
a solitary calculus, in 13 of 26 with mul
tiple calculi and in 6 of 8 with ureteric
calculi. Complications were minimal;
three patients had pulmonary edema
postoperatively as a result of excessive
absorption of irrigating fluid, and one
patient sustained a perforation of the
descending colon. The mean postopera
tive hospital stay was 6.8 days and
patients were able to return to work a
few days after their discharge from
hospital.
Percutaneous stone removal is a safe
and effective procedure and is the surgi
cal procedure of choice for the removal
of upper urinary tract calculi.
D'octobre 1983 a mars 1985, les
auteurs ont retire par voie percutanee,
des calculs des voies urinaires superieures chez 102 patients. Pour 89 patients,
les calculs ont du etre brises a I'aide
d'un lithotriteur a ultrasons, avant d'etre
enleves. Cinquante-deux patients avaient
des calculs du bassinet rgnal alors que
20 avaient des calculs caliciels seulement; 21 avaient des calculs loges aux
deux sites a la fois alors que pour 9, le
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calcul etait loge dans la partie superieure
d'une uretfcre. L'enl&vement complet de
toute substance calculeuse a pu etre
r6ussi chez 67 des 68 patients qui
avaient un seul calcul, chez 13 des 26
patients qui avaient des calculs multiples
et chez 6 des 8 patients qui avaient des
calculs uret£raux. Les complications
furent rares: trois patients souffrirent
d'un oedeme pulmonaire postoperatoire
resultant de I'absorption excessive du
liquide d'irrigation, et un patient a subi
une perforation du colon descendant. La
duree moyenne du sejour hospitalier post
operatoire a ete de 6.8 jours et les
patients ont pu reprendre leur travail
quelques jours apres avoir recu leur
conge de I'hopital.
L'enlevement des calculs par voie per
cutanee est une intervention sure et efficace et c'est I'operation de premier choix
dans les cas de calculs des voies urinai
res superieures.

Removal of an intrarenal calculus
through a percutaneous nephrostomy
tract was first described in 1976.1 The
subsequent development of an ultrasonic
lithotriptor has made it possible for the
urologist to disrupt intrarenal calculi
before removal. Following encouraging
early reports from Europe,2'3 percutane
ous ultrasonic lithotripsy was introduced
into the United States in late 1981.4,5 We
report our experience since October 1983,
at the Health Sciences Centre in Winni
peg, using percutaneous techniques with
or without ultrasonic stone destruction to
remove renal and upper ureteric calculi.
Patients

From October 1983 to March 1985, 102
patients (65 men, 37 women) with sym
ptomatic upper urinary tract calculi or
calculi associated with obstruction or per
sistent urinary infection underwent per
cutaneous stone removal. During the
period of this report, no patient under

went open surgery for an upper urinary
tract calculus without first undergoing an
attempt at percutaneous removal. The
mean age of the patients was 51.1 years
(range from 20 to 85 years).
Fifty-two patients had a stone in the
renal pelvis and 20 had calyceal stones
only. Twenty-one patients had stones in
both the renal pelvis and calyces and in
7 of these patients the stones were
branched pelvic calculi associated with
separate calyceal calculi. Nine patients
had ureteric calculi. Thirteen patients had
urinary infection with urea-splitting
organisms; in all the calculus was thought
to have developed secondary to the uri
nary infection (i.e., struvite stone).
Methods

On the day before stone removal, per
cutaneous nephrostomy is performed
under local anesthesia. Using fluoro
scopic control, this is done through
the calyx, decided upon in advance as the
most appropriate for stone removal.
Through this nephrostomy tract a no. 6
French angiocatheter is inserted down the
ureter almost to the bladder and the
exterior end is connected to a drainage
bag. The patient returns to the ward and
has the stone removed usually under
general anesthesia on the following day.
Technique
For stone removal, the patient is placed
in the prone position on a fluoroscopic
table. A 0.038-inch torque guide wire is
passed through the nephrostomy tube
down the ureter into the bladder. The
nephrostomy tube is removed and a 1-cm
incision made adjacent to the guide wire.
Flexible fascial dilators are used to dilate
a tract to 12 French at which stage a dou
ble lumen catheter is used to introduce a
second wire down the ureter. This second
wire is needed to provide a means of gain
ing access back into the renal pelvis
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should the operating nephroscope be dis
placed from the renal pelvis during the
procedure. The tract around one of the
guide wires is then dilated to 24 French,
which is large enough to permit the
introduction of the operating nephro
scope sheath into the renal pelvis. Tract
dilatation and nephroscope insertion are
performed under fluoroscopic control. In
a few patients, a balloon catheter has been
used to dilate the tract instead of flexi
ble fascial dilators. A special pump is used
to inflate the balloon to 30 French at a
pressure of 12 atmospheres and a mano
meter is required to monitor the pressure
and minimize the risk of balloon disrup
tion. Despite the size of the balloon, it is
usually necessary to pass at least one or
two flexible dilators as well to create a
suitable tract.
Recently, the tract has been dilated to
between 24 French and 30 French, and
once the largest dilator has been inserted,
a rigid plastic sheath (Amplatz sheath),
which fits closely over the dilator, is
passed over it into the renal pelvis under
fluoroscopic control. The dilator is then
removed and the nephroscope passed into
the renal pelvis through the sheath.
Small stones may be removed by grasp
ing forceps under direct vision. Larger
stones require disruption by an ultrasonic
probe before removal. The stone may be
broken into smaller pieces and removed
with forceps or the stone may be com
pletely disintegrated and the gravel aspi
rated through the hollow core of the
ultrasonic probe which is attached to con
tinuous suction. During the procedure,
the renal pelvis is continually irrigated
with normal saline, which either passes
down the ureter or is removed by suction
applied to either the probe or the nephro
scope. An accurate record of fluid inflow
and outflow is essential because the
irrigating fluid may be absorbed, in which
case the procedure must be terminated to
prevent excessive absorption.
When all stone fragments have been
removed, a stone basket catheter is passed
to remove any small fragments that may
have been flushed down the ureter. A
plain film is taken and if this shows com
plete stone removal then a no. 20 French
catheter is passed through the nephro
scope sheath into the renal pelvis and the
nephroscope is removed. A nephrostogram is obtained through the nephro
stomy tube and, if it is satisfactory, the
tube is sutured to the skin and connected
to drainage. In patients who have under
gone extensive ureteric instrumentation or
who have sustained possible injury, a no.
6 French polyethylene catheter is passed
down the ureter over the spare guide wire
which is then removed. This is also of
value when the possibility of residual cal
culus exists, as it will permit more ready
access to the renal pelvis for repeat
nephroscopy.
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On the following day, a plain film of
the kidney and a nephrostogram are
obtained. If there is no evidence of
residual stone, contrast extravasation or
ureteric obstruction, and the calculus was
uninfected, the nephrostomy tube is
clamped. If this does not cause pain or
fever, the tube is removed and the patient
is usually discharged from hospital either
on the same or the following day. No res
trictions on activity are recommended
apart from avoiding violent physical
activity for approximately 6 weeks. Most
patients can return to work within a week
of stone removal.
In patients with infected renal calculi,
in whom the nephrostogram shows free
drainage of contrast down the ureter into
the bladder, the renal pelvis is irrigated
with Solution G (citric acid) for 48 hours
even when stone removal is thought to be
complete. This is done to dissolve any
small residual fragments which, if left,
would predispose to further stone for
mation.
Results
Sixty-eight patients had a single renal
calculus either in the renal pelvis or in a
calyx. Complete removal of all calculous
material was achieved in 67 (99%). In one
patient with a large, branched, upper-pole
calculus, a small fragment migrated into
a lower calyx and could not be retrieved.
This fragment subsequently passed down
the ureter spontaneously and renal tomo
grams showed no evidence of renal cal
culi 6 months postoperatively. Twenty-six
patients had multiple renal calculi; in 13
of them, all calculi were removed. In 10
others, small fragments were identified on
plain films taken at the end of the
lithotripsy procedure. In all these patients
the fragments were situated in calyces that
could not be reached with the rigid
nephroscope or it was considered that the
calculi were not sufficiently large to
justify risking renal damage to remove
them. In three patients with large
branched calculi, a substantial amount of
stone material remained at the end of the
procedure. In all three patients, second
nephrostomies were placed in an attempt
to remove all the stone material but in
none was it possible to clear the kidney
completely of the stone material. Of eight
patients with ureteric calculi, the stones
were completely removed in six. In both
failures, the stone could not be engaged
in a basket in order to manipulate it into
the renal pelvis. One of these patients had
had three previous ureterolithotomies
involving the affected ureter.
In 89 of our first 94 patients, ultrasonic
stone disruption was required. In the last
eight patients in whom an Amplatz sheath
was inserted before removing the stone,
disruption was not necessary.
Postoperatively, 22 patients had a fever

with body temperatures greater than
38.5°C. In eight of these patients the fever
was a single temperature spike and in nine
others the calculus was associated with
urinary infection preoperatively. Follow
ing removal of the nephrostomy tube, 15
patients experienced urine leakage from
the nephrostomy tract for longer than 24
hours. This resolved spontaneously in 14
of them. In one patient a ureteric stent
was required for 48 hours. Three patients
in our series suffered from pulmonary
edema during the procedure. None of the
three had an identifiable pelvic rupture.
In two of them metabolic acidosis deve
loped with a profound drop in blood
bicarbonate concentration. A third
patient did not have pulmonary edema
but did have metabolic acidosis. In one
patient the descending colon was perfo
rated. The perforation was detected the
day after stone removal when a
nephrostogram showed drainage of con
trast into the descending colon. This
patient required repair of her colon and
a temporary transverse colostomy. Four
patients experienced gross hematuria after
their discharge from hospital. Three of
them had a single painless episode of
between 1 and 2 weeks after their dis
charge from hospital, while the fourth
patient required readmission to hospital
6 days after discharge for hematuria that
had persisted for 24 hours. This patient
was treated with hydration and bed rest.
The hematuria stopped within 48 hours
and did not recur.
The mean postoperative hospital stay
for all our patients was 6.8 days. Those
with infected renal calculi required longer
hospitalization as in these patients we rou
tinely irrigate the kidney with Solution G
for a minimum of 48 hours postopera
tively to try and dissolve any remaining
fragments even if none are identified radiologically. If the 20 patients with infected
calculi, and the 2 who required open sur
gery for stone removal, are excluded, the
mean postoperative hospital stay in the
remaining 80 patients was 5.3 days.
Stone analysis was available in 73 of the
patients. Nineteen (26%) stones were cal
cium oxalate, and 35 (47.9%) both cal
cium oxalate and calcium phosphate.
Eight patients (11%) had stones contain
ing magnesium ammonium phosphate
(struvite) and seven patients (9.6%) had
pure calcium phosphate stones. One stone
was reported as being pure calcium car
bonate and one as calcium acid urate.
One stone was reported as consisting of
pure uric acid and the remaining stone
was a mixture of calcium oxalate and uric
acid.
Discussion
Percutaneous stone removal can no
longer be considered experimental. Our
success rate with the procedure is com-
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parable to that of others6’7 and we have
found the complications associated with
the procedure acceptable. One of our
most serious complications, pulmonary
edema, was likely related to systemic
absorption of irrigating fluid, and has not
been a problem since we adopted the
practice of strict monitoring of fluid
balance intraoperatively. It is important
to note that in no patient who had pul
monary edema was a rupture of the renal
pelvis identified intraoperatively. Fre
quently, at the end of one of these proce
dures, inspection of the peripheral calyx
through which the nephrostomy has been
performed reveals a small rupture of the
renal pelvic wall deep within the renal
sinus, and it is possible that this was the
site of fluid absorption in our patients.
In some patients early in our series, the
guide wire was inserted on the day of
lithotripsy under the same general
anesthetic. In this situation, it is difficult
to be sure that no bowel lies between the
kidney and the skin puncture site. The
patient who sustained a bowel perforation
in our series had the wire placed under
general anesthesia immediately before
lithotripsy. All guide wires are now placed
under local anesthesia. The patient is
asked to rotate on the fluoroscopy table
during the wire placement and, with the
kidney visualized from a lateral view
point, any bowel lying close to the kid
ney can be avoided.
Excessive bleeding has not been a
problem. Two patients received one unit
of packed cells each. In one patient there
was brisk bleeding from the nephrostomy
tube postoperatively, so the tube was
clamped to stop further bleeding by tam
ponade secondary to blood clot forming
in the renal pelvis; this maneuver was suc
cessful.
Stone fragments were retained in few
patients. A plain film of the kidney at the
end of the procedure is essential since
fluoroscopy is not sensitive enough to
detect small fragments. If there is any sus
picion of retained fragments, the renal
pelvis should be reinspected carefully, and
another roentgenogram obtained if neces
sary. In some patients, retained fragments
are identified postoperatively; if the frag
ments are thought to be accessible,
nephroscopy should be repeated.
In patients with multiple stones,
residual stone material was identified in
13 of 26 patients. However, 10 of these
were considered to have a successful out
come in that the stone causing the sym
ptoms was completely removed and all
associated stones considered large enough
to cause symptoms were also removed. In
10 of the 13 patients with residual stones,
the fragments were considered inaccessi
ble to the rigid nephroscope or the risk
of renal injury was considered too high
to justify attempting to remove the frag
ments. In most of these patients it is pos

sible that even with open surgical proce
dures these stones might not have been
removable. In recent cases use of a flexi
ble nephroscope has made retrieval of
small calyceal stones possible, and in one
case use of the flexible nephroscope cou
pled with electrohydraulic stone disrup
tion made it possible to remove a calcu
lus that would not have been accessible
with the rigid nephroscope.
The nephrostomy tract may be dilated
in various ways before removing the stone
and the technique used may influence the
speed and method of stone removal. For
most of our patients (94 of 102), the tract
was dilated to 24 French and the nephro
scope inserted into the renal pelvis
without using an Amplatz sheath. The
instrumentation channel in this instru
ment is 4.1 mm in diameter and as most
renal calculi requiring removal are larger
than this, ultrasonic disruption is usually
required. The technique also carries the
risk of fluid absorption so fluid balance
must be carefully monitored. An advan
tage of the technique is that the renal col
lecting system is distended, making it eas
ier to identify the intrarenal anatomy and
find stone fragments. Also, the nephro
scope is more easily maneuvered than
when it is inside a separate sheath, and
this may facilitate at least the initial dis
ruption of large branched calculi. The
Amplatz sheath system involves dilating
the tract up to as much as 30 French and
passing a rigid plastic sheath over the lar
gest dilator used into the renal pelvis. The
nephroscope or a visual grasping forceps
can then be passed through the sheath and
the stone either lifted out or disrupted.
Stones up to 1 cm in diameter can be
lifted out and in all eight patients in whom
we have used this technique, stone disrup
tion was unnecessary. Irrigating fluid is
able to leak around the nephroscope,
reducing the risk of fluid absorption and
possible pulmonary edema. For better
visualization of the collecting system, a
cap can be fitted over the sheath and the
nephroscope passed through a hole in the
cap. This seals the system, allowing dis
tension of the collecting system, and is
useful particularly when performing flex
ible nephroscopy. Balloon dilatation of
the tract using strengthened balloons is
relatively simple and probably less trau
matic than serial dilators. The balloons
are expensive and we have found them
suitable for one or two dilatations only.
Moreover, we have found it necessary to
pass one or two of the larger dilators as
well to create a suitable tract, so balloon
dilatation does not possess any major
advantage over flexible fascial dilators.
Rigid metal coaxial dilators were used in
one of our patients. A thin metal tube is
passed over the guide wire into the renal
pelvis and serial metal dilators of increas
ing size are passed over the preceding one.
This is useful in patients who have under

gone previous renal surgery in whom
dense scar tissue surrounding the kidney
makes other forms of dilatation difficult.
Percutaneous stone removal is not a
quick procedure. The average operating
time was 101 minutes. Also, the urologist
must be prepared to take the time to rein
spect the renal pelvis if intraoperative
roentgenograms suggest retained frag
ments, and be willing to subject the
patient to multiple procedures in order to
achieve complete clearance of stone
material.
Despite the difficulties associated with
percutaneous stone removal, the proce
dure has major advantages over conven
tional open surgical techniques. A 1-cm
incision is required rather than the large
muscle-dividing incision needed for open
surgery and postoperative discomfort
associated with the small incision is rare.
The duration of postoperative hospitali
zation is substantially reduced. Patients
are allowed to eat their normal diet as
soon as they have recovered from the
anesthetic and are not confined to bed
postoperatively. A prolonged convales
cence at home following discharge from
hospital is not necessary and we advise
patients that they may return to work
within a week of stone removal. One
patient returned to work directly from the
hospital 72 hours after the procedure.
We consider percutaneous stone
removal with or without stone disruption
to be the surgical procedure of choice in
the management of renal calculi. The
introduction of extracorporeal shockwave techniques may reduce the need for
percutaneous stone surgery in the future.
Nevertheless, the modest cost, availabil
ity, effectiveness and safety of percutane
ous stone surgery will ensure a continu
ing role for this technique in the
management of renal calculi.
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Pseudomembranous Colitis and Wound Infection Following
Perioperative Use of Multiple Antibiotics
The prophylactic use of antibiotics in
elective surgery of the colon is accepted
practice, but it has inherent risks. The
authors report the case of a 70-year-old
woman who had wound infection and
severe, relapsing pseudomembranous
colitis due to Clostridium difficile after a
short course of antibiotics given orally
and parenterally at the time of elective
resection of the colon. Perioperatively,
she received erythromycin base and
neomycin orally, plus netilmicin and
metronidazole intravenously. Although
the concomitant administration of paren
teral antibiotics may enhance the benefit
of antibiotics given orally before opera
tion, this does not entirely prevent
wound infection. Until the relation
between the number of drugs and risk of
antibiotic-associated colitis is more
clearly defined, caution should be exer
cised in the use of multiple antibiotics in
elective colonic surgery.

En chirurgie non urgente du colon,
I'usage prophylactique des antibiotiques
est une pratique acceptee, mais elle
comporte des risques inherents. Les
auteurs decrivent le cas d'une femme de
70 ans qui a presente une infection de
plaie et une colite pseudo-membraneuse
severe et recidivante a cause de Clostri
dium d ifficile apres avoir recu par voies
orale et parenterale un traitement antibiotique de courte duree au moment d'un
resection non urgente du colon. En perop6ratoire, elle avait regu de l'6rythromycine base et de la neomycine par voie
orale, suivies de n£tilmicine et de
metronidazole en intraveineuse. Meme si
('administration d'antibiotiques par voie
parenterale est susceptible d’ameliorer
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les effets des antibiotiques oraux donnes
avant I'intervention, ceci ne protege pas
entierement des infections de plaie.
Jusqu'a ce qu'on connaisse mieux le rap
port entre le nombre de medicaments
administres et le risque de colite m£dicamenteuse, des precautions s'imposent
dans I'emploi d'antibiotiques multiples
lors de chirurgies coliques non urgentes.

rature of 39°C. Sigmoidoscopy revealed
mucus, pus and pseudomembranes. The stool
contained a heavy growth of Clostridium dif
ficile and stool filtrate contained a toxin cytopathic to McCoy cells to a titre of 1:50 000 and
neutralized by antitoxin to Clostridium sordellii
toxin. The organism was sensitive to metroni
dazole, one of the antibiotics that had been
given perioperatively.
On the day that diarrhea developed, the
patient’s wound was noted to be inflamed.
Prophylactic administration of antibiotics Wound exudate contained a heavy growth of
Staphylococcus aureus resistant to erythromy
in elective gastrointestinal surgery is a cin. Sensitivity to netilmicin was not tested. A
two-edged sword. Clarke and colleagues1 light growth of Pseudomonas aeruginosa, sen
have shown that antibiotics reduce the sitive to netilmicin, was also cultured. The
incidence of postoperative wound infec wound was opened and drained and did not
tions in colorectal surgery; however, there cause further morbidity.
The patient was given vancomycin (500 mg
is a risk of drug complications that
include antibiotic-associated colitis.2 Can orally every 6 hours) for 9 days. This control
a zero wound infection rate be achieved led her intestinal symptoms and eradicated
in colonic surgery and, if so, would this both the C. difficile and its toxin from the
stool. Two days after withdrawing the van
be paid for by more frequent colitis? The comycin, the patient was discharged from hos
relations between the number of antibi pital. Thirteen days later she was readmitted
otics given perioperatively, the incidence because of explosive watery diarrhea, fever and
of wound infection and of colitis have not anorexia. Barium enema revealed pancolitis.
been determined. We report on a patient Vancomycin was restarted orally, followed by
who had a wound infection and severe bacitracin 100 000 units orally four times a day.
pseudomembranous colitis after receiving Various drug combinations, including cholesty
a short course of four antibiotics in ramine and metronidazole, were tried with little
success. Over the next 2 months, toxin-positive
association with elective colectomy.
diarrhea continued and was complicated by
hypovolemia, metabolic acidosis and malnu
trition requiring parenteral alimentation. She
Case Report
was discharged 2 months after readmission,
A 70-year-old woman underwent left hemi still taking cholestyramine and bacitracin, but
colectomy to remove an adenocarcinoma of the
with the diarrhea under control.
splenic flexure. Her past history included cho
Four months after her diarrhea began, the
lecystectomy, hysterectomy and hiatal hernia
patient was admitted a third time for a right
repair. She had been taking hydrochlorothia upper lobectomy to remove an adenocarci
zide for mild hypertension.
noma of the lung. This had been detected
Preoperatively, the bowel was mechanically
shortly before her colectomy. Despite conti
cleansed with oral magnesium citrate cathar nued therapy, her stool was still positive for
sis and saline enemas. The day before opera
C. difficile toxin. Her postoperative course was
tion the patient was given neomycin and
uncomplicated this time, and the colitis resol
erythromycin base orally, 1 g each at 13,00.
ved completely after several weeks’ further the
16,00 and 23,00 hours; neither of these drugs
rapy with bacitracin and cholestyramine.
was given postoperatively. She also received
netilmicin (80 mg) and metronidazole (500 mg)
intravenously 1 hour before operation. Two
Discussion
further doses of each of these drugs were admi
nistered over the next 16 hours (netilmicin) and
Colitis associated with the periopera
20 hours (metronidazole). The operation was
tive administration of antibiotics has not
prolonged (2 hours, 40 minutes) because of
been adequately investigated. Keighley
extensive adhesions due to previous surgery and
and associates2 in their prospective study
diverticular disease.
found that of 81 patients who underwent
The patient did well initially, but on day 9
colorectal operations, 39 (48%) suffered
following operation, watery diarrhea and abdo
from diarrhea postoperatively and 8
minal cramps developed and she had a tempe
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(10%) had C. difficile toxin in the stool.
Their report does not say how many
patients had colitis. The actual frequency
of this complication is unknown, and
would require prospective analysis of a
large number of colorectal procedures.
Unfortunately, there is no way at present
to predict which patients are at high risk
for the subsequent development of colitis.
The patient in this report had two
postoperative infections (wound and coli
tis) caused by three bacteria. Two of these
organisms (C. difficile and P. aeruginosa)
were sensitive to at least one of the antibi
otics given before operation. The S.
aureus was resistant to erythromycin; its
sensitivity to netilmicin was not tested.
Although the wound infection caused lit
tle disability, the colitis was a major
insult.
Neomycin and erythromycin base given
orally before operation are effective in
reducing the number of wound infections
following colonic surgery. However,
Clarke and colleagues' found that these
antibiotics do not sterilize the colonic
lumen and do not completely prevent
wound infection. Coppa and associates3
showed that a parenteral agent added
preoperatively conferred increased
benefit. It is therefore not unreasonable
to augment oral prophylaxis with systemic
antibiotics. However, this means that at
least three antibiotics must be given and,

as demonstrated by our case, they may
still not prevent wound infection. Shapiro
and coworkers4 found that prolonged
surgery is as important in the develop
ment of wound infection as the adminis
tration of antibiotics.
It is interesting that C. difficile, the
organism implicated in the cause of
antibiotic-associated colitis, was sensitive
to metronidazole. Orally administered
metronidazole is an effective treatment
for colitis due to C. difficile ,5 and
intravenously administered metronidazole
is secreted into the colonic lumen.6 One
might assume, therefore, that orally or
intravenously administered metronidazole
should protect against colitis. However,
most isolates of C. difficile are sensitive
to the drug that caused the colitis,7 and
metronidazole itself has been implicated
as a cause- of antibiotic-associated coli
tis.8 In Keighley’s study,2 patients who
suffered diarrhea associated with C.
difficile toxin had received kanamycin
and metronidazole (the route of adminis
tration was not described). Metronidazole
does not appear to protect against
antibiotic-associated colitis.
The relation between the number of
drugs given perioperatively and the inci
dence of colitis requires further study.
This case is a warning that caution should
be exercised in the use of multiple antibi
otics in elective surgery of the colon.
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In many patients, there is usually need for repeated
access to body compartments for drug delivery or fluid col
lection.
Port-A-Cath is a totally implantable drug delivery
system, specifically designed for safe and easy repeated
access.
Since the Port-A-Cath is implanted under the skin, it
reduces the risk of infectious complications, spares the peri
pheral vasculature, allows targeted drug infusion, facilitates
ambulatory treatment and does not interfere with the normal
daily acitivities of the patient.
Port-A-Cath ". With the patient in mind.

Pharmacia (Canada) Inc., 2044 St. Regis Blvd., Dorval. Quebec
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C. Del Campo , md , frcsc

Simplified Insertion of the Port-A-Cath
Implantable Drug-Delivery System
The increasing frequency with which
antineoplastic drugs are being used
demands improved vascular access for
their administration. Venous access
through implantable catheters facilitates
treatment when veins are no longer
available. Totally implantable catheters
of the Port-A-Cath type are preferred
because they give better performance
and cosmetic results, and are more con
venient for the patients.
The flexibility of these catheters makes
their introduction difficult. The author
describes a simplified technique, using a
commercially available introducer that
has been used satisfactorily in thousands
of pacemaker implantations. The author
has used this technique routinely with a
5 0 % decrease in operative and fluoro
scopy time and without complications.

L'usage de plus en plus frequent des
medicaments antindoplasiques exige de
meilleures voies d'administration vasculaire. Quand les veines sont devenues
inutilisables, I'etablissement d'un acces
veineux grace a un catheter & demeure
facilite le traitement. On preffere les
catheters totalement implantables de
type Port-A-Cath car ils offrent un meilleur rendement, donnent des resultats
cosmetiques superieures et sont plus
commodes pour le patient.
La flexibility de ces catheters en rend
la pose difficile. L'auteur decrit une tech
nique simplifiee utilisant un instrument
d'insertion du commerce qui a deja ete
employe avec satisfaction des milliers de
fois pour I'implantation de stimulateurs
cardiaques. En utilisation de routine,
l'auteur a obtenu par cette technique une
diminution de 5 0 % du temps d'operation
et de fluoroscopie, et ceci sans compli
cations.

Advances in the development o f new and
more effective antineoplastic drugs have
made possible the control and cure o f
several malignant neoplasms. Most of
these agents require intravenous adminis
tration. Drug combinations and multiple
injections over a long period are usually
necessary. Many o f these drugs induce

local changes in the venous wall charac
terized by inflammation followed by
thrombosis and ultimately sclerosis. Soon
venous access becomes a major problem.
Pain, frustration, anxiety and expenditure
o f time increase with every treatment and
may result in incomplete treatment or ter
mination o f therapy.

FIG. 1—J guide wire, introducer and sheath assembled after introducer and sheath have
been inserted into subclavian vein. Note that J wire is positioned with J portion forward for
easy cannulation without vein damage or perforation.
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FIG. 2—Silicone catheter in position before cannula is removed. Notice that J wire inside
silicone catheter is inserted in reverse fashion. Wire does not protrude past silicone catheter
to avoid vein injury. Insert shows portal before connection.
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Over the years some ingenious proce
dures have been designed in an attempt
to solve this problem. Arteriovenous
fistulas, vascular grafts and a variety of
“ permanent” intravenous catheters are
commonly used.
A totally implantable drug-delivery sys
tem (Port-A-Cath, Pharmacia [Canada]
Inc., Dorval, PQ) has recently been
introduced. It allows blood sampling and
bolus injections or continuous infusions
of drugs. The device is composed of a
stainless steel portal with a silicone
catheter that self-seals by means of a
stainless steel lock. The catheter is
introduced usually through the cephalic
vein and positioned under fluoroscopic
control in a large central vein, most com
monly the superior vena cava. The
catheter is then connected to the portal.
Because the flexibility of the catheter
and, in many cases, the unsuitability of
the cephalic vein make this procedure
difficult, I present a simplified technique
for inserting the catheter.
Technique

Under sterile conditions in the operat
ing room and using local anesthesia, a
1-cm incision is made 2 cm below the
angulation of the left clavicle, in the same
location that normally would be selected
for a direct subclavian vein puncture. A
Littleford-Spector introducer (Cordis
Corp., Miami, Fla.) has all the necessary
items for this. First, the subclavian vein
is punctured through the incision using
the syringe and 18-gauge needle provided.
Blood is aspirated and then the steel J
guide wire is introduced and its position
checked by fluoroscopy. The needle is
removed and the vessel dilator and sheath
introducer are slid into place (Fig. 1). The
J wire is removed. A no. 10.5 French can
nula should be used because it matches
the portal silicone catheter best. The J
guide wire is then introduced inside the
catheter to prevent it from coiling and to
speed its insertion into the superior vena
cava. The J guide wire is best introduced
backwards, leaving the “ J ” part outside
because this way it slides better into the
portal catheter. It should be lubricated
with heparinized saline solution. The
guide wire is advanced no further than the
tip of silicone catheter to avoid damage
to the venous wall during its insertion.
The catheter is then inserted through the
sheath and positioned (Fig. 2). The sheath
is removed. A nonabsorbable suture is
used to fix the catheter. The J guide wire
should not be removed until the suture is
tied to prevent inadvertent occlusion or
narrowing of the lumen. This complete
maneuver usually takes less than 5
minutes. The catheter is then tunnelled
subcutaneously to the area of the perma
nent pocket and connected to the portal
as described by the manufacturer.
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Discussion

The Littleford-Spector introducer was
originally manufactured for the rapid
insertion of permanent endocardial elec
trodes for cardiac pacing.1 The tech
nique is widely used. It is the alternative
procedure of choice for me when the
cephalic vein is unsuitable for cannulation
during pacemaker insertion. I have not
experienced any complications with this
technique in over 300 pacemaker inser
tions.
The original technique has been
adapted and modified to facilitate the
insertion of the silicone catheter of the
portal delivery system. The silicone
catheter is softer and more flexible than
a pacemaker lead. Thus, it may coil inside
the large central veins. Because of its flex
ibility, it is also difficult to manipulate
into position. Use of the J guide wire to
stent the silicone catheter has several
advantages: it provides temporary sup
port for catheter insertion and manipu
lation, increases the visibility of the
catheter during fluoroscopy, reduces
fluoroscopic time to a minimum because
of easier manipulation and the predeter
mined location of the introducing cannula
and prevents inadvertent occlusion or nar
rowing o f the silicone catheter by the
securing suture. When the no. 10.5
French introducer is used, the inner
diameter of the cannula matches perfectly
the outer diameter of the silicone catheter.
Thus, insertion is easy and blood loss is
almost nil. This has been my procedure
of choice for all my recent insertions.
There have been no complications and
time taken for insertion has been reduced
by more than 50%.
Reference
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Delayed Intestinal Perforation After
Nonpenetrating Abdominal Trauma
The incidence of hollow-organ injury has
increased steadily since the use of seatbelts was introduced. It has become
apparent that the clinical manifestations
of intestinal injury may be delayed con
siderably. Delayed perforations can pose
a diagnostic challenge to the attending
surgeon. The authors report four patients
who suffered delayed intestinal perfora
tion 6 or more days after sustaining non
penetrating abdominal trauma in motor
vehicle accidents while wearing passive
seat-belt restraints. All patients had low
severity of injury (scores ranging from 4
to 13) but had persistent vague abdomi
nal pain before perforation occurred.
Three of the four patients suffered spinal
trauma as their major initial injury. Such
patients appear to be at higher risk for
delayed perforation and should be moni
tored carefully.
La frequence des blessures des organes
creux augmente regulierement depuis
I'avenement de la ceinture de securite. II
est devenu evident que les manifesta
tions cliniques des blessures intestinales
peuvent etre considerablement retardees.
Les perforations retardees peuvent constituer pour le chirurgien traitant un defi
de diagnostic important. Les auteurs
decrivent quatre patients qui ont souffert
d'une perforation intestinale retardee, 6
jours ou plus apres avoir subi une contu
sion abdominale au cours d'un accident
de la route, alors qu'ils portaient une
ceinture de securite. Tous les patients
avaient subi des blessures de peu de gra
vity (cotes variant de 4 a 13) mais souffraient de douleur abdominale vague
persistante avant que la perforation ne
survienne. Trois des quatres patients
avaient subi un traumatisme spinal
comme blessure initiate majeure. Ces
patients semblent presenter un risque
plus eleve de perforation retardee et
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devraient faire I’objet d'une surveillance
attentive.

The incidence of intestinal injury secon
dary to nonpenetrating abdom inal
trauma has increased markedly in North
America in conjunction with the use of
seat-belt restraints in motor vehicles.1
Injury to hollow organs is difficult to
diagnose even when there is perforation
as it is not usually associated with major
blood or volume loss. Furthermore,
specific physical findings and definitive
diagnostic, laboratory and radiologic
investigations are lacking. Intestinal
injury is usually discovered during
exploratory laparotomy for a hemoperitoneum uncovered during peritoneal
lavage or for injury to other abdominal
or retroperitoneal viscera. The present
trend towards nonoperative management
of hemoperitoneum in an effort to
preserve splenic function will make such
discoveries less frequent.2"4
Delayed intestinal perforation is a
potentially lethal complication of blunt
abdominal trauma. The surgical literature
contains only isolated case reports or
anecdotal mention of this pheno
menon.5'7 We report four such cases of
delayed intestinal perforation managed at
this institution over the past 24 months.
We discuss the diagnostic difficulties and
concepts of pathophysiology and make
recommendations for the management of
patients with this complication.
Case Presentations
Table I documents the salient features
of the four patients with delayed posttraumatic intestinal perforation referred
to the Kingston General Hospital for
management. All were males who were
involved in motor vehicle accidents. All
wore seat-belts, three of the lap type and
one a three-point shoulder type.
The four patients demonstrated the fol
lowing findings in common. The clinical
manifestations on original admission sug
gested a modest insult but there was no
serious hypotension (injury severity scores
4, 10, 10 and 138). The abdominal find
ings were nonspecific. All had persistent
abdominal complaints but no localized or
generalized abnormalities could be found
despite repeated physical examinations.
There was a substantial interval between

the time of admission and the diagnosis
of perforation (6 to 36 days). None of the
laboratory or radiologic studies, per
formed initially or during the period
before operation, were diagnostic. The
patients had resumed oral intake and had
normal bowel movements before the full
evolution of their intestinal perforation.
Acute peritoneal signs eventually deve
loped on physical examination and at
operation localized perforation of small
or large bowel was found.
In three patients there was evidence of
an adjacent mesenteric hematoma and
three had an associated spinal injury.
After definitive treatment, these patients
are alive and well and intestinal continuity
has been re-established in the two patients
who had a colostomy. Examination of the
resected intestinal segments (Fig. 1)
showed transmural ischemic necrosis of
either small or large bowel in all four
patients.
Discussion
In North America, motor vehicle acci
dents remain the commonest cause of
blunt abdominal traum a.1’6 Before the
use of seat-belts became widespread,
intestinal injury as a result of blunt
trauma was most often reported as an
incidental finding during laparotomy for
hemoperitoneum due to splenic and
hepatic injuries.9' 13 At most, 25% of
laparotomies for blunt abdominal trauma
have an intestinal component. Usually,
this is either a serosal or mesenteric hema
toma, with less than 5% of the injuries
requiring small- or large-bowel resec
tion.14 The incidence of injury to hollow
organs has risen concomitantly with the
increased use of seat-belts. In a single ser
ies, Denis and associates5 reported that
over 80% of their patients sustained seri
ous intestinal injury in motor vehicle acci
dents while wearing selt-belts. Within this
group, 17 of 27 patients had a spontane
ous perforation while 5 more had evi
dence of intestinal ischemia without
necrosis. When a patient suffers injury to
the lumbar spine in a motor vehicle acci
dent while wearing a seat-belt, an intesti
nal injury should be suspected even in the
initial absence of abdominal findings.
Several reports have documented a sig
nificant correlation between these inju
ries.5’7 The clinical diagnosis of peritoni-
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tis in association with spinal trauma can
be very difficult. Physical findings may
be misleading because o f local abdomi
nal wall trauma or neurologic deficits
related to the spinal injury. Moreover,
prolonged ileus is a well-known sequela
o f spinal fractures in the absence o f neu
rologic deficits.
The early and late diagnosis o f posttraumatic intestinal injury is difficult.
Minilaparotomy (peritoneal lavage) as
recommended by the Committee on
Trauma of the American College o f Sur
geons, will aid in the diagnosis of immedi
ate intestinal perforation should Gram’s
staining of the abdominal effluent iden
tify organisms.5,15 Peritoneal lavage that
contains no organisms or blood or one
that contains 50 to 100 x 10VL erythro
cytes, which is often found with a mesen
teric hematoma, is of no help.
There has been a definite move to
nonoperative management o f patients
with a positive peritoneal lavage who are
hemodynamically stable and have low
injury severity scores.24'1618 This has
been based on the observation that splenic
or hepatic injuries, the commonest causes
o f positive peritoneal lavage, are often

not actively bleeding at the time of
laparotomy. The development of sophis
ticated imaging techniques has aided diag
nosis o f intra-abdominal traumatic injury

and has spared many individuals (mostly
children) an unnecessary laparotomy and
splenectomy with the possibility o f post
splenectomy sepsis.19,20

FIG. 1—Photomicrograph adjacent to site of perforation. There is hemorrhage and very
recent necrosis of muscularis propria (arrow). Inset: necrosis of this muscle (arrow) is associated
with neutrophilic infiltrate, suggesting recent ischemic necrosis. (Hematoxylin-phloxine-safranine
X 120; inset x 300.)

___________________ Table I—Clinical Summary of Patients With Delayed Intestinal Perforation After Trauma________
Injury
Age,
Abdominal
Peritoneal
Associated
severity
Radiologic
Laparotomy
yr Sex Hypotension
findings
lavage
injury
score8
findings
Course
findings
~1 wf No
Abdominal wall
No
Fracture
Absent psoas
Persistent mild Perforation midcontusion.
dislocation
right side.
abdominal
jejunum.
Diffuse
L3—4
Retroperitoneal
pain. Sudden
Mesenteric
tenderness
signs on
onset
hematoma.
computerized
peritoneal
Seromuscular
tomogram
signs on day
tears proximal
6
and distal to
perforation
29 M
Yes
Diffuse
No
Fracture pubic
3 views of
Day 6 — acute Perforated
(crystalloid
tenderness
rami and L3
abdomen all
onset of
jejunum 12
only
only)
normal
peritoneal
cm distal to
signs,
ligament of
hypotension,
Treitz.
free intraIschemic
peritoneal air
sigmoid colon
with
mesenteric
hematoma
47 M
No
Abdominal wall
Yes,
Compression
Plain films
Persistent
Perforated
contusion.
negative
fracture L3
normal
abdominal
fibrotic
and L4
Diffuse
pain. Day 36
stricture of
tenderness
— large
mid-sigmoid,
bowel
communicating
obstruction
with abscess
with flow of
cavity
barium into
abscess
cavity
41 M
No
3 views of
None
Abdominal wall
Yes,
Persistent mild Free perforation
abdomen all
hematoma
positive
abdominal
mid-transverse
pain.
(100 X 109/L
normal.
colon;
Computerized
erythrocytes)
Discharged
mesenteric
tomogram
on day 7.
hematoma
normal
Returned 12
h later with
acute onset
rigid abdomen
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Surgical
management
Resection with
primary
anastomosis

Jejunal
resection.
primary
anastomosis,
sigmoid
resection,
end-colostomy
and mucous
fistula
Hartmann
procedure,
drainage of
abscess

Colonic
resection with
doublebarrelled
colostomy
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Unfortunately, there are no reliable
symptoms or signs to lead to a definitive
diagnosis of hollow-organ injury.7’1113
As in previous series,21 abdominal pain
of variable severity and initially without
notable physical findings was the only
consistent feature. Abdominal guarding,
rebound tenderness and auscultation of
bowel sounds are notoriously unreliable.
In fact, tolerance of oral intake and
return of bowel function occurred in all
our patients despite serious underlying
intestinal injury.
Similarly, there are no specific labora
tory investigations that lead to a defini
tive diagnosis of intestinal injury. Plain
films of the abdomen are unreliable.19
Evidence of free intraperitoneal air is seen
in less than 50% of patients with intesti
nal perforation.19 Although abdominal
computerized axial tomography is effec
tive in diagnosing disruption of solid
organs, it is less reliable in detecting
hollow-organ injury.19-20 Water-soluble
contrast studies have been used to rule out
proximal small-bowel injury or disrup
tion. In patients who sustain vascular
damage to the mesentery, resulting in
eventual ischemic necrosis, early radiologic signs may be difficult if not impos
sible to detect.
Laparoscopy under general or local
anesthesia has been used in the emergency
room to replace peritoneal lavage and
allow complete examination of the
peritoneal cavity.22 This modality could
identify patients with potential intestinal
injuries that might lead to perforation.
Carefully staged, progressive resumption
of oral intake should be undertaken with
this possibility in mind. However, it must
be remembered that even with laparo
scopy, serious trauma might be missed.
Repeat minilaparotomy may be useful in
this period as Gram’s staining of the
effluent is more likely to identify a mix
ture of intestinal organisms.
The pathological findings of the
resected intestinal segments in one of our
patients lead us to agree with Bolton and
colleagues9 that delayed post-traumatic
perforation of the intestine occurs as a
result of ischemia either through direct
trauma to the intestinal wall or indirectly
by trauma to the mesenteric vessels.
Robbs and colleagues12 have suggested
that this process can evolve within 24 to
48 hours of the initial injury. Presuma
bly, the most common mechanism of in
jury to the intestine or adjacent mesen
tery is due to the lap belt, properly placed
or otherwise, which compresses these
structures against the fixed spinal column
during rapid deceleration of the motor
vehicle. This would account for the
associated spinal fractures seen in this ser
ies as well as others.4’7’11'13 These authors
subsequently treated another patient who
suffered localized peritonitis 24 hours
after blunt abdominal trauma. A segment

of devascularized necrotic jejunum was
found which undoubtedly would have
resulted in perforation.
Following blunt abdominal trauma
caused by the seat-belt in a motor vehi
cle accident, the persistence of abdomi
nal pain during the first week should alert
the attending surgeon that an undiag
nosed intestinal injury may exist.
Associated spinal or pelvic fractures
should heighten the suspicion. The use of
water-soluble radiologic studies to outline
the colon or small bowel should be con
sidered. Repeat minilaparotomy or
laparoscopy should also be considered if
the radiologic findings are inconclusive.
It is obvious that the development of
peritonitis is an indication for immediate
laparotomy.
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Preoperative Gelfoam Embolization of
Supratentorial Meningiomas
Intracranial meningiomas are often highly
vascular and a successful outcome
depends upon surgical resection.
Preoperative embolization of supraten
torial meningiomas, which have a major
blood supply from the external carotid
artery, has been advocated to reduce
intraoperative bleeding and thus facilitate
surgical extirpation. The authors carried
out transfemoral, Gelfoam embolization
preoperatively in eight patients with
supratentorial meningiomas. In seven of
the cases, post-embolization, contrastenhanced, computerized tomography
was carried out. Areas of low-density
tumour necrosis were identified in five.
In three of the eight patients, post
embolization angiography demonstrated
elimination of the tumour blush and in
the other five, the blush was reduced in
intensity. Histologic evidence of tumour
embolization was identified in each case
to a varying degree.
Preoperative embolization resulted in
an identifiable radiologic change in the
majority of these tumours, but the
authors could not determine, in this
small series, whether intraoperative
bleeding was reduced.
Les meningiomes intracraniens sont souvent tr&s vascularises et la guerison
depend souvent de la resection chirurgicale. Une embolisation preoperatoire des
meningiomes supratentoriaux qui possedent une circulation sanguine importante
provenant de I'artere carotide externe, a
et6 recommandee pour reduire I'h^morragie operatoire et, ainsi, faciliter I'extirpation chirurgicale. Les auteurs ont
pratique en preoperatoire une embolisa
tion transfemorale au Gelfoam chez huit
patients porteurs de meningiomes supra
tentoriaux. Apres I'embolisation, on a

From the Department o f Surgery, Division
o f Neurosurgery and Department o f Radio
logy, Division o f Neuroradiology, St.
Michael’s Hospital, and University o f
Toronto, Toronto, Ont.

effectue, dans sept de ces cas, une
tomographie transverse axiale sur ordinateur avec augmentation du contraste.
Des regions de necrose tumorale a faible
densite ont ete identifies chez cinq
patients. Chez trois des huits patients,
I'angiographie post-embolisation a revele
('elimination de I'ombre tumorale et dans
les cinq autres cas I'intensite en etait
reduite. Des signes histologiques
d'embolisation tumorale ont ete identifies
a des degres divers dans tous les cas.
L'embolisation preoperatoire a
entraine des changements radiologiques
identifiables pour la majorite des tumeurs
mais, a cause du petit nombre de sujets
dans cette etude, il n'a pas ete possible
pour les auteurs de determiner si elle
avait reduit les saignements durant
('intervention chirurgicale.

Meningiomas account for approximately
14% of all intracranial tumours.1 They
are usually histologically benign and the
subsequent outcome depends on the suc
cess of surgical resection.2 This may be
compromised by the highly vascular
nature of many of these tumours. Menin
giomas arise from arachnoid cap cells, are
usually attached to dura and often receive
their main blood supply from the exter
nal carotid artery. Embolization of the
vessels supplying the tumour may reduce
intraoperative bleeding and make total
surgical resection more likely. The
preoperative embolization of the external
carotid feeding vessels was introduced by
Manelfe and associates in 19733 and has
been advocated by others.4,5 Both superselective angiography and embolization of
appropriate external carotid branches4
and subselective embolization of the ter
minal external carotid artery proximal to
the maxillary artery5 have been used.
We report herein the results of preoper
ative transfemoral embolization in eight
patients with supratentorial menin
giomas.
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Methods and Findings
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Patient Selection
Patients with computerized tomograms

compatible with a supratentorial menin
gioma were selected for angiographic
assessment and possible embolization.
Informed consent was first obtained from
the patient. Embolization was carried out
at the time of initial angiography if the
angiogram confirmed the diagnosis of
meningioma and demonstrated that the
external carotid artery formed the main
blood supply to the tumour. The proce
dure was carried out under local
anesthesia.
Patients
The eight patients ranged in age from
28 to 66 years. There were two men and
six women. The tumours were located at
the lateral sphenoid wing in two cases, the
frontoparietal convexity in five and arose
from the temporal fossa floor and
occupied the temporoparietal convexity
in one case. Maximum tumour diameters,
as determined from the computerized
tomograms, ranged from 4.8 to 8.3 cm.
The ages, sex, clinical presentation,
tumour location and histologic type are
summarized in Table I.
Embolization
The transfemoral route was used to
obtain selective internal and external
carotid angiograms in each case. Superselective catheterization of feeding vessels
from the external carotid artery was
attempted and embolization was carried
out using Gelfoam powder. Angiography
was performed immediately after emboli
zation using the same contrast volume
and injection sequence as before. No seri
ous complications occurred; one patient
had ipsilateral facial pain but it resolved
spontaneously within 12 hours.
Computerized Tomography
C ontrast-enhanced com puterized
tomograms were acquired before emboli
zation in each case. In seven patients the
appearance was of a homogeneous,
hyperdense tumour. In five of seven scans
obtained after embolization, there were
areas of low density in the previously
homogeneously high-density tumours
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(Table II) and they were interpreted as
areas of ischemic necrosis (Figs. 1 and 2).
In no case was the contrast enhancement
totally obliterated.

Histologic assessment of the surgical
specimens revealed Gelfoam emboli and
areas of necrosis in six of the seven
patients operated on early after emboli
zation (Table III). The histologic assess
ment of the patient whose operation was
delayed revealed blood-vessel hyalinization and ischemic fibrosis within the
tumour.
Five patients required blood transfu
sion. An estimate of the intraoperative
blood loss was made by adding the num
ber of units of blood transfused and the
postoperative fall in the hemoglobin level
(measured in grams per decilitre). A linear
relation between the estimated blood loss
and the maximum tumour diameter was
evident, but in this small series no corre
lation between blood-loss estimate and
post-embolization blush could be iden
tified.

Angiography
All patients had a demonstrable
tumour blush on the pre-embolization
angiogram. Table II summarizes the
tumour blood supply, the vessels embolized and the angiographic results of
embolization. In three patients the
tumour blush was completely eliminated
(Figs. 3 and 4). In four it was markedly
reduced. In one patient the tumour blush,
although reduced, was still moderately
intense.
Surgical and Pathological Findings
Total surgical resection of the menin
giomas was achieved in all cases. All but
one patient was operated on within 4 days
of embolization; in that case, surgery was
delayed 5 months for medical reasons
unrelated to the tumour or to the emboli
zation procedure. It is of interest that
sequential computerized tomograms on
this patient revealed a reduction in
tum our size but a return of the
homogeneous hyperdensity (Figs. 5 and
6).

Intracranial meningiomas arise from
arachnoid cap cells and, with few excep
tions, have a dural attachment. In the
majority, the main blood supply is from
the external carotid artery; however,
branches of the internal carotid are often
a major source of additional blood sup
ply. It has been shown that the capsule
of the tumour tends to have an internal
carotid supply and the stalk of the tumour
and much of the interior has an external
carotid supply.6 The proportion of inter-

D iscussion

Adegbite and associates2 in their
review of 114 surgically treated menin
giomas found that the degree of surgical
resection was the only important factor
influencing recurrence. It might be
assumed that reducing tumour vascular
ity and thus intraoperative bleeding might
facilitate the total removal of these
tumours.

FIG. 1—Case 2. Pre-embolization, contrastenhanced, computerized tomogram showing
large, homogeneously hyperdense meningioma
located in left frontoparietal convexity.

Table I—Patient Data
Case
no.

Age,

V

Sex

1

36

F

2

66

M

3

27

M

4

34

F

5
6
7
8

57
33
77
60

F
F
F
F

Presentation

Tumour location

Histologic type

Right frontal convexity

Transitional

Left frontoparietal
convexity
Right lateral sphenoid
wing
Headache
Right frontoparietal
convexity
Dysphasia
Left temporal lobe
Seizure, dysphasia Left frontal convexity
Seizure
Right frontal convexity
Memory loss
Left lateral sphenoid
wing

Transitional

Loss of vision,
headache
Dysphasia,
hemiparesis
Seizure

Transitional
Syncical
Transitional
Transitional
Transitional
Transitional
FIG. 2—Case 2. Post-embolization tomo
gram shows large areas of low density within
meningioma.

Table II—Details of Computerized Tomography, Blood Supply to Tumour and Embolization
Post
embolization
Patient low-density
no.
changes
1

2
3
4
5
6
7
8

Yes
Yes
Yes
Slight
Mot done
Yes
No change
No change

Interval from
embolization
h“
12
12
48
48
—
24
24
24

Tumour blood supply
MCA OPH MMA STA
+
+
-

+
+
-

+
+
+
+
+
+
+
+

+
+
-

OCC
+
-

Vessels
embolized

Post
embolization
tumour
blush

Distal ECA
MMA, STA
INT MAX
MMA
INT MAX
MMA
INT MAX
MMA

Reduced 50%
Eliminated
Eliminated
Reduced 50%
Reduced 25%
Eliminated
Reduced 50%
Reduced 75%

MCA - middle cerebral artery, OPH - ophthalmic artery, MMA - middle meningeal artery,
STA = superficial temporal artery, OCC « occipital artery, ECA - external carotid artery,
INT MAX - internal maxillary artery.
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FIG. 3—Case 3. Pre-embolization angio
gram showing tum our blush of lateral
sphenoid-wing meningioma.
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nal carotid to external carotid supply is
quite variable and unpredictable. Even
when the angiographic assessment fails to
show an internal carotid blood supply,
there are often vessels that are too small
for angiographic detection.4 Further
more, it has been suggested that after
external carotid embolization, the inter
nal carotid supply to the tumour increases
and may partly negate the effect of
em bolization.7 Nevertheless, recent
reports have shown that preoperative
embolization of meningiomas can result
in identifiable changes in the tumour.4’5
Richter and Schachenmayer4 described
FIG. 4—Case 3. Post-embolization angio four methods by which the effect of
gram showing obliteration of tumour blush and preoperative embolization might be
occlusion of distal external carotid branches.
assessed: angiographic demonstration of
an alteration or elimination of the tumour
blush; the development o f low-density
areas on post-embolization computerized
tomograms; the intraoperative assessment
of vascularity; the histologic identifica
tion of necrosis, tumour vessel throm bo
sis and embolism. In their series of 31
patients with meningiomas who under
went superselective embolization preoperatively, the external carotid tumour blush
was eliminated in 24. In 18, histologic evi
FIG. 5—Case 4. Post-embolization tomo dence of ischemic or hemorrhagic necro
gram shows low-density tumour core and mar sis was identified although the areas of
gin of contrast enhancement.
necrosis were small, ranging from
microscopic to 5 mm in size. These
authors concluded that preoperative
embolization was a useful adjunct to sur
gical resection of meningiomas, especially
when the tumour blood supply was
primarily derived from the external
carotid artery.
In 23 of 27 patients with intracranial
meningiomas on whom Teasdale and
colleagues5 performed subselective exter
nal caro tid em bolization, p o s t
embolization angiograms showed elimi
nation of the external carotid blush. In
FIG. 6—Case 4. Tomogram obtained 4
8 of 17 patients who underwent post
months after embolization showing return of
embolization computerized tomography,
homogeneous hyperdensity and 50% reduction
in tumour size.
low-density areas were identified. H isto

Table III- Details of Tumour Vascularity, Blood Status and Histologic Findings

Patient
no.

Tumour
diameter
cm

Surgeons'
description of
intraoperative
vascularity

1

5.6

Moderate

6

1.8

7.8

2
3

7.2
4.2

High
Moderate

4
4

4.8
3.4

8.8
7.4

4

4.2

Low

0

1.5

1.5

5

7.0

Moderate

4

4.7

8.7

6

4.0

Low

0

2.0

2.0

7

4.7

Low

0

2.7

2.7

8

5.8

Low

2

2.2

4.2

Blood
Hemoglobin Total loss
Units
transfused change, g/dL
units

Histologic
findings
Gelfoam emboli,
areas of necrosis
Gelfoam emboli
Gelfoam emboli,
areas of necrosis
Hyalinization,
ischemic fibrosis
Gelfoam emboli,
areas of necrosis
Gelfoam emboli,
areas of necrosis
Single dural
Gelfoam embolus
Gelfoam emboli

logically, 10 of 26 specimens contained
embolic material and 14 showed evidence
of necrosis.
Baum and colleagues8 assessed the
difference in radionuclide scans from two
patients with meningiomas before and
after Gelfoam embolization of the exter
nal carotid feeding vessels; in both cases
the tumours were no longer visualized in
the arterial phase but were present in the
venous phase. Teasdale’s group5 used
radioisotope imaging to estimate tumour
blood flow and volume and found no
correlation between the vascularity
demonstrated angiographically and the
assessment of blood flow and volume. In
patients for whom post-embolization iso
tope scans were obtained, no gross
changes were identified overall; in three
with pure external carotid feeding vessels,
some reduction in flow was noted; in
some with both internal and external
carotid supply, flow and volum e
increased. This observation tends to sub
stantiate the view of Djindjian and
Merland7 that internal carotid feeding
vessels multiply after the obliteration of
external carotid feeders.
Conclusions
The use of embolization of menin
giomas preoperatively results in identifi
able computerized tomographic and
angiographic changes in the meningioma
and may reduce intraoperative bleeding
from external carotid artery feeding ves
sels; however, the overall reduction in
vascularity depends on the relative con
tributions of the internal and external
feeders. Because of the small numbers, we
could not speculate as to the efficacy of
reducing tum our blood loss during
surgery.
We thank Drs. Wm. Horsey, Wm. Tucker
and A. Hudson for allowing us to include their
patients; and Miss Dena Evans for secretarial
assistance.
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B e n ig n C y s tic T e ra to m a o f th e O vary: a 6 -Y e a r R e v ie w
Benign c y s tic te ra to m a o f th e o va ry w as
diag no se d h isto lo g ica lly in 1 1 8 patien ts
o ve r 6 years at th e Sir M o rtim e r B.
D a vis-Jew ish General H ospital in M o n t
real. The charts w e re revie w e d w ith
re sp e ct to population d is trib u tio n , sym p 
to m a to lo g y , d ia g n o s tic procedures and
tre a tm e n t. Of th e 1 18 p a tien ts, 8 5 .6 %
w ere younger th a n 4 0 years. O nly 3 .4 %
had do cu m e n te d recurrence and 6 .8 %
w e re pregnant. R oentgenogram s o f the
pelvis revealed c a lc ific a tio n in 6 4 .1 % o f
cases. U ltraso n o g ra p h y o f th e pelvis
failed to make th e diagnosis in 1 9 .4 % .
The m a jo rity o f p a tie n ts had a Pfannenstiel in cision (7 8 .8 % ) and u n d e rw e n t
o o p h o re c to m y (5 5 .3 % ). In h a lf the
p a tie n ts th e contra la te ra l o va ry w a s only
palpated.

En 6 ans, des te ra to m e s kystiq u es
benins des ovaires o n t ete diagnostiques
h is to lo g iq u e m e n t chez 1 18 patientes. a
I'H o p ita l General J u if Sir M o rtim e r B.
D avis de M ontreal. Les dossiers m edicaux de ces p atientes o n t ete etudies
pour la d is trib u tio n de la p o p ula tio n , la
sy m p to m a to lo g ie , les in te rve n tio n s dia
g n o s tiq u e s et le tra ite m e n t. Des 118
p a tie n te s, 8 5 .6 % avaient m oins de 4 0
ans. Seulem ent 3 .4 % o n t m on tre des
p re u ve s de recidive et 6 .8 % eta ien t
en ce inte s. La roe n tgenographie du bassin
a d 6 m o n tr6 la c a lc ific a tio n dans 6 4 .1 %
des cas. L'6chographie ultra so n iq u e du
bassin n 'a pas perm is de fa ire le dia g no s
tic d ans 1 9 .4 % des cas. La m a jo rity des
p a tie n te s o n t eu une incision de Pfannenstiel (7 8 .8 % ) et o n t subi une ovariecto m ie (5 5 .3 % ). Chez la m o iti6 des
p a tie n te s, I'ovaire co n tra la te ra l n 'a 6t6
que palpe.
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Most ovarian teratomas are benign and
cystic. They are usually of ectodermal ori
gin and consist of a large compartment,
containing sebaceous material admixed
with hair, and a small solid portion
known as Rokitansky’s protruberance.
The latter, which is usually located at the
base of the tumour, may consist of
mature cartilage, a well-formed calcific
tooth or ill-defined calcifications.1 Hor
monally active tissue may be found in
benign cystic teratomas.2 Ovarian tera
tomas develop from the products of the
first meiotic division of a single oocyte
and are routinely homozygous, contain
ing a single late replicating X chro
mosome.2

the gynecology service at the Sir Mortimer
B. Davis-Jewish General Hospital in
Montreal with a histologic diagnosis of
benign cystic teratoma of the ovary (Fig.
1). The medical records of these patients
were reviewed to determine the popula
tion distribution, symptomatology and
the diagnostic procedures, and type of
treatment used. The series was drawn
from the pathology department’s com
puterized list of patients classified as hav
ing benign cystic teratoma of the ovary,
within the specified years. The study
included 123 cysts, since five patients had
bilateral tumour.

Patients and Method

Population Distribution

Between Jan. 1, 1978 and Dec. 31,
1983, 118 patients were discharged from

Of the 118 patients, 101 (85.6%) were
younger than 40 years while 12 patients
(10.2%) were younger than 20 (Fig. 2).

Findings

AG E (y ea rs)

FIG. 1—Distribution of cases of benign
ovarian cystic teratoma during 6 years of study.

FIG. 2—Age distribution.

Table 1—Incidence of Recurrence, Bilaterality and
Associated Pregnancy
Recurrence/bilaterality/
pregnancy

Patients
no./total no.

%

Recurrence
Suspected recurrence
Bilateral
Gross
Microscopic
Pregnancy

4/118
4/118
5/118
4/5
1/5
8/118

3.4
3.4
4.2
80.0
20.0
6.8

Reported %2

11.1
82.0
18.0
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The age range was from 13 to 66 years.
The incidences of recurrence, bilaterality
and a coexisting pregnancy are shown in
Table I.
Two patients had recurrence in the con
tralateral ovary and a third patient had
recurrence twice. This patient underwent
a right ovarian cystectomy at 18 years of

age, a left ovarian cystectomy at 19 years
and bilateral ovarian cystectomies at 22
years. Four other patients (3.4%) had
undergone ovarian surgery elsewhere
previously for unknown conditions.
Symptoms
More than half the patients were com

Table II -Diagnostic Test in 64 Asymptomatic Patients
With Benign Ovarian Cystic Teratoma
Test

No.

%

Routine pelvic examination
Roentgenography
Ultrasonography
Laparotomy

46
2
1
15

71.9
3.1
1.6
23.4

Table Ill-Symptoms in 54 of 118 Patients With
Benign Ovarian Cystic Teratoma
Symptom
Amenorrhea
Menometrorrhagia
Abdominal pain

No. (symptoms)

%

3
15
49

5.6
27.8
90.7

Table IV--Diagnostic Procedures: Rate of Use and
Positive Findings
Procedure
Roentgenography
Calcification seen
Computerized tomography
Ultrasonography
Cyst seen
Calcification seen
Normal appearance (missed)

Patients,
no./total no.

%

39/118
25/39
1/118
67/118
57/67
9/67
13/67

33.1
64.1
0.8
56.8
80.6
13.4
19.4

Table V-Operative Findings
Ovarian cyst

No./total no.

%

Left ovary
Right ovary
Bilateral
Diameter, cm
< 6
> 6
Unknown

53/118
60/118
5/118

44.9
50.8
4.2

39/123
81/123
3/123

31.7
65.9
2.4

Table VI--Mode of Surgical Treatment in 118 Patients
Procedure
Total abdominal hysterectomy
Cystectomy
Oophorectomy
Other ovary
Palpated
Bisected
Wedge biopsy
Oophorectomy
Unknown

No. of patients

%

18
54
68

15.3
45.8
57.6

58
13
21
15
11

49.2
11.0
17.8
12.7
9.3

pletely asymptomatic when the teratoma
was discovered (Table II). These masses
were diagnosed on routine pelvic exami
nation, roentgenography, ultrasonogra
phy, or incidentally at laparotomy. The
laparotomies were done for different indi
cations such as suspected ectopic preg
nancy, total abdominal hysterectomy and
cesarean section. Among the sympto
matic patients, the most common sym
ptom was abdominal pain (Table III).
Diagnostic Procedures
One third of the patients underwent
roentgenography and more than half
ultrasonography (Table IV). Only one
patient had computerized tomography
and the tomogram demonstrated the
lesion. Calcification was apparent on
64.1% of the roentgenograms. Ultra
sonography missed 19.4% of the cysts;
calcification was identified in 13.4%.
Mode o f Treatment
All patients underwent laparotomy,
usually through a Pfannenstiel incision
(83.1%). Only 20 patients (16.9%) had a
midline incision. Right-sided teratomas
were slightly more common than left
(Table V). Two thirds of the ovarian ter
atomas were more than 6 cm in diameter,
the largest being 18 cm. The smallest cyst
(1.2 cm in diameter) was discovered as a
pelvic calcification on the roentgenogram.
The patients had a variety of procedures
at laparotomy, ranging from a simple
ovarian cystectomy to total abdominal
hysterectomy and bilateral salpingooophorectomy (Table VI). All patients
who underwent total hysterectomy were
more than 37 years of age and had coex
isting uterine disease. The contralateral
ovary was simply palpated in half of the
patients.
Discussion

It is well known that the majority of
benign cystic teratomas of the ovary occur
in young women, with a peak incidence
between 20 and 40 years of age. It is the
most common ovarian tumour in women
younger than 20, constituting 38% of
ovarian neoplasms.3 Benign cystic tera
tomas are known to recur mainly because
of incomplete removal of the cyst wall ini
tially. In our series, 60% had de-novo
recurrence in the contralateral ovary.
Benign cystic teratomas usually do not
interfere with pregnancy and may coex
ist in the same ovary with a corpus luteum
cyst. According to the literature,4 benign
cystic teratomas represent 12.3% to
44.0% of all tumours complicating preg
nancy. A bimanual examination in early
pregnancy should be directed at detect
ing ovarian masses. Any such mass more

VOLUME 28, NO. 5, SEPTEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

445

than 6 cm in diameter or persisting
beyond the 14th week of gestation should
be managed surgically. The recommended
time o f surgery is after the 12th week o f
gestation since the fetal loss secondary to
the procedure is practically nil.5 The
most common palpable ovarian mass dur
ing pregnancy is the corpus luteum cyst,
followed by the benign cystic teratoma,
then by cystadenoma.6
The majority o f patients with benign
cystic teratomas o f the ovary are asymp
tomatic. The mass is usually discovered
on routine pelvic examination, or as cal
cifications seen in the pelvis during proce
dures done for some other reason. Psam
moma bodies of the serous cystadenomas
may show as nonspecific calcifications on
roentgenograms and should be considered
in the differential diagnosis. Computer
ized axial tomography can accurately
diagnose a teratoma because o f the com
plex appearance o f the mass with divid
ing septae, internal debris, variable
attenuation and distinct calcification.
Ultrasonography usually shows highly
reflective cystic and solid echoes with
areas o f accoustic shadowing that obscure
the back wall o f the cyst, suggesting the
“ tip o f the iceberg” sign o f a teratoma.2
Bilateral benign cystic teratomas
represent 11% to 18% o f all ovarian
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tumours. Most are less than 10 cm in
diam eter. Intraperitoneal rupture
occurred preoperatively in one patient
(0.8%) in our series and has been reported
elsewhere in 1.2% to 1.9% o f cases.7
The perforation may be acute, resulting
in signs o f intraperitoneal irritation, or
may be insidious and fulminant, result
ing in matted adhesions up to the
diaphragm mimicking gynecologic malig
nant disease.
Since most patients are in their
reproductive years and wish to have chil
dren, conservative treatment is recom
mended. Attempts should be made to
conserve the ovary and to remove the cyst
wall completely to avoid recurrence. The
incidence o f torsion o f the pedicle is
reported to be about 21% and associated
infarction 10.8%.8 In our series the inci
dence was 3.2% and 2.4% respectively.
If the contralateral ovary is normal on
intraoperative palpation, it is unlikely to
be diseased and surgical manipulation is
unnecessary.9
Despite the simplicity o f the operation
and the benign outcome o f cystic tera
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in the m ass.10 In our series one case of
struma ovarii occurred in a 51-year-old
woman who had a palpable thyroid
gland. Familial occurrence o f benign cys
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virilizing effects has also been
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Endometriosis:
an Unusual Cause of Ureteral Obstruction
Endom etriosis is a com m on disorder,
affecting w om en in the child-bearing
years. W hile urologic involvem ent is rare,
the bladder is more often affected than
the ureter. The a uthors describe the case
of a 30-year-old w o m a n w h o had uni
lateral ureteral obstruction secon da ry to
an isolated periureteral retroperitoneal
area of endom etriosis. The theories of
histoge n e sis are d iscu sse d . Current treat
ment c o n sists of su rge ry or horm onal
m anipulation or a com bination of the
two.

L 'e nd om e triose est une affection courante touchant les fem m es en age de
concevoir. Bien que les atteintes urologiques soient rares, la ve ssie est plus souvent touchee que les ureteres. Les
auteurs decrivent le ca s d 'u n e fem m e de
3 0 ans qui a souffert d 'u n e obstruction
ureterale u n ila te ra l con secu tive a une
endom etriose limitee a la region periureterale retroperitoneale. O n com m ente les
theories de so n histogenese. Le traitem ent actuel co n siste en une intervention
chirurgicale, en une m anipulation hormonale ou en une com b ina ison des deux.

Case Report

A 30-year-old woman (gravida 2 para 2)
complained of pain in the back, left loin and

■ *»

left lower quadrant, which was more severe
during menstruation. Gynecologic examination
including laparoscopy failed to reveal a cause
for her symptoms. A bone scan (Fig. 1) showed
left hydroureteronephrosis. Clinically, she had
mild flank tenderness, but no pelvic mass or
fixation. Further radiologic evaluation con
firmed the left hydroureteronephrosis (Fig. 2)
and revealed a periureteral mass (Fig. 3) located
just below the pelvic brim. At laparotomy, a
localized solitary area of retroperitoneal fibro
sis, involving the left ureter at the pelvic inlet,
was found. A frozen-section diagnosis of
endometriosis was made. The dilated ureter
was divided as it entered the fibrotic plaque and
was reimplanted into a Boari-type flap. The
permanent sections confirmed the diagnosis of
endometriosis (Figs. 4 and 5).

Discussion
The etiology of endometriosis is
unknown. Several theories exist, the most
popular suggesting that viable
endometrial fragments are regurgitated

Endometriosis is characterized by the
presence and proliferation of endometrial
epithelium and stroma at a site other than
the uterine cavity. It is said to affect up
to 20% of women in the child-bearing
years.1 Clinically important urinary
involvement is rare, amounting to only
1% of cases, but the bladder is more often
affected than the ureter.2 In the case
reported here, ureteral obstruction
occurred as a result of a solitary focus of
extraperitoneal endometriosis.
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FIG. 2—Preoperative intravenous pyeloFIG. 1—Technetium-99m methylene
diphosphonate bone scan demonstrates left gram demonstrates left hydroureteronephro
sis. Obstruction is just below pelvic brim.
hydroureteronephrosis. Bones are normal.
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through the Fallopian tubes during men
struation.3 Other theories to explain the
histogenesis include that of serosal
metaplasia, in which embryonic cells of
Mullerian origin within the peritoneum
persist and proliferate under ovarian hor
monal stimulation, and possibly the
embolization of endometrial tissue along
lymphatic or vascular channels.4 The
only proven mechanism for the develop
ment of endometriosis is direct implan
tation, when endometrium is implanted
into surgical incisions during an operation
in which the uterine cavity is opened.s
The ectopic endometrium undergoes
the same cyclic change as the uterine
endometrium. The response to this peri
odic bleeding is peritoneal irritation,
proliferation of connective tissue, and
secondary formation of adhesions of
varying severity, involving contiguous
FIG. 3—Transverse sonogram demonstrates 2-cm echo-poor nodule (arrow) in
retroperitoneum below pelvic brim.
pelvic structures.
While endometriosis has been reported
to involve all areas of the urinary sys
tem,610 clinically significant urinary
involvement is uncommon.” Ureteral
obstruction is rare, which is surprising
considering the anatomic relationships
within the pelvis.12,13 Ureteral involve
ment can be divided into two groups:14
extrinsic, where the ureter is caught in a
fibrotic reaction in the periureteral tissue
plane, and intrinsic, where the involve
ment is transmural. The intrinsic type is
less common, but both types generally
affect only the pelvic ureter.
The current therapeutic approach
includes surgery or hormonal manipula
tion, or a combination of the two. Sur
gery may be conservative, preserving
reproductive function, or definitive,
involving not only resection of the
endometrial deposits but total hysterec
tomy and bilateral oophorectomy. Occa
FIG. 4—Transverse section of ureter demonstrates periureteral fibrosis and endometrial
sionally, as in our case, surgery is glands (hematoxylin and eosin, original magnification x 25).
performed to deal with a specific compli
* v, r, ** -- •
cation. The surgical approach must be
"S,
tailored to the individual. Certainly when
A V
there is extensive involvement, a pelvic
mass or fixation, preoperative assessment
of the urinary system and preparation of
the bowel should be considered.
Endocrine therapy evolved from the
early observation that endometriosis
undergoes regression during pregnancy
and the menopause.15 This led to the
concept that hormonally induced amenor
rhea might be beneficial. Pseudopreg
nancy is a state of hyperhormonal
amenorrhea that is induced by the con
tinuous administration of estrogen• -X J .
progestogen preparations.16 This results
in decidual transformation, necrosis and
>;
iff f.
•A* '*■
.
t
*
^ ,
absorption of the ectopic endometrium.
*
;
n
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A
f*
'
<*
A more recent approach is the induc
s
'
j.
tion of a state called pseudomeno
1* 4 ' .
* • z~-* \
^
(■
*
,
pause.17 Here, complete ovarian suppres
* * r
sion leads to hypoestrogenic amenorrhea.
This condition is produced by Danazol,
FIG. 5—Higher magnification of endometrial glands and stroma (hematoxylin and eosin,
a synthetic steroid with antigonadotropic original magnification X 65).
** *
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properties. Pseudomenopause appears
more effective than pseudopregnancy and
may cure up to 70% of cases, especially
if the endometriosis is not extensive. Since
the etiology of endometriosis is enigmatic,
effective conservative treatment to pre
vent or permanently cure this condition
has not been developed.18 At present,
castrating hysterectomy is the only ther
apy that offers the possibility of perma
nent control.19'20
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Empyema: Analysis of Treatment Techniques
Empyema is associated with a high mor
tality. To study the factors responsible
for the failure of treatment, the authors
reviewed 90 cases of nontuberculous
thoracic empyema seen at the University
of Western Ontario in London,
between 1970 and 1980. The most
common causes of empyema were bron
chopulmonary infections (6 3 % ), compli
cations of pulmonary surgery (1 4 % ) and
secondary infections of hydrothoraces or
hemothoraces (1 3 % ). In 51 patients
(5 7 % ) the condition was acquired in
hospital or was related to previous medi
cal therapy. Nine cases were recognized
only at autopsy.
The treatment of empyema was
assessed in 81 patients, who received
an average of 2.2 antibiotics during the
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course of treatment. Five patients
received antibiotics as the only therapy;
one died. Seventy-two patients were
treated by surgical drainage; 35 (4 9 % )
were cured and 18 (2 5 % ) subsequently
died. Twelve of 18 decortication proce
dures were successful including 4 per
formed as a primary procedure and 8 as
a secondary procedure. Five of seven
patients who underwent thoracoplasty
were cured. The overall mortality in the
series was 2 3 % .
Prevention and early recognition of
empyema may reduce the mortality.
Patients who do not improve promptly
with surgical drainage may benefit from
early decortication.

L’empyeme est accompagne d'une forte
mortalite. Dans le but d'Studier les facteurs responsables des echecs de traitement, les auteurs ont etudie 90 cas
d'empyeme thoracique non tuberculeux
vus a la University of Western Ontario
de London, entre 1970 et 1980. Les
causes les plus frequentes d'empyeme
ont 6te les infections bronchopulmonaires (6 3 % ), les complications d'interventions chirurgicales pulmonaires (1 4 % ) et
les infections secondaires d'hydrothorax
ou d'hemothorax (1 3 % ). Chez 51
patients (5 7 % ), il s'agissait d'une infec
tion d'hopital ou d’une infection reliee a
un traitement prealable. Neuf cas n'ont
ete constate qu’& I'autopsie.

Le traitement de I'empyeme a pu etre
evalue chez 81 patients qui ont repu en
moyenne 2.2 antibiotiques. Pour cinq
patients, I'antibiotherapie a constitue
I'unique traitement; un est mort.
Soixante-douze patients ont ete traites
par drainage chirurgical; 35 (4 9 % ) ont
ete gueris et 18 (2 5 % ) sont morts subsequemment. Douze interventions de
decortication sur 18 ont ete couronnees
de succes, dont 4 interventions primaires
et 8 secondaires. Cinq des sept patients
qui ont subi une thoracoplastie ont ete
gueris. Dans I'ensemble la mortalite a ete
de 2 3 % .
La prevention et le diagnostic precoce
de I'empyeme sont susceptibles de
rgduire la mortalite. Les patients qui ne
s'ameliorent pas apres un drainage chi
rurgical peuvent beneficier d'une decorti
cation immediate.

The current treatment for empyema is
based on work done by Evarts Graham
in 1915. He used surgical drainage to treat
young soldiers with empyema at Camp
Lee, Virginia, and reported an early mor
tality of only 4% .' Because o f his excel
lent results, surgical drainage was adopted
by most surgeons as the standard initial
therapy for thoracic empyema.
Unfortunately, modern surgeons can
not match Evarts G raham ’s success.
Recent studies report death rates ranging
from 15% to 30%, despite the use of
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potent antibiotics and modern surgical
techniques.2-4 This difference is likely
due to the changing etiology of empyema.
Most of Graham ’s patients were young
men with postpneumonic infections.
Today, the patient with empyema is often
elderly, debilitated and immunosuppressed. Many have gram-negative,
anaerobic or mixed infections. For these
reasons, the treatment of empyema that
worked so well in 1915 is less effective
today.
To improve the outcome in this condi
tion, we may have to modify the tradi
tional management. We reviewed 90 cases
of empyema seen at the University of
Western Ontario between 1970 and 1980
to determine the results of treatment and
to identify factors associated with success
or failure of therapy.

Patients
The charts of all patients with a diag
nosis of thoracic empyema, seen in the
three teaching hospitals of the University
of Western Ontario between 1970 and
1980, were reviewed. Only those with
positive cultures of pleural fluid or frank
pus in the pleural cavity were included.
There were 61 males and 29 females,
ranging in age from 1 to 91 years (median
53 years). Nine cases were identified at the
time of autopsy, and these patients were
included in the data on etiology and diag
nosis. The results of treatment are
reviewed in the remaining 81 patients.
Findings
Etiology
In 39 (43%) of the 90 patients, the
empyema was acquired in the community;
in the remaining 51, the condition either
developed in hospital or resulted from
previous medical therapy. The common
causes of empyema included bronchopul
monary infections (63%), complications
of pulmonary surgery (14%), secondary
infections of pleural effusions or
hem othoraces due to pneum onias
acquired in hospital or contamination
from thoracentesis (13%), complications
of esophageal surgery (4%) and secon
dary spread of intra-abdominal infections
(4%). Seven cases occurred after trauma
from m otor vehicle accidents.
Forty-eight patients (53%) had one or
more risk factors associated with
decreased host resistance to infection,
including malnutrition, alcohol abuse,
malignant disease, diabetes mellitus,
severe liver or renal disease, or were
receiving steroids or antineoplastic ther
apy. Eight patients had respiratory dis
ease and 24 had cardiovascular disease.
450

Diagnosis
Patients with empyema presented with
cough (61 patients, 68%), shortness of
breath (55 patients, 61%) and fever (54
patients, 60%). Fatigue, weight loss and
chest pain were also common complaints.
The diagnosis was established by
thoracentesis in 45 patients (50%),
thoracostomy or thoracotomy in 36
(40%) and at autopsy in 9 (10%).
The initial culture of the pleural fluid
was positive in 81 patients (90%). In these
patients, mixed bacterial infections (30
patients, 37%) and anaerobic infections
(26 patients, 32%) were common. The
most frequent gram-positive aerobes
included Staphylococcus sp, (3-hemolytic
streptococci, pneumonococcus and Strep
tococcus viridans. The most frequent
gram-negative aerobes included Pseudo
monas aeruginosa, Escherichia coli and
Klebsiella pneumoniae. The common
anaerobes were micrococcal strep
tococcus, anaerobic streptococcus and
Bacteroides fragilis.

Eighteen patients had decortication,
which included removal of visceral pleura
and radical debridement of the abscess
cavity; 12 of them were cured but the
procedure failed in 6, including 2 who
died. Decortication was performed in 14
patients who already had undergone sur
gical drainage. In this group, which
included the two who died, one was left
with a persistently draining chest tube,
three failed to improve but later under
went successful thoracoplasty and the rest
were cured. The three patients who failed
to improve with decortication had paren
chymal lung disease (previous left upper
lobe resection, large lung abscess in a dis
eased lobe separate from the empyema
and restrictive lung disease from an old
tuberculous infection).
Of the seven patients who underwent
thoracoplasty, five were cured and there
were two sudden unexplained deaths.
Overall, of the 81 patients whose treat
ment for empyema was studied 19 died
(23%).
Discussion

Treatment
The 81 patients with empyema whose
treatment was studied received an aver
age of 2.2 different antibiotics during the
course of treatment. In eight of the
patients, the antibiotic therapy was
suboptimal because of an inadequate
dose, oral administration or failure to
cover the bacteria that were cultured.
Treatment with antibiotics and thora
centesis resulted in four cures and one
death — in a patient with alcoholic cir
rhosis, who was critically ill at the time
of presentation.
Seventy-two patients had a surgical
drainage procedure, either a tube
thoracostomy alone (50), or combined
with a rib resection (22). When surgical
drainage was used as the primary treat
ment, 35 patients (49%) were cured and
18 (25%) subsequently died. Of the 37
patients with failed surgical drainage, 5
were left with persistent chest-tube
drainage, 14 underwent pulmonary decor
tication, 4 thoracoplasty and 14 died
without having another surgical proce
dure (Fig. 1).
Surgical drainage failed in 61% of
those with hospital-acquired infections
(27 patients), in 65% with mixed infec
tions (18 patients) and in 61% of those
who were immunocompromised (28 pa
tients). Of the 45 patients with hospitalacquired infections who were treated with
surgical drainage, 17 (38%) died. Of 11
patients with secondary infections of
pleural effusions or hemothoraces due to
pneumonias acquired in hospital or con
tamination at the time of thoracentesis,
8 (73%) died after surgical drainage.

Surgical drainage was adopted as the
standard initial therapy for the treatment
of thoracic empyema on the basis of
E varts G rah am ’s excellent results
reported in 1915.1
Recent studies of patients with
empyema have reported mortality rang
ing from 25% to 30%.2‘6 The etiology of
empyema has undergone considerable
change since Graham’s time, and this may
explain why his methods are less effective
today. In the past, most patients with
empyema were young and the infectious
agent was usually (J-hemolytic strep
tococcus or Staphylococcus sp. In con
trast, over half of our patients were older
than 40 years, many were immunocom
promised and gram-negative anaerobic

1.

Antibiotics only

5 -• 4 cured (80%)

1 died

2.

Surgical drainage

72 -» 35 cured (49%)

failed 37 (51 %)
------------- ►

died 14

►chronic chest tube 5
<-»> cured 8
__ j—►thoracoplasty 3 (cured)
(—►chronic chest tube 1
'—►died 2

►died 2

3.

Decortication

4 -

cured 4 (100%)

FIG. 1—Treatment of thoracic empyema at
University of Western Ontario, 1970 to 1980.
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infections were common. The overall
mortality in patients treated for an
empyema at our institution between 1970
and 1980 was 23%.
What changes can be made to improve
these results? Over half of our cases of
empyema were due to iatrogenic infec
tions, and these patients accounted for
over 80% of the deaths in this series.
These data emphasize the importance of
standard measures that might prevent
hospital-acquired empyema, including
vigorous postoperative physiotherapy to
reduce the incidence of pulmonary infec
tion, appropriate antibiotic therapy for
pneumonias and strict aseptic technique
when performing diagnostic or therapeu
tic thoracentesis.
In 10% of our cases, the empyema was
not diagnosed until autopsy. Thus, acute
awareness is needed to avoid missing the
diagnosis and delaying treatment. Any
patient with a fever and a pleural effu
sion should be considered to have
empyema until proven otherwise.
Although a chest roentgenogram will
usually localize the empyema, computer
ized tomography or ultrasonography may
help in difficult cases.
Adequate drainage of the pleural space
is still the key element in the treatment of
empyema; 49% of our patients were suc
cessfully treated with a drainage proce
dure alone. Patients who do not improve

J ulie R ighter ,

quickly with chest-tube drainage may
benefit from decortication. Recent
reports have shown that decortication can
be accomplished with a low morbidity
and m ortality, even in debilitated
patients.7-9 This allows the surgeon to
remove all the infected tissue and pus, it
avoids the debilitating effects of
prolonged drainage and improves pulmo
nary function by removing the restrictive
pulmonary peel.
Our data identified groups of patients
with empyema who did not have a good
response to drainage procedures. Patients
with anaerobic infections, hospitalacquired infections, secondary infections
of the pleural space and those with
depressed immunity may benefit from
early decortication.
In our review, 18 patients had a pul
monary decortication (14 after surgical
drainage) and this procedure was success
ful in 12. Patients in whom decortication
failed included two who died of ongoing
sepsis, one who had persistent chest-tube
drainage and three who subsequently
underwent a thoracoplasty and were
cured.
Thoracoplasty is an effective treatment
for empyema in selected patients. Seven
of our patients had a thoracoplasty: five
were cured and two died. Three patients
who failed to improve with decortication
had parenchymal lung disease which may

m d , frcpc ;*
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have prevented the lung from re-expanding. These patients were cured with a sub
sequent thoracoplasty. If patients with
empyema and parenchymal lung disease
do not respond to surgical drainage,
thoracoplasty should be combined with
decortication as the next procedure.
Thoracic empyema is still common and
unfortunately often fatal. Prevention,
early recognition and prompt, effective
treatment may reduce the morbidity and
mortality associated with this condition.
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Campylobacter and Endovascular Lesions
Because of the gaps in our knowledge of
the epidemiology and pathogenesis of
Campylobacter infections, particularly
the propensity of Campylobacter fetus
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ssp fetus to infect vascular endothelium,
the authors describe the case of a
56-year-old woman with C. fetus ssp
fetus infection of an aortic aneurysm.
She recovered after a one-stage surgical
repair and antibiotic therapy with
erythromycin.
The organism was cultured from sam
ples of the stool and tissue obtained at
operation. It was identified from its typi
cal characteristics: morphology,
microaerophilic, able to grow at 22°C
and 37°C but not at 42°C, catalase and
oxidase positive and resistant to nalidixic
acid but susceptible to cephalothin.
Considerant les lacunes des connaissances actuelles sur I'epidemiologie et la
pathogen&se des infections a Campylo
bacter, et particulierement sur I'affinite
de Campylobacter fetus variete fetus
pour I'endothelium vasculaire, les auteurs

d^crivent le cas d'une femme de 56 ans
souffrant d'une infection a C. fetus
variate fetus colonisant un anevrisme de
I'aorte. La gugrison a suivi une repara
tion chirurgicale en une etape accompagnee d'une antibiotherapie a
I’erythromycine.
Le microorganisme a pu etre cultive
des echantillons de selles et des tissus
preleves a I'operation. II a ete identifie a
ses caracteristiques typiques: morphologie, microaerophile, capable de pousser a
22°C comme a 37°C mais incapable b
42°C, catalase et oxydase positif, resis
tant a I'acide nalidixique mais sensible a
la cephalothine.

Like Salmonella, Campylobacter fetu s ssp
fetus has an apparent propensity to infect
vascular endothelium, although proof
with the latter is rare. This bacterium has
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been called by various names. According
to Skerman and associates, 1 the genus
Campylobacter contains three pathogenic
species, C. jejuni, C. coli and C. fetu s,
the last being divided into two subspecies,
fetus and venerealis. The incidence of
Campylobacter infection in endovascular
lesions is unknown and unless appropri
ate bacteriologic techniques are used, we
will not be able to diagnose these infec
tions. We describe such a case to illustrate
the characteristic findings and appropri
ate investigations, and to stimulate others
to seek the diagnosis and thus fill in some
of the gaps in our knowledge of Cam
pylobacter syndromes.

Case Report
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Treatment of infected or poten
tially infected burns, crush injuries,
lacerations. Also varicose ulcers,
bedsores, ulcerated wounds and
graft sites.
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of ototoxicity and nephrotoxicity
being eventually produced must
be considered. Prolonged use of
antibiotics may result in the
overgrowth of non-susceptible
organisms, including fungi.
Appropriate measures should
be taken if this occurs.
Dosage:
A single layer to be applied di
rectly to the wound and covered
with an appropriate dressing. If
exudative, dressing should be
changed at least daily. In case of
leg ulcers cut dressing accurately
to size of ulcer.
Supplied:
A lightweight, lano-paraffin gauze
dressing impregnated with 1 %
framycetin sulphate B.P.: avail
able in 2 sizes: 10 cm by 10 cm
sterile single units, cartons of 10
and 50; 10 cm by 30 cm sterile
single units, cartons of 10.
Store in a cool place.
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A 56-year-old woman gave a history of hav
ing crampy abdominal pain associated with
nausea and diarrhea without blood or mucus
for 2 months. She was afebrile, her blood pres
sure was 140/90 mm Hg and pulse rate 84
beats/min. An abdominal aortic aneurysm was
palpable. The hemoglobin value was 136 g/L
and the leukocyte count was 12.1 x lO^L
with 80% neutrophils. Stool sent for culture
was lost in transit.
She improved with nonspecific therapy.
Nineteen days after admission she underwent
elective resection o f the aneurysm and tubegraft aortic reconstruction. Extensive inflam
matory tissue was noted in the retroperitoneum, adherent to the aorta. This tissue, and
stool collected 4 days later, grew C. fetus ssp
fetus. She received a course o f erythromycin
(500 mg orally four times daily for 7 days).
Blood cultures drawn while on this therapy
were sterile. She made a smooth recovery and
was alive 3 years later, with no evidence of
recurrence.
The organism was identified on the basis o f
typical morphology (curved gram-negative
bacilli) and motility, along with the following
characteristics o f C. fetus ssp fetus: microaerophilic, able to grow at 22°C and 37°C but
not at 42°C, oxidase and catalase positive,
resistant to nalidixic acid and susceptible to
cephalothin.

Discussion

Most cases of Campylobacter endovas
cular infections are incom pletely
documented. In one patient with septice
mia, endocarditis was proven, but organ
isms could not be recovered at autopsy . 2
Six patients had thrombophlebitis and
Campylobacter septicemia ;3' 7 in at least
three of these the isolate was clearly C.
fe tu s ssp fe tu s .4'5-1 Examination of
inflamed femoral veins from one patient
at autopsy failed to reveal organisms. 3
In most reported Campylobacter infec
tions of aneurysms, the role of the organ
ism is uncertain. Loeb and associates8
described a patient with a femoral artery
aneurysm and Campylobacter septicemia.
Three patients with C. fetus ssp fetus sep

ticem ia died o f ruptured aortic
aneurysms ; 9' 11 cultures from two at
autopsy were negative, but antibiotics had
been given.
The present report and one by Marty
and associates 12 describe the only two
patients with localized endovascular
infections proven by culture. The other
patient also had an infected abdominal
aortic aneurysm; culture of arterial blood
and aortic wall tissue grew C. fetus ssp
fetus. It is interesting that both patients
were successfully treated with a one-stage
surgical repair.
Campylobacter fetus ssp fetus causes
three distinct syndromes: localized infec
tion (often accompanied by septicemia),
cryptogenic septicemia (a benign entity)
and relapsing septicemia (in immunocom
promised patients ) . 7 The association of
the organism with vascular endothelial
lesions is noteworthy.
Awareness of C. fetus ssp fetus as a
potential pathogen is essential since it may
be missed by usual bacteriologic tech
niques. Little is known about the epidemi
ology and pathogenesis of this infection.
Previous reports have used various sys
tems of nomenclature and often the
organism was not fully identified. It is
vital to distinguish C. fetus ssp fetus from
C. jejuni whenever Campylobacter is cul
tured from any unusual infection in order
that we may gain a clearer understand
ing of the diseases caused by these
organisms.
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Treatment of the Chronically Infected Median
Sternotomy Wound With Muscle Flaps
While infection and dehiscence of the
median sternotomy wound is a serious
complication, debridement, sternal rewir
ing and wound irrigation will often result
in wound healing. However, if these
measures fail, radical debridement of all
infected tissue and immediate recon
struction with muscle flaps is required
and will give excellent results. The pectoralis major muscle based on the
thoracoacromial artery is most satisfac
tory for this reconstruction. The rectus
abdominis muscle, while also used, is
not as effective because of variations in
its proximal blood supply.
The author describes 10 patients with
chronically infected median sternotomy
wounds, seen at St. Michael's Hospital
in Toronto, in whom use of these tech
niques led to a rapid recovery with few
complications.
L'infection et le lachage des sutures
representent de serieuses complications
de sternotomie mediane. Le debridement,
la pose de nouvelles broches sternales et
I'irrigation de la plaie entrainent generalement la guerison. Lorsque ces mesures
echouent un debridement radical du tissu
infecte et une reconstruction immediate
avec des lambeaux musculaires sont
requis et donnent d'excellents resultats.
Le grand pectoral irrigue par I'artere
acromio-thoracique est juge des plus
satisfaisants pour cette reconstruction.
Bien qu'il soit aussi utilise, le grand droit
de I'abdomen est moins efficace a cause
des variations de son apport sanguin
proximal.
L'auteur decrit 10 patients vus au StMichael's Hospital de Toronto alors qu'ils
etaient porteurs d'infections chroniques
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de plaies de sternotomies medianes, et
chez qui ces techniques ont entraine une
guerison rapide avec de rares compli
cations.

Dehiscence of the median sternotomy
wound with chronic infection is a serious
complication. Aggressive early debride
ment of the wound followed by sternal
rewiring and continuous wound
irrigation1 is successful in 90% of early
cases,2 but if this fails, the morbidity and
mortality are high.3 Radical debridement
of the sternum and adjacent cartilage is
then necessary but results in an extensive
bone and soft-tissue defect. In the past,
these wounds were allowed to heal by
secondary intention or were skin grafted.
Recent reconstruction of the soft-tissue
defect with muscle flaps, musculocutane
ous flaps and omentum4-7 has lowered
the morbidity and mortality. These flaps
provide excellent vascularized tissue to fill
the defect, obliterate dead space and pro
tect the underlying structures.
Another group of patients who require
this type of management are those with
single or multiple sinus tracts. Frequently,
they have been discharged from hospital
with a healed sternal wound and initially
present with evidence of infection several
months after the operation. The approach
to treatment in these cases should be
aggressive because the infection tends to
recur following surgical treatment.8 Ster
nal resection followed by reconstruction
is usually necessary.
We have used pectoralis major and
rectus abdominis muscle flaps following
radical debridement of the sternal wound.
The purpose of this paper is to present the
experience of our group at St. Michael’s
Hospital in Toronto with these flaps and
to describe the technical refinements we
have made.
Patients

The charts of 10 consecutive patients
with major sternal infections treated at St.
Michael’s Hospital between June 1981
and December 1983 were reviewed. Seven
represented failure of standard manage
VOLUME 28, NO. 5, SEPTEMBER 1985 / THE CANADIAN JOURNAL OF

ment of sternal dehiscence or wound
infection that consisted of debridement,
rewiring and wound irrigation.
Osteomyelitis and mediastinitis developed
in all patients and eight were critically ill
as a result. Eight patients were treated
within 2 months of their cardiac opera
tions. Two patients had chronic
osteomyelitis of the sternum; one was
seen 1 year after and the second 3 years
after the original procedure. The courses
of these patients are summarized in Table
I.

Surgical Techniques

All infected material including skin,
sternum and costal cartilage is radically
debrided. Frequently, the entire sternum
and adjacent cartilage must be removed
(Figs. 1 and 2), especially when secondary
rewiring has been performed as in 9 of
our 10 patients. In chronic osteomyelitis,
multiple sinus tracts often involve car
tilage, which must be excised back to the
costochondral junction. In the vicinity of
the costal arch care must be taken to
preserve the internal mammary and
superior epigastric vessels. The
manubrium is debrided to healthy appear
ing bone. Tissue overlying the heart is
gently removed. Some granulation tissue
and fibrinous exudate is often left in this
area. After the wound is irrigated exten
sively, the defect is closed with muscle
flaps, using one or both pectoralis major
muscles and often the rectus abdominis
muscle.
The pectoralis major muscle is dis
sected as follows. Initially, it is freed from
the overlying soft tissues. The origin of
the sternal portion is completely detached
if this has not already been done during
the radical debridement. The origin of the
clavicular head is preserved. The lateral
border is freed from its soft-tissue attach
ments. Occasionally, simple muscle
advancement to the midline will provide
adequate coverage of the defect as in two
of our patients. If additional tissue is
required, the insertion of the sternal head
into the humerus is divided to mobilize
the muscle further. A second incision in
453
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the region of the deltopectoral groove can
be made but this can also be done through
the central incision. The muscle is then
rotated on its thoracoacromial vascular
pedicle into the defect. Often only one
muscle needs to be mobilized in this
fashion but both may be necessary if a
large defect is present or the muscles are
small.
In one patient the muscle was not used
in this fashion but was “ turned over” ,
preserving the internal mammary blood
supply while dividing the thoracoacromial
pedicle. We have found it more satisfac
tory to divide the internal mammary ves
sels as these may have been damaged dur
ing the debridement.
Large defects involving the lower one
third of the sternum may not be ade
quately covered with the pectoralis major
muscles alone. This area is very well
covered by the rectus abdominis muscle
based on the superior epigastric artery.
The muscle is dissected by making a
paramedian incision from the lower end
of the sternal incision to the level of the
umbilicus. The anterior sheath is incised.
The muscle is carefully dissected from the
sheath, care being taken to preserve the
superior epigastric vessels. Once adequate
length has been obtained, the muscle and
inferior epigastric vessels are transected
and the proximal vascular pedicle is dis
sected as necessary to allow the muscle to
rotate 180°, filling in the lower chest
defect. The anterior sheath is then closed.
The mobilized pectoralis and rectus
abdominis muscles are approximated in
the midline (Figs. 3 and 4), completely
covering the debrided area and filling in
the soft-tissue defect. Numerous suction
drains are inserted to help control fluid
accumulation and obliterate dead space.
One is placed beneath the muscle flaps,
two beneath the skin and two laterally in
each area of pectoralis detachment. The
skin is then closed primarily. An elastic
chest binder is applied over a well-padded
dressing.
Suction drains are removed 1 week
after operation. Antibiotics are given

intravenously for 1 week than orally for
3 weeks, according to culture and sensi
tivity findings. The patients wear the chest
binder for 1 month after the operation.
Results

Most patients recovered rapidly and

FIG. 1—Infected sternal wound following
debridement and wound irrigation.

IIG. 3
muscles.

were discharged from hospital 2 weeks
after operation. Major complications
were few. One patient suffered a pulmo
nary embolism. One died early postoperatively from refractory congestive heart
failure and renal failure. Sternal infection
recurred in one patient. This was thought
to be a failure of reconstruction rather

FIG. 2—Defect following total sternectomy
and removal of costal cartilage.

Technique of muscle reconstruction using bilateral pectoralis and rectus abdominis
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Table 1-Data on 10 Patients With Chronic Sternal Infections
atient
no.

Sex
M
F
M
M
M
M
M
M

9
10

65
71

M
M

'

2
3
4
5
6
7
8

62
66
71
29
68
57
63
66

1

Operation
CABG, MV
CABG
CABG
(Trauma)
CABG
CABG
CABG
CABG

Organism

Enterobacter aerogenes
Diphtheroids
__
—

Enterobacter
Klebsiella sp
Staphylococcus epidermidis
S. epidermidis

CABG
Staphylococcus aureus
CABG
Diphtheroids
CABG - coronary artery bypass grafting, MV - mitral valve replacement.
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Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral
Bilateral

Procedure
pectoralis, bilateral rectus
pectoralis
pectoralis, right rectus
pectoralis, right rectus
pectoralis, left rectus
pectorallis, left rectus
pectoralis, right rectus
pectoralis, right rectus

Bilateral pectoralis, right rectus
Bilateral pectoralis, right rectus

_________Outcome
Recurrence of infection
Healed without complication
Healed without complication
Healed without complication
Hematoma, healed
Died 2 d postop
Healed without complication
Healed without complication,
pulmonary embolism
Healed without complication
Healed without complication
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than inadequate debridement, as at re
exploration 48 hours after his initial
reconstructive procedure the rectus mus
cle and one pectoralis muscle were found
to be necrotic. The defect had been recon
structed with the pectoralis turnover mus
cle flaps, and although the rectus
abdominis muscle had been used in the
described fashion, the superior epigastric
vessels could not be identified. This aspect
will be discussed further.
Discussion
When debridement, rewiring and
wound irrigation of the sternum fail to
heal an infected median sternotomy
wound or when chronic osteomyelitis has
developed, complete debridement of all
infected tissue followed by reconstruction
is the treatment of choice. New recon
structive techniques using wellvascularized soft tissue in the form of
muscle have given us the means to carry
this out. Healthy tissue with a new blood
supply is brought into the contaminated
field and this has resulted in decreased
morbidity and mortality.4 It is important
that the muscles used for this be reliable.
Based on our laboratory and clinical
experience, we have improved the use of
the muscles normally used for the recon
struction.
The blood supply to the pectoralis
major muscle is from the intercostal per
forators of the internal mammary, the
lateral pectoral and the thoracoacromial
vessels. The pectoralis major muscle,
based on the thoracoacromial vessel, is
reliable, but the turnover flap of this

FIG. 4—Healed sternal wound 2 weeks after
reconstruction.

muscle, based on the internal mammary
vessels, is less so for several reasons. The
internal mammary vessels may have been
divided at the previous surgery. If still
intact, the perforators to the pectoralis
major muscle have often been interrupted
during the debridement. These factors
account for the one treatment failure.
Unfortunately, in this same patient the
rectus abdominis muscle also failed
because of an inadequate blood supply.
The blood supply to the rectus
abdominis muscle is from the superior
epigastric vessels (terminal branches of
the internal mammary), intercostal arter
ies and the inferior epigastric system.
Anatomically, the superior epigastric ves
sels vary as to their size and distri
bution.9
We have verified this in our anatom i
cal dissections. In addition, they may also
be interrupted at the previous surgery. We
therefore perform selective angiography
of the internal mammary superior epigas
tric vessels to verify their patency preoperatively. Complete interruption o f the
internal mammary vessel on one side was
identified preoperatively in two patients,
so we used the normal side at surgery.
Further, based on our clinical findings of
bleeding at the end of the muscle, the
supraumbilical portion is in our opinion
the most reliable, especially when multi
ple transverse fibrous bands are present
in the muscle and the longitudinal vessels
appear attenuated. With these modifica
tions we have not had any further
problems related to the rectus abdominis
muscle flap.
Muscle has been used to cover many
different contaminated wounds. Uncom
plicated healing following removal of all
infected material and primary reconstruc
tion has become common.10 The benefit
and reliability of muscle flaps in this sit
uation has also been demonstrated
experimentally.11
In most of these patients, the entire
sternum was infected so that total
removal was necessary, making sternal
approximation impossible. Although
some stabilization of the chest following
removal of the sternum would be
expected to be necessary, this has not been
the case. After a short period of postoper
ative ventilation, patients had few
problems with respiratory function. It is
likely that the soft tissues are fixed to the
surrounding structures, preventing
respiratory paradox. The use of foreign
material or autogenous bone to improve
chest contour is contraindicated.
Eight of our patients were gravely ill
at the time of operation and often had
serious associated diseases, such as
chronic lung disease, congestive heart
failure, diabetes mellitus and obesity,
which increased their difficulties. We
believed that debridement and reconstruc
tion in one stage would be the best

approach and this was indeed the case.
Convalescence was usually rapid. Care
ful attention to nutritional status led to
an early discharge.
We concluded that the sternal portion
of the pectoralis major muscle, based on
the thoracoacromial vessels, is reliable
and may suffice for the reconstruction.
Preservation of the clavicular portion
retains some pectoralis function if divi
sion of the insertion is required. The
supraumbilical portion of the rectus
abdominis muscle, based on the superior
epigastric vessels, is useful for lower ster
nal defects but the viability of its vascu
lar pedicle must be verified as this can be
compromised by previous surgery. When
used in the described fashion, these mus
cles will provide all the requirements for
reconstruction, allowing primary repair
of the chronic sternal wound when
required and facilitating a rapid convales
cence.
References
1. Bryant LR, Spe n c e r FC, T rink le JK: Treatment of
median sternotomy infection by mediastinal irrigation
with an antibiotic solution. Ann Surg 1969; 169: 914-20

2. CULLIFORD AT, CUNNINGHAM JN JR, ZEFF RH, ISOM
OW, TEIKO P, SPENCER FC: Sternal and costochondral
infections following open-heart surgery. A review of 2,594
cases. J Thorac Cardiovasc Surg 1976; 72: 714-26

3. Serry C, Bleck PC, J a v id H, H u n ter JA , G oldin
MD, DELARIA GA, N a ja fi H: Sternal wound compli
cations. Management and results. J Thorac Cardiovasc
Surg 1980; 80: 861-7

4. JURKIEWICZ MJ, BOSTWICK J III, HESTER TR, BISHOP
JB, CRAVER J: Infected median sternotomy wound. Suc
cessful1treatment by muscle flaps. A n n Surg 1980; 191:
738-44

5. N ahai F, Mora les L j r , Bo n e DK, Bostw ick J in:
Pectoralis major muscle turnover flaps for closure of the
infected sternotomy wound with preservation o f form and
function. Plast Reconstr Surg 1982; 70: 471-4

6.

NEALE HW, KREILEIN JG , SCHRE1BER JT , GREGORY
RO: Complete sternectomy for chronic osteomyelitis with
reconstruction using a rectus abdominis musculocutane
ous island flap. A n n Plast Surg 1981; 6: 305-14

7.

HERRERA HR, GlNSBURG ME: The pectoralis major
myocutaneous flap and omental transposition for closure
of infected median sternotomy wounds. Plast Reconstr
Surg 1982; 70: 465-70

8.

PAIROLERO PC, ARNOLD PG: Management o f recal
citrant median sternotomy wounds. J Thorac Cardiovasc
Surg 1984; 88: 357-64

9.

MlLLOY FJ, ANSON BJ, MCAFEE DK: The rectus
abdominis muscle and the epigastric arteries. Surg
Gynecol Obstet 1960; 111: 293-302

10.

M athes SJ, F eng LJ, h u n t TK: Coverage o f the
infected wound. A nn Surg 1983; 198: 420-9

11.

Ma thes SJ, A l per t BS, C ha ng N: Use o f the muscle
flap in chronic osteomyelitis: experimental and clinical
correlation. Plast Reconstr Surg 1982; 69: 815-29

VOLUME 28, NO. 5, SEPTEMBER 1985 / THE CANADIAN JOURNAL OF SURGERY

455

OUR SURGICAL HERITAGE
M arcel J. R heault ,

m d , frcsc , facs *

Pierre Masson: His Influence on the Teaching
of Pathology in Canada
Pierre Masson, William Boyd, Louis
Berger and Lyman Duff: these four men
were responsible for the development of
pathology in Canada during the first half
of this century. Their influence is still
important and there must be few depart
ments of pathology in this country that
do not have one or more pathologists on
their staff trained by one of these physi
cians. They are truly the cornerstone of
pathology in Canada. My paper concerns
one of these men: Pierre Masson.
Masson was born on Nov. 12, 1880 in
Dijon, France, in the middle of the rich
vineyards of Gevrey-Chambertin. His
family was one of prominent jurists and
lawyers. After obtaining a licence in
general chemistry and natural sciences
from the science faculty of Dijon, Mas
son moved to Paris and became chief of
laboratory at Lariboisiere Hospital. In
1909, he graduated from the Faculty of
Medicine, University of Paris.
From 1909 to 1919, he worked at the
Pasteur Institute in Paris in the labora
tory of Amedee Borrel, a microbiologist.
In 1911, he became chief of laboratory
at La Salpetriere, being under the direc
tion of Pierre Gosset, the chief of surgery.
Pierre Masson was preparing his unique
career in the field of pathology. Using his
knowledge of the chemistry of dyes, he
developed the personal techniques of
staining that were to make him world
renowned. On Aug. 5, 1911, he reported
his first discovery: by adding saffron to
hematoxylin and eosin as a third dye in

the routine colorations, M asson’s
trichrome stain was born.1
Masson always processed his own
specimens, cutting and staining, dissect
ing each cell under the microscope and
making many new observations. In 1913,
when he introduced his silver impregna
tion method for melanin using Fontana’s
solution, he discovered the argentaffin
reaction.2 This led to the discovery of
the argentaffinity of enterochromaffin
cells: the argentaffin cells. In 1914, he
described the carcinoid cells of the appen
dix and the carcinoids. During the same
year, too early for his era, he noted the
existence of a diffuse endocrine gland sys
tem in the intestine. This concept was
extended to other regions 24 years later
by the Austrian pathologist Feyrter and
half a century later, in 1969, by the Brit
ish histochemist Pearse, when he pro
claimed the existence of the APUD cell
system. The original presentation of this
discovery was given at the Academy of
Sciences in Paris on Jan. 5, 1914, under
the title “ The intestinal endocrine gland
in man” .3
In 1914, the first world war interrupted
his work. He became an army physician,
was captured by the enemy and sent to

Presented at the meeting o f the Central
Surgical Association, Montreal, PQ, Mar.
14, 1985
*Professor, Department o f Surgery, HotelDieu de Montreal, Universite de Montreal,
Montreal, PQ
Accepted fo r publication Apr. 29, 1985
Reprint requests to: Dr. Marcel J. Rheault,
Hotel-Dieu de Montreal, 3840 St-Urbain,
Montreal, PQ H 2W 1T8
456

FIG. 1—Pierre Masson (1880-1959).

Germany as a prisoner of war. After his
release, he was assigned to the military
hospital in Dijon and later to a military
research unit near Reims. There, with
Rene Leriche, he conducted studies on the
natural history of scarring of war
wounds.
Strasbourg Period
With the ending of the war in 1918, the
provinces of Alsace and Lorraine were
returned to France. From 1870 to 1918,
the University of Strasbourg had been led
by many illustrious German professors
such as Chiari, Monckeberg, Lobstein
and von Recklinghausen. The French
government, when it repossessed the
university, wanted to continue its excel
lent academic reputation, albeit with a
French touch. From all over France, the
most promising physicians were chosen to
fill the vacancies left by the departure of
the Germans.
Masson’s reputation was so great that
in spite of his lack of a formal academic
title, he was named chairman of the
Department of Pathology and chief of the
Institute of Anatomy and Pathology of
Strasbourg. He was then only 37 years
old, by European standards very young
for such an important post.
From 1919 to 1927, he published 38
original works mainly on neuromas, car
cinoids of the appendix, glomus tumours
and neuronevi. In 1923, he published the
first edition of his original work:
“Tumeurs” — diagnostiques histologiques”.4 Masson’s reputation spread
and from various parts of the world,
gifted students came to learn directly
from the master the basic principles of
pathology and his personal staining and
processing techniques. Among those who
came to work with him were Orban from
Brussels, Sotero del Rio from Santiago,
Chile, Prodanoff who later became direc
tor of the Institute of Pathology of Bul
garia, Famagalli from Florence, Shtull
from Prague and Nicaud from Lausanne.
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A few Canadian physicians went there to
complete their training: Louis-Charles
Simard who became director of the
Cancer Institute of Montreal and J.
Edouard Morin, member of the Royal
Society of Canada and director of the
D epartm ent of P athology at StSacrement Hospital in Quebec. Masson’s
reputation was such that Abraham Flexner from the Rockfeller Foundation
visited the Institute of Anatomy and
Pathology of Strasbourg and asked Mas
son and five of his collaborators to visit
the United States. France added its own
recognition of his greatness; in 1923 he
was created “ Chevalier” of the Legion of
Honour.
Montreal Period

In 1926, the University of Montreal
wanted to reorganize the teaching of
pathology, which until then had been
unstructured and was generously done by
volunteer doctors. The chairmanship of
the department was offered to Pierre
Masson mainly through the influence of
several former students, especially LouisCharles Simard. Why did he accept when
his institute in Strasbourg was doing so
well? Was it a personal mission or were
there any political motives? Masson said
that he received an official mandate from
the French government for 3 years to
organize the teaching of pathology at the
University of Montreal. Thus, at 48 years
of age he became professor and chairman
of the Department of Pathology at the
University of Montreal. He insisted on
being also consulting pathologist at
Notre-Dame, Hotel-Dieu and Ste-Justine
hospitals. Every morning he worked in
each hospital. All the pathologists, resi
dents and students were in direct contact
with him daily. He recruited many faith
ful collaborators such as Louis-Charles
Simard, Joseph Luc Riopelle and others.
From 1927 on, Masson published 53
papers and books. He continued his
studies from Strasbourg, but also worked
in new areas: on tumours of peripheral
nerves, benign mesothelial tumours of
serosal surfaces, cancers of the genital
area of women and testicular tumours.
Finally, he published what was to be his
masterpiece and certainly his greatest con
tribution to pathology: “Les tumeurs
humaines, histologie, diagnostics et tech
niques”.5 Dr. Sidney Kobernick, a
graduate of McGill University, translated
the book with Masson’s permission and
it was published in English in 1970 by the
Wayne State University Press.6
The quality of Masson’s work and
teaching was recognized by many Cana
dian universities. They awarded him a
doctorate honoris causa at the University
of Montreal in 1929, McGill University
in 1940, Laval University in 1957 and
the University of Ottawa in 1958.

Although it may be said that he did not
m aster perfectly the language o f
Shakespeare, he corresponded with
several leading Canadian and American
pathologists: William Boyd, Lyman
Duff, James Ewing, Georges Laidlaw and
Arthur Purdy Stout. In 1948, he was
invited by the New York Academy of
Sciences to speak at a symposium on the
biology of melanomas.
While Masson was the undisputed
leader of the French pathologists in M on
treal, his influence also extended to the
anglophone sector. With one of his great
admirers, F.W. Wiglesworth, professor
of pathology at McGill University and
pathologist in chief to the Montreal Chil
dren’s Hospital, he organized many scien
tific exchanges with Ste-Justine Hospital.
Later, one of Masson’s former students,
Dr. Gilles Tremblay, became professor
and director of the Department of Pathol
ogy at the Royal Victoria Hospital.
Masson died on May 11, 1959, but his
work has been continued by his students,
all of them being admirers of a great
pathologist.
His Legacy

Twenty-five years after his death,
papers and biographies are still being pub
lished to his memory in French and
English medical journals as testimony to
the importance of his work.7-11
To complete this testimony, I will quote
MacDermot from his history of the first
100 years of Canadian medicine.12
One of the most distinguished histopathologists of his time, Professor Masson has
carried international fame with his work on
tumours of the nervous system, along with
many other contributions in pathology; his
histopathological techniques, particularly his
trichrome stain, are familiar in all pathologi
cal laboratories.

I cannot omit that superb statement of
Sidney Kobernick in his introduction of
Masson’s traduction: “ Masson’s ap
proach represents a lost art both in
technique and observation.”
William Boyd, in 1956, speaking at
Lyman Duff’s funeral, said: “ Canadians
do not have the ‘giants’ in medicine.” 13
Looking back 25 years after the death of
Pierre Masson and acknowledging his
enduring influence on pathology, I would
argue with Boyd’s opinion. I have had the
privilege to meet and work with Pierre
Masson who was indeed a giant of
medicine.
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himself as an administrator, clinician,
teacher and researcher, Downs has been
an active member and held offices in
several medical societies and was a
founder of the Canadian Society for Vas
cular Surgery. Known for his expertise in
vascular research, he also served as exter
nal referee for the Medical Research
Council and the Canadian Heart Foun
dation projects.
In recognition of the contribution of
Downs to the Department of Surgery, the
departm ent’s research committee estab
lished the Allan R. Downs Lecture to be
delivered annually during the surgical
research symposium at the University of
Manitoba.

Pan-Pacific Surgical Association — will
be learning about how to manage the vic
tims of trauma and, in their spare time,
will be soaking up the sunshine or sight
seeing in Hawaii.
The meeting, which is the 18th in a
series of congresses, will be held Jan. 11
to 17, 1986. It will feature plenary ses
sions with trauma experts from the
United States, Canada, Japan, Australia
and Korea as well as smaller groups,

Trauma in Hawaii in January:
Surgical Society Beckons
While hundreds of surgeons suffer the
trauma of another Canadian winter, some
of their colleagues — members of the

Chornell: Join us in Hawaii.

focusing on trauma from the point of
view of obstetrics and gynecology, general
surgery, thoracic and cardiovascular sur
gery, plastic surgery, ophthalmology,
orthopedic surgery, otolaryngology, urol
ogy, and neurosurgery as well as
anesthesiology.
The president of the Canadian chapter
of the association, J. Gary Chornell, an
ophthalmologist in Edmonton, is urging
all Canadian surgeons to join the associ
ation in time to attend the upcoming con
gress. The association is committed to
improving medical and surgical care in the
Pacific basin countries and, to this pur
pose, manages an endowment fund that
is used for temporary placement of cer
tificated surgeons in countries requesting
assistance or for continuing education for
surgeons from isolated developing coun
tries in the basin. Currently, the associa
tion numbers about 3000, mostly from
the United States, and Chornell, who also
is vice-president for Canada on the execu
tive of the parent association and, at 42,
is the youngest to have held the job, is
hoping that at least 200 Canadians will
find out what a contradiction in terms
Hawaii and trauma are.
A my C h o u in a r d
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SESAP IV Critique

ITEM 247
The densities and air fluid levels in the pleural space indicate that the patient
has developed a significant empyema. Inflammatory reaction that has reached
this stage of organization cannot be resolved by antibiotics alone. Multiple ad
ditional chest tubes would probably be of little value. Instillation of enzymes
via the chest tube is ineffective, and may contribute to recurrent or continuing
air leak. Instillation of antibiotics into the chest tube would be of value only
in the area served by the tube. If the chest tube is not functioning, antibiotics
would not be distributed throughout the pleural cavity. This patient has several
of the indications for operation. These criteria include multiple air fluid levels,
failure of tube thoracostomy, and a protracted worsening febrile course. The
patient is an ideal candidate for thoracotomy and evacuation of the preural
cavity. Although not decortication in the strict sense, this term has often been
used to describe the procedure. Recovery from the operation is rapid.
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